UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-05251
Fidelity Concord Street Trust
(Exact name of registrant as specified in charter)
245 Summer St., Boston, MA 02210
(Address of principal executive offices) (Zip code)
Cynthia Lo Bessette, Secretary
245 Summer St.
Boston, Massachusetts 02210
(Name and address of agent for service)
Registrant's telephone number, including area code:
617-563-7000
Date of fiscal year end: | November 30 |
Date of reporting period: | May 31, 2021 |
Item 1.
Reports to Stockholders
Fidelity® Nasdaq Composite Index® Fund
Semi-Annual Report
May 31, 2021
Contents
Board Approval of Investment Advisory Contracts and Management Fees | |
To view a fund's proxy voting guidelines and proxy voting record for the 12-month period ended June 30, visit http://www.fidelity.com/proxyvotingresults or visit the Securities and Exchange Commission's (SEC) web site at http://www.sec.gov.
You may also call 1-800-544-8544 to request a free copy of the proxy voting guidelines.
Nasdaq®, OMX®, NASDAQ OMX®, Nasdaq Composite®, and The Nasdaq Stock Market®, Inc. are registered trademarks of The NASDAQ OMXGroup, Inc. (which with its Affiliates are the Corporations) and are licensed for use by Fidelity. The product has not been passed on by the Corporations as to its legality or suitability. The product is not issued, endorsed or sold by the Corporations. The Corporations make no warranties and bear no liability with respect to shares of the product.
Standard & Poor's, S&P and S&P 500 are registered service marks of The McGraw-Hill Companies, Inc. and have been licensed for use by Fidelity Distributors Corporation.
Other third-party marks appearing herein are the property of their respective owners.
All other marks appearing herein are registered or unregistered trademarks or service marks of FMR LLC or an affiliated company. © 2021 FMR LLC. All rights reserved.
This report and the financial statements contained herein are submitted for the general information of the shareholders of the Fund. This report is not authorized for distribution to prospective investors in the Fund unless preceded or accompanied by an effective prospectus.
A fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-PORT. Forms N-PORT are available on the SEC’s web site at http://www.sec.gov. A fund's Forms N-PORT may be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information regarding the operation of the SEC's Public Reference Room may be obtained by calling 1-800-SEC-0330.
For a complete list of a fund's portfolio holdings, view the most recent holdings listing, semiannual report, or annual report on Fidelity's web site at http://www.fidelity.com, http://www.institutional.fidelity.com, or http://www.401k.com, as applicable.
NOT FDIC INSURED •MAY LOSE VALUE •NO BANK GUARANTEE
Neither the Fund nor Fidelity Distributors Corporation is a bank.
Note to Shareholders:
Early in 2020, the outbreak and spread of a new coronavirus emerged as a public health emergency that had a major influence on financial markets, primarily based on its impact on the global economy and the outlook for corporate earnings. The virus causes a respiratory disease known as COVID-19. On March 11, 2020 the World Health Organization declared the COVID-19 outbreak a pandemic, citing sustained risk of further global spread.
In the weeks following, as the crisis worsened, we witnessed an escalating human tragedy with wide-scale social and economic consequences from coronavirus-containment measures. The outbreak of COVID-19 prompted a number of measures to limit the spread, including travel and border restrictions, quarantines, and restrictions on large gatherings. In turn, these resulted in lower consumer activity, diminished demand for a wide range of products and services, disruption in manufacturing and supply chains, and – given the wide variability in outcomes regarding the outbreak – significant market uncertainty and volatility. Amid the turmoil, global governments and central banks took unprecedented action to help support consumers, businesses, and the broader economies, and to limit disruption to financial systems.
The situation continues to unfold, and the extent and duration of its impact on financial markets and the economy remain highly uncertain. Extreme events such as the coronavirus crisis are “exogenous shocks” that can have significant adverse effects on mutual funds and their investments. Although multiple asset classes may be affected by market disruption, the duration and impact may not be the same for all types of assets.
Fidelity is committed to helping you stay informed amid news about COVID-19 and during increased market volatility, and we’re taking extra steps to be responsive to customer needs. We encourage you to visit our websites, where we offer ongoing updates, commentary, and analysis on the markets and our funds.
Investment Summary (Unaudited)
Top Ten Stocks as of May 31, 2021
% of fund's net assets | |
Apple, Inc. | 9.6 |
Microsoft Corp. | 8.6 |
Amazon.com, Inc. | 7.5 |
Facebook, Inc. Class A | 3.6 |
Alphabet, Inc. Class C | 3.6 |
Alphabet, Inc. Class A | 3.3 |
Tesla, Inc. | 2.8 |
NVIDIA Corp. | 1.9 |
PayPal Holdings, Inc. | 1.4 |
Comcast Corp. Class A | 1.2 |
43.5 |
Top Market Sectors as of May 31, 2021
% of fund's net assets | |
Information Technology | 40.4 |
Communication Services | 17.6 |
Consumer Discretionary | 16.3 |
Health Care | 10.1 |
Financials | 4.9 |
Industrials | 4.4 |
Consumer Staples | 3.6 |
Real Estate | 1.0 |
Utilities | 0.7 |
Energy | 0.4 |
Asset Allocation (% of fund's net assets)
As of May 31, 2021* | ||
Stocks and Equity Futures | 100.0% |
* Foreign investments - 5.9%
Schedule of Investments May 31, 2021 (Unaudited)
Showing Percentage of Net Assets
Common Stocks - 99.8% | |||
Shares | Value | ||
COMMUNICATION SERVICES - 17.6% | |||
Diversified Telecommunication Services - 0.2% | |||
Alaska Communication Systems Group, Inc. | 34,501 | $114,543 | |
Anterix, Inc. (a) | 9,410 | 465,419 | |
AST SpaceMobile, Inc. (a)(b) | 25,713 | 185,648 | |
ATN International, Inc. | 7,220 | 341,289 | |
Bandwidth, Inc. (a) | 12,478 | 1,476,023 | |
Cogent Communications Group, Inc. | 25,499 | 1,927,724 | |
Consolidated Communications Holdings, Inc. (a) | 35,218 | 329,640 | |
Cuentas, Inc. (a) | 6,700 | 15,075 | |
Iridium Communications, Inc. (a) | 76,355 | 2,917,525 | |
Liberty Global PLC: | |||
Class A (a) | 112,326 | 3,067,623 | |
Class B (a) | 327 | 9,172 | |
Class C (a) | 207,371 | 5,644,639 | |
Liberty Latin America Ltd.: | |||
Class A (a) | 17,405 | 248,369 | |
Class C (a) | 105,781 | 1,521,131 | |
ORBCOMM, Inc. (a) | 53,636 | 600,187 | |
Radius Global Infrastructure, Inc. (a) | 37,222 | 595,552 | |
Sify Technologies Ltd. sponsored ADR (a)(b) | 10,869 | 34,998 | |
Vonage Holdings Corp. (a) | 142,421 | 1,962,561 | |
21,457,118 | |||
Entertainment - 2.2% | |||
Activision Blizzard, Inc. | 430,360 | 41,852,510 | |
Bilibili, Inc. ADR (a)(b) | 110,239 | 11,815,416 | |
Blue Hat Interactive Entertainment Technology (a)(b) | 13,117 | 10,886 | |
Chicken Soup For The Soul Entertainment, Inc. (a)(b) | 2,911 | 113,500 | |
Cinedigm Corp. (a) | 80,948 | 115,756 | |
CuriosityStream, Inc. Class A (a)(b) | 29,770 | 336,401 | |
Dolphin Entertainment, Inc. (a)(b) | 1,963 | 16,803 | |
DouYu International Holdings Ltd. ADR (a) | 82,330 | 650,407 | |
Electronic Arts, Inc. | 160,763 | 22,977,856 | |
Gaia, Inc. Class A (a)(b) | 13,031 | 151,290 | |
GigaMedia Ltd. (a)(b) | 1,957 | 5,714 | |
Gravity Co. Ltd. ADR (a) | 1,840 | 240,966 | |
iQIYI, Inc. ADR (a) | 204,220 | 2,912,177 | |
Liquid Media Group Ltd. (a)(b) | 1,038 | 1,962 | |
LiveXLive Media, Inc. (a)(b) | 40,255 | 198,860 | |
Lizhi, Inc. ADR (a)(b) | 11,176 | 74,544 | |
Motorsport Games, Inc. Class A | 4,828 | 78,407 | |
NetEase, Inc. ADR | 166,906 | 19,683,225 | |
Netflix, Inc. (a) | 245,026 | 123,201,523 | |
Playtika Holding Corp. | 227,853 | 6,250,008 | |
Reading International, Inc. Class A (a) | 23,664 | 155,236 | |
Roku, Inc. Class A (a) | 61,595 | 21,355,602 | |
Scienjoy Holding Corp. (a)(b) | 14,618 | 119,575 | |
Sciplay Corp. (A Shares) (a)(b) | 15,716 | 271,101 | |
Score Media & Gaming, Inc. (a) | 24,700 | 414,219 | |
Take-Two Interactive Software, Inc. (a) | 64,280 | 11,927,797 | |
The9 Ltd. sponsored ADR (a)(b) | 3,020 | 35,455 | |
Versus Systems, Inc. (a)(b) | 3,758 | 26,456 | |
Warner Music Group Corp. Class A | 60,450 | 2,169,551 | |
Zynga, Inc. (a) | 607,231 | 6,582,384 | |
273,745,587 | |||
Interactive Media & Services - 11.4% | |||
36Kr Holdings, Inc. ADR (a) | 1,078 | 2,781 | |
9F, Inc. ADR (a)(b) | 42,546 | 58,288 | |
Alphabet, Inc.: | |||
Class A (a) | 166,179 | 391,658,976 | |
Class C (a) | 181,326 | 437,278,529 | |
ANGI Homeservices, Inc. Class A (a) | 41,962 | 595,021 | |
Autoweb, Inc. (a)(b) | 8,678 | 24,819 | |
Baidu.com, Inc. sponsored ADR (a) | 150,395 | 29,518,027 | |
BlueCity Holdings Ltd. ADR (a)(b) | 6,509 | 45,823 | |
Bumble, Inc. | 64,323 | 3,069,494 | |
CarGurus, Inc. Class A (a) | 54,093 | 1,526,504 | |
Enthusiast Gaming Holdings, Inc. (a)(b) | 27,099 | 187,525 | |
EverQuote, Inc. Class A (a) | 11,861 | 373,977 | |
Facebook, Inc. Class A (a) | 1,330,502 | 437,375,922 | |
Fangdd Network Group Ltd. ADR (a) | 11,938 | 37,247 | |
Glory Star New Media Group Holdings Ltd. (a)(b) | 31,038 | 111,116 | |
IAC (a) | 46,263 | 7,377,561 | |
Izea Worldwide, Inc. (a) | 31,302 | 87,020 | |
JOYY, Inc. ADR | 31,222 | 2,402,533 | |
Kubient, Inc. | 6,524 | 33,860 | |
Liberty TripAdvisor Holdings, Inc. (a) | 44,349 | 211,101 | |
Match Group, Inc. (a) | 149,317 | 21,409,071 | |
Momo, Inc. ADR | 89,497 | 1,255,643 | |
Professional Diversity Network, Inc. (a)(b) | 1,922 | 2,729 | |
QuinStreet, Inc. (a) | 27,593 | 499,709 | |
Qutoutiao, Inc. ADR (a)(b) | 66,007 | 142,575 | |
So-Young International, Inc. ADR (a)(b) | 33,998 | 333,180 | |
Sohu.Com Ltd. ADR (a) | 24,154 | 425,835 | |
Super League Gaming, Inc. (a) | 10,938 | 49,987 | |
Travelzoo, Inc. (a) | 6,862 | 114,184 | |
TripAdvisor, Inc. (a) | 67,405 | 2,928,747 | |
Trivago NV ADR (a)(b) | 43,707 | 173,080 | |
TrueCar, Inc. (a) | 56,073 | 331,391 | |
Vimeo, Inc. (a) | 75,107 | 3,154,494 | |
Weibo Corp. sponsored ADR (a) | 41,806 | 2,125,417 | |
Yandex NV Series A (a)(b) | 177,987 | 12,021,242 | |
Zillow Group, Inc.: | |||
Class A (a) | 35,240 | 4,168,540 | |
Class C (a)(b) | 95,171 | 11,165,462 | |
Zoominfo Technologies, Inc. | 56,499 | 2,476,351 | |
1,374,753,761 | |||
Media - 2.9% | |||
Advantage Solutions, Inc. Class A (a) | 177,154 | 2,232,140 | |
AirNet Technology, Inc. ADR (a)(b) | 5,468 | 17,498 | |
AMC Networks, Inc. Class A (a)(b) | 15,873 | 852,063 | |
AppLovin Corp. (a)(b) | 116,984 | 8,693,081 | |
Baosheng Media Group Holding Ltd. (b) | 9,967 | 27,011 | |
Beasley Broadcast Group, Inc. Class A (a) | 286,682 | 791,242 | |
Boston Omaha Corp. (a) | 14,140 | 433,532 | |
Cardlytics, Inc. (a) | 17,246 | 1,837,561 | |
Charter Communications, Inc. Class A (a) | 107,263 | 74,497,371 | |
Comcast Corp. Class A | 2,526,885 | 144,891,586 | |
comScore, Inc. (a) | 34,018 | 136,072 | |
Criteo SA sponsored ADR (a) | 32,862 | 1,223,781 | |
Cumulus Media, Inc. (a) | 11,565 | 126,984 | |
Daily Journal Corp. (a) | 1,146 | 366,147 | |
Discovery Communications, Inc.: | |||
Class A (a)(b) | 97,609 | 3,134,225 | |
Class B (a)(b) | 338 | 23,626 | |
Class C (non-vtg.) (a) | 174,356 | 5,239,398 | |
DISH Network Corp. Class A (a) | 158,925 | 6,916,416 | |
E.W. Scripps Co. Class A | 39,165 | 830,690 | |
Fluent, Inc. (a) | 46,702 | 134,969 | |
Fox Corp.: | |||
Class A | 195,524 | 7,302,821 | |
Class B | 131,955 | 4,787,327 | |
Hemisphere Media Group, Inc. (a) | 12,950 | 160,192 | |
iClick Interactive Asia Group Ltd. (A Shares) ADR (a)(b) | 35,410 | 402,612 | |
iHeartMedia, Inc. (a) | 59,410 | 1,378,906 | |
Insignia Systems, Inc. (a)(b) | 1,817 | 13,155 | |
Lee Enterprises, Inc. (a)(b) | 2,126 | 61,888 | |
Liberty Broadband Corp.: | |||
Class A (a) | 16,672 | 2,701,864 | |
Class C (a) | 91,286 | 15,179,949 | |
Liberty Media Corp.: | |||
Liberty Braves Class A (a) | 14,692 | 410,201 | |
Liberty Braves Class C (a) | 16,512 | 451,603 | |
Liberty Formula One Group Series C (a) | 111,860 | 4,994,549 | |
Liberty Media Class A (a) | 14,368 | 575,295 | |
Liberty SiriusXM Series A (a) | 60,111 | 2,624,446 | |
Liberty SiriusXM Series C (a) | 127,389 | 5,542,695 | |
Loral Space & Communications Ltd. | 10,892 | 412,262 | |
Magnite, Inc. (a) | 63,953 | 1,899,404 | |
Marchex, Inc. Class B (a) | 34,542 | 88,082 | |
MDC Partners, Inc. Class A (a) | 47,873 | 223,088 | |
Mediaco Holding, Inc. (a) | 911 | 2,760 | |
National CineMedia, Inc. | 42,414 | 205,284 | |
News Corp.: | |||
Class A | 214,018 | 5,776,346 | |
Class B | 111,410 | 2,862,123 | |
Nexstar Broadcasting Group, Inc. Class A | 24,021 | 3,649,030 | |
Perion Network Ltd. (a) | 18,565 | 307,065 | |
Salem Communications Corp. Class A (a) | 18,198 | 36,578 | |
Scholastic Corp. | 14,533 | 489,471 | |
Sinclair Broadcast Group, Inc. Class A (b) | 30,876 | 1,040,212 | |
Sirius XM Holdings, Inc. (b) | 2,305,455 | 14,409,094 | |
SRAX, Inc. (a) | 4,853 | 24,022 | |
TechTarget, Inc. (a) | 16,622 | 1,168,693 | |
Thryv Holdings, Inc. (a) | 17,809 | 516,461 | |
Troika Media Group, Inc. (a)(b) | 13,068 | 34,107 | |
TuanChe Ltd. ADR (A Shares) (a) | 5,969 | 18,623 | |
Urban One, Inc.: | |||
Class A (a)(b) | 4,568 | 33,575 | |
Class D (non-vtg.) (a) | 21,932 | 105,274 | |
ViacomCBS, Inc.: | |||
Class A | 25,071 | 1,166,804 | |
Class B | 311,783 | 13,225,835 | |
WiMi Hologram Cloud, Inc. ADR (a)(b) | 26,959 | 143,152 | |
ZW Data Action Technologies, Inc. (a) | 7,173 | 12,696 | |
346,842,937 | |||
Wireless Telecommunication Services - 0.9% | |||
Boingo Wireless, Inc. (a) | 33,020 | 461,620 | |
Frontier Communications Parent, Inc. (a) | 128,100 | 3,199,938 | |
Gogo, Inc. (a)(b) | 49,687 | 676,737 | |
Millicom International Cellular SA (a) | 56,253 | 2,514,509 | |
NII Holdings, Inc. (a)(c) | 5,182 | 11,245 | |
Partner Communications Co. Ltd. ADR (a) | 3,584 | 16,881 | |
Shenandoah Telecommunications Co. | 29,094 | 1,451,500 | |
Spok Holdings, Inc. | 21,855 | 255,048 | |
T-Mobile U.S., Inc. | 688,566 | 97,397,661 | |
uCloudlink Group, Inc. ADR (b) | 867 | 10,352 | |
VEON Ltd. sponsored ADR (a)(b) | 955,565 | 1,739,128 | |
Vodafone Group PLC sponsored ADR | 207,213 | 3,827,224 | |
111,561,843 | |||
TOTAL COMMUNICATION SERVICES | 2,128,361,246 | ||
CONSUMER DISCRETIONARY - 16.3% | |||
Auto Components - 0.2% | |||
China Automotive Systems, Inc. (a)(b) | 19,314 | 80,926 | |
China XD Plastics Co. Ltd. (a)(b) | 32,740 | 20,921 | |
Dorman Products, Inc. (a) | 17,959 | 1,838,642 | |
Foresight Autonomous Holdings Ltd. ADR (a) | 22,345 | 95,860 | |
Fox Factory Holding Corp. (a) | 23,255 | 3,615,687 | |
Gentex Corp. | 137,295 | 4,873,973 | |
Gentherm, Inc. (a) | 17,553 | 1,273,119 | |
Kandi Technolgies, Inc. (a)(b) | 39,238 | 213,455 | |
Luminar Technologies, Inc. (a)(b) | 132,157 | 2,710,540 | |
Motorcar Parts of America, Inc. (a) | 12,691 | 296,589 | |
Patrick Industries, Inc. | 13,038 | 1,117,357 | |
Strattec Security Corp. (a) | 1,858 | 93,272 | |
Sypris Solutions, Inc. (a) | 6,622 | 21,786 | |
The Goodyear Tire & Rubber Co. (a) | 127,662 | 2,531,537 | |
Visteon Corp. (a) | 15,401 | 1,886,006 | |
XPEL, Inc. (a) | 16,220 | 1,330,040 | |
21,999,710 | |||
Automobiles - 2.9% | |||
Arcimoto, Inc. (a)(b) | 23,426 | 228,404 | |
Arrival Group (a)(b) | 340,277 | 6,529,916 | |
AYRO, Inc. (a)(b) | 18,733 | 91,604 | |
Canoo, Inc. (a)(b) | 134,890 | 1,068,329 | |
ElectraMeccanica Vehicles Corp. (a)(b) | 60,611 | 227,291 | |
Li Auto, Inc. ADR (a)(b) | 92,236 | 2,149,099 | |
Lordstown Motors Corp. (a)(b) | 96,741 | 957,736 | |
Niu Technologies ADR (a)(b) | 21,921 | 730,408 | |
Tesla, Inc. (a) | 530,976 | 331,976,815 | |
Workhorse Group, Inc. (a)(b) | 69,202 | 648,423 | |
344,608,025 | |||
Distributors - 0.2% | |||
Core-Mark Holding Co., Inc. | 24,611 | 1,128,660 | |
Educational Development Corp. | 7,081 | 101,966 | |
Funko, Inc. (a) | 21,098 | 553,823 | |
LKQ Corp. (a) | 164,269 | 8,371,148 | |
Pool Corp. | 22,204 | 9,693,156 | |
Weyco Group, Inc. | 6,799 | 139,923 | |
19,988,676 | |||
Diversified Consumer Services - 0.1% | |||
17 Education & Technology Group, Inc. ADR (b) | 16,514 | 80,258 | |
Afya Ltd. (a) | 26,135 | 611,820 | |
American Public Education, Inc. (a) | 10,578 | 296,184 | |
Amesite, Inc. (b) | 4,562 | 10,858 | |
Arco Platform Ltd. Class A (a)(b) | 16,917 | 491,608 | |
Aspen Group, Inc./Co. (a)(b) | 13,497 | 78,553 | |
ATA Creativity Global ADR (a) | 852 | 2,539 | |
Elite Education Group International Ltd. (a) | 1,797 | 8,644 | |
Frontdoor, Inc. (a) | 47,662 | 2,559,449 | |
Grand Canyon Education, Inc. (a) | 26,726 | 2,430,462 | |
Hailiang Education Group, Inc. ADR (a) | 2,666 | 108,186 | |
Houghton Mifflin Harcourt Co. (a) | 73,089 | 726,505 | |
Laureate Education, Inc. Class A (a) | 65,299 | 954,018 | |
Lincoln Educational Services Corp. (a) | 18,674 | 144,724 | |
Meten EdtechX Education Group Ltd. (a)(b) | 24,844 | 23,940 | |
OneSpaWorld Holdings Ltd. (b) | 36,193 | 405,724 | |
Perdoceo Education Corp. (a) | 34,522 | 420,823 | |
RISE Education Cayman Ltd. ADR (a)(b) | 9,767 | 34,087 | |
Select Interior Concepts, Inc. (a) | 10,751 | 120,196 | |
Strategic Education, Inc. | 13,286 | 941,180 | |
Tarena International, Inc. ADR (a) | 24,820 | 90,593 | |
Vasta Platform Ltd. (a)(b) | 15,730 | 138,267 | |
Vitru Ltd. (a)(b) | 11,520 | 171,648 | |
WW International, Inc. (a) | 37,856 | 1,487,741 | |
Xpresspa Group, Inc. (a)(b) | 47,091 | 65,456 | |
Zovio, Inc. (a) | 16,099 | 37,833 | |
12,441,296 | |||
Hotels, Restaurants & Leisure - 2.2% | |||
Airbnb, Inc. Class A | 106,576 | 14,963,270 | |
Allied Esports Entertainment, Inc. (a)(b) | 17,647 | 40,941 | |
BBQ Holdings, Inc. (a) | 3,815 | 51,083 | |
BJ's Restaurants, Inc. (a) | 13,822 | 764,080 | |
Bloomin' Brands, Inc. (a) | 47,883 | 1,414,943 | |
BurgerFi International, Inc. (a)(b) | 4,365 | 46,138 | |
Caesars Entertainment, Inc. (a) | 115,094 | 12,366,850 | |
Carrols Restaurant Group, Inc. (a) | 18,564 | 109,713 | |
Century Casinos, Inc. (a) | 13,204 | 184,724 | |
Churchill Downs, Inc. | 21,193 | 4,228,639 | |
Chuy's Holdings, Inc. (a) | 9,648 | 399,910 | |
Cracker Barrel Old Country Store, Inc. | 13,041 | 2,056,827 | |
Dave & Buster's Entertainment, Inc. (a) | 26,022 | 1,100,210 | |
Del Taco Restaurants, Inc. | 26,399 | 268,214 | |
Denny's Corp. (a) | 38,087 | 669,569 | |
DraftKings, Inc. Class A (a)(b) | 220,744 | 11,026,163 | |
El Pollo Loco Holdings, Inc. (a) | 18,467 | 311,354 | |
Elys Game Technology Corp. (b) | 9,181 | 46,364 | |
Esports Entertainment Group, Inc. (a)(b) | 9,215 | 105,235 | |
Esports Technologies, Inc. (a)(b) | 6,743 | 150,301 | |
Expedia, Inc. (a) | 77,117 | 13,645,853 | |
Extended Stay America, Inc. unit | 95,783 | 1,887,883 | |
FAT Brands, Inc. (b) | 4,334 | 43,990 | |
Fiesta Restaurant Group, Inc. (a) | 12,322 | 167,456 | |
Full House Resorts, Inc. (a) | 12,432 | 139,984 | |
GAN Ltd. (b) | 21,916 | 379,147 | |
Golden Entertainment, Inc. (a) | 16,184 | 690,086 | |
Golden Nugget Online Gaming, Inc. (a) | 30,268 | 398,327 | |
Good Times Restaurants, Inc. (a) | 9,092 | 38,459 | |
Hall of Fame Resort & Entertainment Co. (a)(b) | 57,261 | 209,003 | |
Huazhu Group Ltd. ADR (a) | 84,738 | 4,844,471 | |
Inspired Entertainment, Inc. (a)(b) | 15,862 | 181,779 | |
Jack in the Box, Inc. | 12,571 | 1,428,066 | |
Kura Sushi U.S.A., Inc. Class A (a)(b) | 4,116 | 176,906 | |
Lindblad Expeditions Holdings (a) | 29,723 | 505,885 | |
MakeMyTrip Ltd. (a) | 37,977 | 1,044,368 | |
Marriott International, Inc. Class A (a) | 179,112 | 25,716,901 | |
Melco Crown Entertainment Ltd. sponsored ADR (a) | 120,068 | 2,063,969 | |
Monaker Group, Inc. (a) | 4,554 | 11,385 | |
Monarch Casino & Resort, Inc. (a) | 10,263 | 732,368 | |
Muscle Maker, Inc. (a)(b) | 92,471 | 119,288 | |
Nathan's Famous, Inc. | 3,678 | 237,488 | |
NeoGames SA | 14,676 | 940,732 | |
Noodles & Co. (a) | 27,889 | 359,210 | |
Papa John's International, Inc. | 18,186 | 1,708,575 | |
Penn National Gaming, Inc. (a) | 86,489 | 7,089,503 | |
Playa Hotels & Resorts NV (a) | 84,615 | 618,536 | |
Potbelly Corp. (a) | 12,369 | 85,222 | |
Rave Restaurant Group, Inc. (a)(b) | 5,714 | 8,514 | |
RCI Hospitality Holdings, Inc. | 5,507 | 426,793 | |
Red Robin Gourmet Burgers, Inc. (a) | 10,497 | 376,422 | |
Red Rock Resorts, Inc. (a) | 40,224 | 1,800,024 | |
Ruth's Hospitality Group, Inc. (a) | 22,375 | 540,133 | |
Scientific Games Corp. Class A (a) | 52,401 | 3,801,169 | |
Starbucks Corp. | 651,344 | 74,175,055 | |
Target Hospitality Corp. (a) | 58,530 | 225,341 | |
Texas Roadhouse, Inc. Class A | 38,296 | 3,856,790 | |
The Booking Holdings, Inc. (a) | 22,649 | 53,486,746 | |
The Cheesecake Factory, Inc. (a) | 25,493 | 1,499,498 | |
The ONE Group Hospitality, Inc. (a) | 13,247 | 142,008 | |
Tuniu Corp. Class A sponsored ADR (a)(b) | 16,132 | 41,621 | |
Wendy's Co. | 121,893 | 2,830,355 | |
Wingstop, Inc. | 16,370 | 2,335,672 | |
Wynn Resorts Ltd. (a) | 64,337 | 8,484,120 | |
269,799,629 | |||
Household Durables - 0.3% | |||
Aterian, Inc. (a)(b) | 16,374 | 293,913 | |
Bassett Furniture Industries, Inc. | 4,416 | 133,761 | |
Cavco Industries, Inc. (a) | 5,108 | 1,130,247 | |
Dixie Group, Inc. (a) | 3,321 | 9,299 | |
Dream Finders Homes, Inc. (b) | 17,179 | 545,777 | |
Flexsteel Industries, Inc. | 3,070 | 142,694 | |
Garmin Ltd. | 105,842 | 15,054,966 | |
GoPro, Inc. Class A (a) | 70,308 | 788,856 | |
Green Brick Partners, Inc. (a) | 28,580 | 667,057 | |
Helen of Troy Ltd. (a) | 13,721 | 2,887,996 | |
Hooker Furniture Corp. | 6,220 | 222,987 | |
iRobot Corp. (a)(b) | 15,616 | 1,525,683 | |
Koss Corp. (a)(b) | 3,692 | 85,174 | |
Landsea Homes Corp. (a) | 25,608 | 230,728 | |
Legacy Housing Corp. (a) | 10,995 | 209,345 | |
LGI Homes, Inc. (a) | 13,970 | 2,525,916 | |
Lifetime Brands, Inc. | 13,509 | 202,635 | |
Live Ventures, Inc. (a) | 1,095 | 59,338 | |
Lovesac (a)(b) | 7,926 | 658,017 | |
Nephros, Inc. (a) | 896 | 7,840 | |
Newell Brands, Inc. | 233,512 | 6,699,459 | |
Nova LifeStyle, Inc. (a) | 1,669 | 4,990 | |
Purple Innovation, Inc. (a)(b) | 36,365 | 1,037,130 | |
Sonos, Inc. (a) | 66,509 | 2,460,833 | |
Turtle Beach Corp. (a) | 8,432 | 279,099 | |
Universal Electronics, Inc. (a) | 7,167 | 358,780 | |
Viomi Technology Co. Ltd. ADR Class A (a)(b) | 21,467 | 174,956 | |
VOXX International Corp. (a) | 13,480 | 202,739 | |
Vuzix Corp. (a)(b) | 31,880 | 556,625 | |
ZAGG, Inc. rights (a)(c) | 14,972 | 1,347 | |
39,158,187 | |||
Internet & Direct Marketing Retail - 8.8% | |||
1-800-FLOWERS.com, Inc. Class A (a)(b) | 21,092 | 642,673 | |
Amazon.com, Inc. (a) | 278,522 | 897,695,903 | |
Baozun, Inc. sponsored ADR (a)(b) | 30,699 | 1,064,948 | |
Betterware de Mexico SAPI de CV | 19,006 | 825,431 | |
CarParts.com, Inc. (a)(b) | 26,339 | 430,379 | |
ContextLogic, Inc. (b) | 281,208 | 2,232,792 | |
Dada Nexus Ltd. ADR | 42,689 | 1,072,775 | |
Duluth Holdings, Inc. (a)(b) | 13,890 | 223,629 | |
eBay, Inc. | 378,665 | 23,053,125 | |
ECMOHO Ltd. ADR (a)(b) | 46,854 | 82,932 | |
Etsy, Inc. (a) | 70,145 | 11,554,986 | |
Future FinTech Group, Inc. (a)(b) | 31,219 | 96,155 | |
Global-e Online Ltd. (a) | 75,300 | 2,474,358 | |
Groupon, Inc. (a) | 15,919 | 752,173 | |
iMedia Brands, Inc. (a)(b) | 9,667 | 95,703 | |
JD.com, Inc. sponsored ADR (a) | 460,173 | 34,025,192 | |
Lands' End, Inc. (a) | 18,511 | 474,067 | |
Liquidity Services, Inc. (a) | 20,910 | 499,958 | |
MercadoLibre, Inc. (a) | 27,658 | 37,578,095 | |
Molecular Data, Inc. ADR (a)(b) | 16,490 | 13,274 | |
Moxian, Inc. (a)(b) | 7,230 | 76,638 | |
Oriental Culture Holding Ltd. (a)(b) | 8,674 | 41,462 | |
Overstock.com, Inc. (a)(b) | 23,484 | 2,006,238 | |
Ozon Holdings PLC ADR (b) | 23,716 | 1,258,608 | |
PetMed Express, Inc. (b) | 11,354 | 328,131 | |
Pinduoduo, Inc. ADR (a) | 191,211 | 23,878,430 | |
Points International Ltd. (a) | 12,126 | 213,054 | |
Porch Group, Inc. Class A (a) | 46,943 | 803,664 | |
Poshmark, Inc. (b) | 5,613 | 261,005 | |
PubMatic, Inc. (b) | 3,537 | 104,589 | |
Qurate Retail, Inc. | 1,734 | 25,871 | |
Qurate Retail, Inc. Series A | 222,309 | 3,030,072 | |
Remark Holdings, Inc. (a)(b) | 47,241 | 78,892 | |
RumbleON, Inc. Class B (a) | 1,191 | 48,128 | |
Secoo Holding Ltd. ADR (a)(b) | 8,591 | 21,735 | |
Stamps.com, Inc. (a) | 10,259 | 1,925,409 | |
Stitch Fix, Inc. (a) | 35,391 | 1,892,003 | |
The Honest Co., Inc. (b) | 46,500 | 733,770 | |
The RealReal, Inc. (a)(b) | 49,020 | 856,379 | |
thredUP, Inc. (a)(b) | 6,150 | 145,079 | |
Trip.com Group Ltd. ADR (a) | 292,946 | 12,259,790 | |
Trxade Group, Inc. (a) | 55,473 | 200,812 | |
Uxin Ltd. ADR (a)(b) | 133,417 | 493,643 | |
Waitr Holdings, Inc. (a) | 61,095 | 124,023 | |
Wunong Net Technology Co. Ltd. (b) | 13,855 | 98,925 | |
Yatra Online, Inc. (a) | 6,606 | 13,939 | |
Yunji, Inc. ADR (a)(b) | 27,988 | 50,518 | |
1,065,859,355 | |||
Leisure Products - 0.3% | |||
American Outdoor Brands, Inc. (a) | 7,566 | 242,339 | |
AMMO, Inc. (b) | 50,109 | 343,748 | |
BRP, Inc. | 22,856 | 1,927,446 | |
Clarus Corp. | 16,429 | 389,203 | |
Escalade, Inc. | 7,721 | 188,778 | |
Genius Brands International, Inc. (a)(b) | 160,281 | 282,095 | |
Hasbro, Inc. | 75,737 | 7,268,480 | |
JAKKS Pacific, Inc. (a) | 21,533 | 184,753 | |
Johnson Outdoors, Inc. Class A | 5,547 | 677,788 | |
Malibu Boats, Inc. Class A (a) | 11,640 | 912,809 | |
MasterCraft Boat Holdings, Inc. (a) | 12,347 | 342,753 | |
Mattel, Inc. (a) | 192,502 | 4,082,967 | |
Peloton Interactive, Inc. Class A (a) | 146,405 | 16,149,936 | |
Smith & Wesson Brands, Inc. (b) | 30,266 | 643,455 | |
Vinco Ventures, Inc. (a)(b) | 8,054 | 22,793 | |
33,659,343 | |||
Multiline Retail - 0.1% | |||
Dollar Tree, Inc. (a) | 131,005 | 12,772,988 | |
Franchise Group, Inc. | 22,084 | 815,783 | |
Ollie's Bargain Outlet Holdings, Inc. (a) | 36,387 | 3,145,292 | |
16,734,063 | |||
Specialty Retail - 0.9% | |||
Academy Sports & Outdoors, Inc. | 51,233 | 1,871,541 | |
America's Car Mart, Inc. (a) | 3,745 | 615,641 | |
Arko Corp. (a)(b) | 75,986 | 797,093 | |
Bed Bath & Beyond, Inc. (a)(b) | 61,018 | 1,707,894 | |
Big 5 Sporting Goods Corp. (b) | 11,018 | 338,804 | |
Blink Charging Co. (a)(b) | 23,316 | 792,744 | |
CarLotz, Inc. Class A (a)(b) | 60,458 | 264,806 | |
Citi Trends, Inc. (a) | 5,929 | 494,123 | |
Conn's, Inc. (a) | 14,596 | 338,481 | |
Cricut, Inc. (a) | 7,331 | 247,568 | |
DavidsTea, Inc. (a)(b) | 19,290 | 74,845 | |
Five Below, Inc. (a) | 31,073 | 5,721,161 | |
GrowGeneration Corp. (a) | 32,198 | 1,429,913 | |
Hibbett Sports, Inc. (a) | 9,681 | 820,562 | |
JOANN, Inc. | 21,074 | 297,776 | |
Kaixin Auto Holdings (a)(b) | 31,869 | 76,167 | |
Kirkland's, Inc. (a) | 7,395 | 190,125 | |
Lazydays Holdings, Inc. (a)(b) | 4,667 | 108,181 | |
Leslie's, Inc. (b) | 103,099 | 3,006,367 | |
LMP Automotive Holdings, Inc. (a)(b) | 4,849 | 73,220 | |
Monro, Inc. | 17,865 | 1,113,704 | |
National Vision Holdings, Inc. (a) | 44,963 | 2,233,312 | |
O'Reilly Automotive, Inc. (a) | 38,875 | 20,802,790 | |
OneWater Marine, Inc. Class A (a) | 5,012 | 246,791 | |
Petco Health & Wellness Co., Inc. (b) | 125,762 | 2,848,509 | |
Rent-A-Center, Inc. | 30,235 | 1,868,825 | |
Ross Stores, Inc. | 196,809 | 24,874,690 | |
Shift Technologies, Inc. Class A (a)(b) | 41,600 | 294,528 | |
Shoe Carnival, Inc. | 8,397 | 566,881 | |
Sleep Number Corp. (a) | 14,174 | 1,580,259 | |
Smart Share Global Ltd. ADR (a)(b) | 7,345 | 44,364 | |
Sportsman's Warehouse Holdings, Inc. (a) | 25,040 | 445,712 | |
The Children's Place Retail Stores, Inc. (a) | 8,107 | 753,870 | |
The ODP Corp. (a) | 28,644 | 1,252,889 | |
Tractor Supply Co. | 64,529 | 11,724,919 | |
TravelCenters of America LLC (a) | 7,299 | 208,897 | |
Ulta Beauty, Inc. (a) | 31,267 | 10,798,371 | |
Urban Outfitters, Inc. (a) | 54,234 | 2,123,803 | |
Vroom, Inc. (b) | 75,250 | 3,326,803 | |
Winmark Corp. | 2,110 | 413,180 | |
Zumiez, Inc. (a) | 13,387 | 586,618 | |
107,376,727 | |||
Textiles, Apparel & Luxury Goods - 0.3% | |||
Charles & Colvard Ltd. (a) | 22,010 | 57,006 | |
Columbia Sportswear Co. | 36,434 | 3,742,865 | |
Crocs, Inc. (a) | 36,419 | 3,687,060 | |
Crown Crafts, Inc. | 9,628 | 74,617 | |
Ever-Glory International Group, Inc. (a)(b) | 13,112 | 29,502 | |
Fossil Group, Inc. (a) | 29,540 | 417,105 | |
G-III Apparel Group Ltd. (a) | 27,453 | 907,047 | |
Lakeland Industries, Inc. (a)(b) | 4,176 | 105,319 | |
lululemon athletica, Inc. (a) | 69,261 | 22,380,307 | |
Naked Brand Group, Inc. (a)(b) | 252,302 | 156,175 | |
PLBY Group, Inc. (a)(b) | 18,050 | 822,539 | |
Rocky Brands, Inc. | 4,879 | 284,543 | |
Sequential Brands Group, Inc.(a)(b) | 1,677 | 12,527 | |
Steven Madden Ltd. | 45,830 | 1,897,362 | |
Superior Group of Companies, Inc. | 9,905 | 252,875 | |
Vera Bradley, Inc. (a) | 13,988 | 160,582 | |
34,987,431 | |||
TOTAL CONSUMER DISCRETIONARY | 1,966,612,442 | ||
CONSUMER STAPLES - 3.6% | |||
Beverages - 1.5% | |||
Alkaline Water Co., Inc. (a)(b) | 24,367 | 28,509 | |
Celsius Holdings, Inc. (a) | 40,284 | 2,640,213 | |
Coca-Cola Bottling Co. Consolidated | 3,834 | 1,552,463 | |
Keurig Dr. Pepper, Inc. (b) | 778,018 | 28,755,545 | |
MGP Ingredients, Inc. (b) | 11,606 | 808,822 | |
Monster Beverage Corp. (a) | 290,994 | 27,432,004 | |
National Beverage Corp. (b) | 52,067 | 2,599,705 | |
Newage, Inc. (a)(b) | 64,269 | 152,318 | |
PepsiCo, Inc. | 761,286 | 112,624,651 | |
REED'S, Inc. (a)(b) | 38,061 | 37,680 | |
Willamette Valley Vineyards, Inc. (a) | 1,065 | 15,304 | |
176,647,214 | |||
Food & Staples Retailing - 1.1% | |||
111, Inc. ADR (a)(b) | 17,084 | 166,227 | |
Andersons, Inc. | 15,472 | 480,870 | |
BOQI International Medical, Inc. (a)(b) | 17,839 | 22,477 | |
Casey's General Stores, Inc. | 20,433 | 4,512,424 | |
Chefs' Warehouse Holdings (a) | 21,604 | 664,539 | |
China Jo-Jo Drugstores, Inc. (a)(b) | 47,150 | 46,745 | |
Costco Wholesale Corp. | 246,081 | 93,085,060 | |
G Willi-Food International Ltd. (a) | 5,646 | 129,632 | |
Grocery Outlet Holding Corp. (a)(b) | 52,534 | 1,789,833 | |
HF Foods Group, Inc. (a)(b) | 38,952 | 237,997 | |
iFresh, Inc. (a) | 18,845 | 24,687 | |
Ingles Markets, Inc. Class A | 9,556 | 591,899 | |
MedAvail Holdings, Inc. (a)(b) | 17,470 | 224,315 | |
Oatly Group AB ADR (a) | 44,500 | 1,055,095 | |
PriceSmart, Inc. | 17,300 | 1,527,590 | |
SpartanNash Co. | 22,023 | 461,822 | |
Sprouts Farmers Market LLC (a)(b) | 62,788 | 1,670,161 | |
Urban Tea, Inc. (a)(b) | 15,078 | 32,418 | |
Village Super Market, Inc. Class A | 6,605 | 159,247 | |
Walgreens Boots Alliance, Inc. | 481,011 | 25,330,039 | |
132,213,077 | |||
Food Products - 0.9% | |||
Alico, Inc. | 5,485 | 175,520 | |
AppHarvest, Inc. (a)(b) | 57,171 | 951,897 | |
Beyond Meat, Inc. (a)(b) | 35,278 | 5,130,127 | |
Bioceres Crop Solutions Corp. (a)(b) | 4,860 | 74,650 | |
Bridgford Foods Corp. (a)(b) | 3,580 | 63,259 | |
Cal-Maine Foods, Inc. (a)(b) | 24,897 | 869,154 | |
Calavo Growers, Inc. | 8,985 | 639,732 | |
China Xiangtai Food Co. Ltd. (a)(b) | 30,160 | 40,716 | |
Farmer Brothers Co. (a) | 13,797 | 166,116 | |
Freshpet, Inc. (a) | 23,945 | 4,233,955 | |
Hostess Brands, Inc. Class A (a)(b) | 69,302 | 1,086,655 | |
J&J Snack Foods Corp. | 10,693 | 1,877,477 | |
John B. Sanfilippo & Son, Inc. | 5,270 | 491,744 | |
Lancaster Colony Corp. | 16,021 | 2,990,640 | |
Landec Corp. (a) | 22,245 | 266,273 | |
Lifeway Foods, Inc. (a) | 9,131 | 52,138 | |
Limoneira Co. | 11,551 | 217,043 | |
Mission Produce, Inc. | 38,524 | 782,422 | |
Mondelez International, Inc. | 787,681 | 50,041,374 | |
Nuzee, Inc. (a)(b) | 6,728 | 20,722 | |
Origin Agritech Ltd. (a)(b) | 3,770 | 43,544 | |
Pilgrim's Pride Corp. (a) | 134,622 | 3,236,313 | |
Pingtan Marine Enterprise Ltd. (a)(b) | 41,107 | 38,336 | |
RiceBran Technologies (a) | 20,420 | 21,645 | |
S&W Seed Co. (a) | 18,677 | 66,490 | |
Sanderson Farms, Inc. | 12,122 | 1,972,856 | |
Seneca Foods Corp. Class A (a) | 5,752 | 265,972 | |
SunOpta, Inc. (a) | 55,068 | 688,350 | |
Tattooed Chef, Inc. (a)(b) | 46,113 | 981,285 | |
TDH Holdings, Inc. (a) | 18,662 | 39,750 | |
The Hain Celestial Group, Inc. (a) | 58,319 | 2,377,082 | |
The Kraft Heinz Co. | 680,013 | 29,641,767 | |
The Simply Good Foods Co. (a) | 53,130 | 1,834,579 | |
Village Farms International, Inc. (a)(b) | 42,805 | 417,349 | |
Vital Farms, Inc. (a)(b) | 21,832 | 464,803 | |
Whole Earth Brands, Inc. Class A (a) | 17,247 | 227,833 | |
112,489,568 | |||
Household Products - 0.1% | |||
Central Garden & Pet Co. Class A (non-vtg.) (a) | 30,266 | 1,526,920 | |
Ocean Bio-Chem, Inc. | 6,206 | 84,712 | |
Reynolds Consumer Products, Inc. | 123,430 | 3,720,180 | |
WD-40 Co. (b) | 7,704 | 1,885,939 | |
7,217,751 | |||
Personal Products - 0.0% | |||
DSwiss, Inc. (c)(d) | 7,648 | 0 | |
Guardion Health Sciences, Inc. (a) | 26,340 | 41,354 | |
Happiness Biotech Group Ltd. (b) | 6,115 | 10,640 | |
Inter Parfums, Inc. | 18,677 | 1,428,417 | |
Jowell Global Ltd. (a)(b) | 11,744 | 81,386 | |
Jupiter Wellness, Inc. (a)(b) | 6,237 | 27,755 | |
Lifemd, Inc. (a)(b) | 13,704 | 176,508 | |
LifeVantage Corp. (a) | 7,378 | 58,803 | |
Mannatech, Inc. | 1,514 | 38,077 | |
Natural Alternatives International, Inc. (a) | 4,379 | 60,386 | |
Natural Health Trends Corp. | 6,237 | 45,468 | |
Nature's Sunshine Products, Inc. | 13,052 | 267,435 | |
Neptune Technologies & Bioressources, Inc. (a)(b) | 73,564 | 93,426 | |
Shineco, Inc. (a)(b) | 3,572 | 28,362 | |
Summer Infant, Inc. (a) | 1,330 | 17,144 | |
United-Guardian, Inc. | 2,521 | 41,748 | |
Veru, Inc. (a) | 43,597 | 384,962 | |
2,801,871 | |||
TOTAL CONSUMER STAPLES | 431,369,481 | ||
ENERGY - 0.4% | |||
Energy Equipment & Services - 0.0% | |||
Championx Corp. (a) | 108,000 | 2,862,000 | |
CSI Compressco LP | 45,237 | 81,879 | |
Dawson Geophysical Co. (a) | 26,712 | 63,842 | |
DMC Global, Inc. (a) | 9,930 | 525,992 | |
ENGlobal Corp. (a) | 17,757 | 45,458 | |
Geospace Technologies Corp. (a) | 17,265 | 140,882 | |
Gulf Island Fabrication, Inc. (a) | 18,749 | 92,245 | |
KLX Energy Services Holdings, Inc. (a) | 7,083 | 84,075 | |
Mammoth Energy Services, Inc. (a) | 30,249 | 114,946 | |
MIND Technology, Inc. (a) | 6,775 | 15,041 | |
NCS Multistage Holdings, Inc. (a) | 2,198 | 63,698 | |
Patterson-UTI Energy, Inc. | 107,721 | 901,625 | |
Profire Energy, Inc. (a) | 47,414 | 52,155 | |
Recon Technology Ltd. (a)(b) | 12,004 | 145,128 | |
U.S. Well Services, Inc. (a)(b) | 26,071 | 31,024 | |
5,219,990 | |||
Oil, Gas & Consumable Fuels - 0.4% | |||
Abraxas Petroleum Corp. (a)(b) | 36,874 | 94,029 | |
Aemetis, Inc. (a) | 14,634 | 198,583 | |
Alliance Resource Partners LP | 64,519 | 384,533 | |
Alto Ingredients, Inc. (a)(b) | 38,730 | 258,329 | |
Altus Midstream Co. (b) | 1,176 | 74,064 | |
American Resources Corp. (a)(b) | 26,610 | 76,105 | |
Amplify Energy Corp. warrants 5/4/22 (a) | 717 | 50 | |
APA Corp. | 206,630 | 4,297,904 | |
Berry Petroleum Corp. | 30,538 | 194,222 | |
Blueknight Energy Partners LP | 54,017 | 216,068 | |
Brooge Energy Ltd. (a)(b) | 37,918 | 340,883 | |
Calumet Specialty Products Partners LP (a) | 61,788 | 374,435 | |
Centennial Resource Development, Inc. Class A (a)(b) | 146,958 | 777,408 | |
Chesapeake Energy Corp. | 54,200 | 2,861,760 | |
Clean Energy Fuels Corp. (a) | 110,509 | 875,231 | |
Diamondback Energy, Inc. | 100,922 | 8,080,825 | |
Dorchester Minerals LP | 21,696 | 329,779 | |
Epsilon Energy Ltd. (a) | 2,419 | 9,870 | |
Extraction Oil & Gas, Inc. (a) | 13,352 | 655,850 | |
Falcon Minerals Corp. | 45,603 | 212,510 | |
Gevo, Inc. (a) | 109,249 | 825,922 | |
Golar LNG Ltd. (a) | 58,331 | 740,804 | |
Green Plains Partners LP | 18,721 | 232,889 | |
Green Plains, Inc. (a)(b) | 22,988 | 733,087 | |
Hallador Energy Co. (a) | 35,000 | 84,700 | |
HighPeak Energy, Inc. (a)(b) | 51,002 | 520,220 | |
Marine Petroleum Trust | 339 | 1,536 | |
Martin Midstream Partners LP | 28,709 | 75,218 | |
National Energy Services Reunited Corp. (a) | 46,953 | 602,407 | |
New Fortress Energy, Inc. | 97,604 | 4,109,128 | |
Nextdecade Corp. (a) | 77,128 | 148,857 | |
Oasis Midstream Partners LP | 16,476 | 465,447 | |
Oasis Petroleum, Inc. | 13,114 | 1,162,032 | |
PDC Energy, Inc. | 53,812 | 2,271,943 | |
Penn Virginia Corp. (a)(b) | 7,152 | 137,891 | |
Plains All American Pipeline LP | 391,676 | 4,124,348 | |
Plains GP Holdings LP Class A | 96,390 | 1,051,615 | |
PrimeEnergy Corp. (a) | 938 | 38,721 | |
Rattler Midstream LP | 28,222 | 297,460 | |
Renewable Energy Group, Inc. (a) | 24,593 | 1,501,895 | |
StealthGas, Inc. (a) | 34,922 | 105,814 | |
Tellurian, Inc. (a)(b) | 204,847 | 893,133 | |
Top Ships, Inc. (a)(b) | 32,230 | 50,601 | |
Torchlight Energy Resources, Inc. (a)(b) | 84,218 | 200,439 | |
TORM PLC (b) | 42,268 | 396,474 | |
TransGlobe Energy Corp. (a) | 84,684 | 143,963 | |
U.S. Energy Corp. (a)(b) | 7,677 | 30,708 | |
Vertex Energy, Inc. (a)(b) | 61,060 | 476,879 | |
Viper Energy Partners LP (b) | 33,309 | 600,561 | |
42,337,130 | |||
TOTAL ENERGY | 47,557,120 | ||
FINANCIALS - 4.9% | |||
Banks - 1.9% | |||
1st Constitution Bancorp | 6,490 | 136,939 | |
1st Source Corp. | 12,820 | 634,205 | |
ACNB Corp. | 4,529 | 130,435 | |
Allegiance Bancshares, Inc. | 13,633 | 552,954 | |
Altabancorp | 12,757 | 586,822 | |
Amalgamated Financial Corp. | 18,900 | 307,503 | |
Amerant Bancorp, Inc. Class A (a) | 21,076 | 508,353 | |
American National Bankshares, Inc. | 6,531 | 226,495 | |
American River Bankshares | 3,500 | 67,410 | |
Ameris Bancorp | 41,411 | 2,275,120 | |
Ames National Corp. (b) | 6,067 | 153,495 | |
Arrow Financial Corp. | 9,726 | 360,835 | |
Atlantic Capital Bancshares, Inc. (a) | 17,597 | 494,828 | |
Atlantic Union Bankshares Corp. | 43,652 | 1,790,605 | |
Auburn National Bancorp., Inc. | 551 | 21,048 | |
BancFirst Corp. | 18,889 | 1,302,774 | |
Bancorp, Inc., Delaware (a) | 36,202 | 877,536 | |
Bank First National Corp. | 3,233 | 230,254 | |
Bank of Commerce Holdings | 11,306 | 166,764 | |
Bank of Marin Bancorp | 9,882 | 333,122 | |
Bank OZK | 70,392 | 3,006,442 | |
Bank7 Corp. (b) | 2,512 | 45,794 | |
BankFinancial Corp. | 14,628 | 161,639 | |
Bankwell Financial Group, Inc. | 4,285 | 122,380 | |
Banner Corp. | 18,237 | 1,067,412 | |
BayCom Corp. (a) | 3,947 | 73,098 | |
BCB Bancorp, Inc. | 9,394 | 137,246 | |
BOK Financial Corp. | 38,544 | 3,509,046 | |
Boston Private Financial Holdings, Inc. | 36,865 | 565,140 | |
Brookline Bancorp, Inc., Delaware | 31,420 | 529,741 | |
Bryn Mawr Bank Corp. | 10,749 | 513,802 | |
Business First Bancshares, Inc. | 8,715 | 212,646 | |
C & F Financial Corp. (b) | 2,765 | 136,812 | |
California Bancorp, Inc. (a) | 1,627 | 30,767 | |
Cambridge Bancorp | 2,788 | 239,071 | |
Camden National Corp. | 10,935 | 520,725 | |
Capital Bancorp, Inc. (a) | 4,569 | 100,472 | |
Capital City Bank Group, Inc. | 17,094 | 458,119 | |
Capstar Financial Holdings, Inc. | 13,933 | 304,993 | |
Carter Bankshares, Inc. (a) | 17,756 | 276,461 | |
Cathay General Bancorp | 45,999 | 1,917,238 | |
CBTX, Inc. | 13,467 | 398,623 | |
Central Valley Community Bancorp | 8,707 | 185,198 | |
Century Bancorp, Inc. Class A (non-vtg.) | 2,504 | 285,706 | |
Chemung Financial Corp. | 4,490 | 209,234 | |
ChoiceOne Financial Services, Inc. (b) | 2,947 | 75,885 | |
Citizens & Northern Corp. | 1,569 | 38,739 | |
Citizens Community Bancorp, Inc. | 4,935 | 66,672 | |
Citizens Holding Co. (b) | 2,179 | 41,183 | |
City Holding Co. | 9,999 | 802,120 | |
Civista Bancshares, Inc. | 12,037 | 285,758 | |
CNB Financial Corp., Pennsylvania | 11,686 | 284,087 | |
Coastal Financial Corp. of Washington (a) | 5,404 | 168,064 | |
Codorus Valley Bancorp, Inc. | 7,465 | 141,536 | |
Colony Bankcorp, Inc. (b) | 4,381 | 80,435 | |
Columbia Banking Systems, Inc. | 39,869 | 1,720,746 | |
Commerce Bancshares, Inc. | 65,883 | 5,130,968 | |
Community Bankers Trust Corp. | 16,444 | 145,365 | |
Community Financial Corp. | 4,047 | 143,547 | |
Community Trust Bancorp, Inc. | 12,339 | 545,137 | |
ConnectOne Bancorp, Inc. | 16,385 | 453,701 | |
County Bancorp, Inc. | 4,222 | 105,128 | |
CrossFirst Bankshares, Inc. (a) | 26,193 | 385,299 | |
CVB Financial Corp. | 76,652 | 1,700,141 | |
Dime Community Bancshares, Inc. | 19,145 | 664,523 | |
Eagle Bancorp Montana, Inc. | 2,880 | 72,029 | |
Eagle Bancorp, Inc. | 12,960 | 740,534 | |
East West Bancorp, Inc. | 79,134 | 5,917,641 | |
Eastern Bankshares, Inc. | 100,469 | 2,250,506 | |
Enterprise Bancorp, Inc. | 7,478 | 257,692 | |
Enterprise Financial Services Corp. | 17,311 | 855,337 | |
Equity Bancshares, Inc. (a) | 7,783 | 255,749 | |
Esquire Financial Holdings, Inc. (a) | 1,609 | 39,630 | |
Farmers & Merchants Bancorp, Inc. | 7,012 | 154,264 | |
Farmers National Banc Corp. | 23,198 | 403,645 | |
Fidelity D & D Bancorp, Inc. (b) | 1,959 | 109,175 | |
Fifth Third Bancorp | 394,075 | 16,606,321 | |
Financial Institutions, Inc. | 9,689 | 311,308 | |
First Bancorp, North Carolina | 21,011 | 932,258 | |
First Bancshares, Inc. | 9,721 | 379,605 | |
First Bank Hamilton New Jersey | 14,532 | 199,524 | |
First Busey Corp. | 27,899 | 747,414 | |
First Capital, Inc. (b) | 2,233 | 99,592 | |
First Choice Bancorp | 2,515 | 80,807 | |
First Citizens Bancshares, Inc. | 4,989 | 4,293,533 | |
First Community Bankshares, Inc. | 13,105 | 408,352 | |
First Community Corp. | 3,875 | 77,888 | |
First Financial Bancorp, Ohio | 55,952 | 1,425,097 | |
First Financial Bankshares, Inc. | 80,098 | 4,032,934 | |
First Financial Corp., Indiana | 8,773 | 398,119 | |
First Financial Northwest, Inc. | 10,995 | 159,867 | |
First Foundation, Inc. | 27,783 | 697,353 | |
First Guaranty Bancshares, Inc. (b) | 7,321 | 144,297 | |
First Hawaiian, Inc. | 79,393 | 2,235,707 | |
First Internet Bancorp | 8,345 | 283,062 | |
First Interstate Bancsystem, Inc. | 23,864 | 1,123,278 | |
First Merchants Corp. | 29,303 | 1,357,901 | |
First Mid-Illinois Bancshares, Inc. | 11,244 | 493,612 | |
First Midwest Bancorp, Inc., Delaware | 61,314 | 1,283,302 | |
First Northwest Bancorp | 7,546 | 134,394 | |
First of Long Island Corp. | 15,039 | 338,378 | |
First Savings Financial Group, Inc. | 448 | 32,274 | |
First U.S. Bancshares, Inc. | 3,641 | 37,320 | |
First Western Financial, Inc. (a) | 2,387 | 66,239 | |
Flushing Financial Corp. | 10,637 | 248,587 | |
FNCM Bancorp, Inc. | 3,698 | 27,254 | |
Fulton Financial Corp. | 95,023 | 1,646,749 | |
FVCBankcorp, Inc. (a) | 3,791 | 67,290 | |
German American Bancorp, Inc. | 17,425 | 728,365 | |
Glacier Bancorp, Inc. | 53,714 | 3,128,841 | |
Great Southern Bancorp, Inc. | 10,419 | 588,569 | |
Grupo Financiero Galicia SA sponsored ADR (b) | 29,288 | 260,077 | |
Guaranty Bancshares, Inc. Texas | 8,980 | 344,293 | |
Hancock Whitney Corp. | 50,242 | 2,487,481 | |
Hanmi Financial Corp. | 11,598 | 243,326 | |
HarborOne Bancorp, Inc. | 42,787 | 635,387 | |
Hawthorn Bancshares, Inc. | 2,650 | 63,998 | |
HBT Financial, Inc. | 16,600 | 301,954 | |
Heartland Financial U.S.A., Inc. | 18,176 | 904,256 | |
Heritage Commerce Corp. | 20,515 | 243,308 | |
Heritage Financial Corp., Washington | 15,826 | 459,112 | |
Home Bancshares, Inc. | 93,540 | 2,559,254 | |
HomeTrust Bancshares, Inc. | 11,346 | 321,886 | |
Hope Bancorp, Inc. | 64,741 | 990,537 | |
Horizon Bancorp, Inc. Indiana | 31,602 | 584,637 | |
Howard Bancorp, Inc. (a) | 11,970 | 201,814 | |
Huntington Bancshares, Inc. | 566,941 | 8,991,684 | |
Independent Bank Corp. | 10,908 | 254,156 | |
Independent Bank Corp., Massachusetts | 16,954 | 1,383,616 | |
Independent Bank Group, Inc. | 22,585 | 1,778,569 | |
International Bancshares Corp. | 39,634 | 1,839,018 | |
Investar Holding Corp. (b) | 8,715 | 196,785 | |
Investors Bancorp, Inc. | 150,190 | 2,234,827 | |
Lakeland Bancorp, Inc. | 23,940 | 455,099 | |
Lakeland Financial Corp. | 13,946 | 860,608 | |
Landmark Bancorp, Inc. (b) | 2,780 | 71,974 | |
LCNB Corp. (b) | 12,147 | 214,273 | |
Level One Bancorp, Inc. | 1,322 | 36,633 | |
Limestone Bancorp, Inc. (a) | 621 | 9,880 | |
Live Oak Bancshares, Inc. | 24,006 | 1,454,283 | |
Macatawa Bank Corp. | 20,908 | 200,717 | |
Mackinac Financial Corp. | 1,919 | 41,604 | |
Mercantile Bank Corp. | 12,064 | 389,667 | |
Meridian Bank/Malvern, PA | 1,196 | 32,376 | |
Metrocity Bankshares, Inc. (b) | 10,365 | 178,382 | |
Middlefield Banc Corp. (b) | 1,133 | 27,192 | |
Midland States Bancorp, Inc. | 11,372 | 316,824 | |
MidWestOne Financial Group, Inc. | 11,723 | 369,743 | |
MVB Financial Corp. | 5,314 | 227,811 | |
National Bankshares, Inc. | 4,034 | 141,593 | |
NBT Bancorp, Inc. | 16,063 | 626,296 | |
Nicolet Bankshares, Inc. (a) | 7,073 | 560,889 | |
Northeast Bank | 7,547 | 221,580 | |
Northrim Bancorp, Inc. | 5,057 | 220,232 | |
Norwood Financial Corp. | 3,432 | 87,207 | |
Oak Valley Bancorp Oakdale California | 5,385 | 101,777 | |
OceanFirst Financial Corp. | 24,691 | 545,918 | |
Old National Bancorp, Indiana | 106,368 | 2,026,310 | |
Old Point Financial Corp. | 2,955 | 69,443 | |
Old Second Bancorp, Inc. | 25,460 | 352,876 | |
Origin Bancorp, Inc. | 13,756 | 607,327 | |
Orrstown Financial Services, Inc. | 7,486 | 188,947 | |
Pacific Mercantile Bancorp (a) | 11,962 | 101,916 | |
Pacific Premier Bancorp, Inc. | 54,299 | 2,496,125 | |
PacWest Bancorp | 66,795 | 3,017,130 | |
Parke Bancorp, Inc. | 2,888 | 62,092 | |
Partners Bancorp | 1,425 | 11,186 | |
Patriot National Bancorp, Inc. (a) | 1,781 | 15,049 | |
Peapack-Gladstone Financial Corp. | 10,114 | 335,987 | |
Penns Woods Bancorp, Inc. | 4,912 | 125,796 | |
Peoples Bancorp of North Carolina | 3,056 | 76,064 | |
Peoples Bancorp, Inc. | 10,652 | 345,977 | |
Peoples Financial Services Corp. | 4,449 | 191,974 | |
Peoples United Financial, Inc. | 229,978 | 4,348,884 | |
Pinnacle Financial Partners, Inc. | 43,486 | 3,953,747 | |
Popular, Inc. | 47,523 | 3,878,352 | |
Preferred Bank, Los Angeles | 7,653 | 522,623 | |
Premier Financial Bancorp, Inc. | 13,603 | 253,696 | |
Primis Financial Corp. | 16,511 | 243,207 | |
Professional Holdings Corp. (A Shares) (a) | 3,172 | 58,048 | |
QCR Holdings, Inc. | 11,391 | 544,604 | |
RBB Bancorp | 8,755 | 213,622 | |
Red River Bancshares, Inc. | 3,386 | 184,909 | |
Reliant Bancorp, Inc. | 8,809 | 261,187 | |
Renasant Corp. | 27,558 | 1,218,615 | |
Republic Bancorp, Inc., Kentucky Class A | 13,488 | 626,518 | |
Republic First Bancorp, Inc. (a) | 49,587 | 204,298 | |
Riverview Financial Corp. | 571 | 6,127 | |
S&T Bancorp, Inc. | 12,247 | 415,541 | |
Salisbury Bancorp, Inc. | 1,630 | 75,811 | |
Sandy Spring Bancorp, Inc. | 24,020 | 1,115,969 | |
SB Financial Group, Inc. (b) | 4,486 | 88,823 | |
Seacoast Banking Corp., Florida | 28,597 | 1,060,091 | |
Select Bancorp, Inc. (a) | 8,656 | 121,876 | |
ServisFirst Bancshares, Inc. | 28,308 | 1,966,274 | |
Shore Bancshares, Inc. | 9,065 | 155,827 | |
Sierra Bancorp | 9,675 | 268,191 | |
Signature Bank | 29,954 | 7,481,012 | |
Simmons First National Corp. Class A (b) | 53,486 | 1,631,323 | |
SmartFinancial, Inc. | 10,154 | 246,235 | |
Sound Financial Bancorp, Inc. | 1,189 | 52,292 | |
South Plains Financial, Inc. | 6,245 | 146,508 | |
South State Corp. | 39,778 | 3,532,684 | |
Southern First Bancshares, Inc. (a) | 4,670 | 249,518 | |
Southside Bancshares, Inc. | 20,855 | 893,428 | |
Spirit of Texas Bancshares, Inc. | 8,516 | 196,549 | |
Stock Yards Bancorp, Inc. | 13,953 | 749,834 | |
Summit Financial Group, Inc. | 11,557 | 275,403 | |
Summit State Bank | 3,403 | 55,197 | |
SVB Financial Group (a) | 28,913 | 16,853,099 | |
TCF Financial Corp. | 85,680 | 4,069,800 | |
Texas Capital Bancshares, Inc. (a) | 28,839 | 1,986,430 | |
The Bank of Princeton | 4,666 | 137,320 | |
The First Bancorp, Inc. | 6,787 | 213,791 | |
TowneBank | 30,225 | 968,107 | |
Trico Bancshares | 20,207 | 968,926 | |
TriState Capital Holdings, Inc. (a) | 14,151 | 325,331 | |
Triumph Bancorp, Inc. (a) | 13,714 | 1,148,548 | |
Trustmark Corp. | 36,708 | 1,231,553 | |
UMB Financial Corp. | 28,181 | 2,725,385 | |
Umpqua Holdings Corp. | 137,604 | 2,625,484 | |
Union Bankshares, Inc. | 2,283 | 76,960 | |
United Bankshares, Inc., West Virginia | 67,656 | 2,786,751 | |
United Community Bank, Inc. | 50,798 | 1,756,595 | |
Unity Bancorp, Inc. | 6,284 | 152,324 | |
Univest Corp. of Pennsylvania | 13,955 | 406,928 | |
Valley National Bancorp | 242,173 | 3,467,917 | |
Veritex Holdings, Inc. | 34,367 | 1,207,313 | |
Virginia National Bank Corp. (b) | 1,029 | 33,391 | |
Washington Trust Bancorp, Inc. | 8,141 | 447,674 | |
WesBanco, Inc. | 42,022 | 1,635,496 | |
West Bancorp., Inc. | 9,814 | 274,007 | |
Westamerica Bancorp. | 15,600 | 978,588 | |
Wintrust Financial Corp. | 33,135 | 2,664,717 | |
Zions Bancorp NA | 90,451 | 5,235,304 | |
231,387,223 | |||
Capital Markets - 1.7% | |||
ABG Acquisition Corp. I Class A (a) | 6,871 | 68,366 | |
ACON S2 Acquisition Corp. Class A (a) | 14,618 | 144,718 | |
AGM Group Holdings, Inc. (a)(b) | 2,758 | 31,910 | |
Alberton Acquisition Corp. (a)(b) | 2,725 | 30,275 | |
Alkuri Global Acquisition Corp. (a) | 20,057 | 196,960 | |
Artius Acquisition, Inc. Class A (a) | 39,589 | 394,306 | |
ARYA Sciences Acquisition Corp. IV Class A (a) | 7,820 | 80,859 | |
B. Riley Financial, Inc. | 15,733 | 1,158,578 | |
Benessere Capital Acquisition Corp. (a) | 7,833 | 77,938 | |
BGC Partners, Inc. Class A | 176,695 | 1,042,501 | |
Blucora, Inc. (a) | 33,176 | 575,272 | |
Blue Water Acquisition Corp. Class A (a) | 2,415 | 24,271 | |
CA Healthcare Acquisition Corp. Class A (a)(b) | 23,727 | 233,711 | |
Capital Southwest Corp. | 19,472 | 523,797 | |
Capitala Finance Corp. (a) | 3,628 | 90,519 | |
Carlyle Group LP | 195,931 | 8,550,429 | |
China Finance Online Co. Ltd. ADR (a)(b) | 4,821 | 45,510 | |
CME Group, Inc. | 199,329 | 43,605,212 | |
Coinbase Global, Inc. (a)(b) | 78,185 | 18,493,880 | |
Cowen Group, Inc. Class A (b) | 16,234 | 638,483 | |
Crescent Capital BDC, Inc. (b) | 11,222 | 208,393 | |
Decarbonization Plus Acquisition Corp. II Class A (a)(b) | 27,138 | 266,495 | |
Deep Lake Capital Acquisition Corp. Class A (a) | 15,606 | 151,222 | |
Diamond Hill Investment Group, Inc. | 1,539 | 269,956 | |
Diginex Ltd. (a)(b) | 19,237 | 112,536 | |
Dragoneer Growth Opportunities Corp. II (a) | 16,758 | 167,580 | |
ECP Environmental Growth Opportunities Corp. Class A (a)(b) | 16,762 | 163,262 | |
Fintech Acquisition Corp. V (a)(b) | 13,427 | 145,951 | |
Focus Financial Partners, Inc. Class A (a) | 31,470 | 1,595,214 | |
Freedom Holding Corp. (a)(b) | 34,232 | 1,739,670 | |
FS Development Corp. II Class A (a) | 8,828 | 88,192 | |
Futu Holdings Ltd. ADR (a)(b) | 36,569 | 5,202,672 | |
GCM Grosvenor, Inc. Class A (b) | 32,247 | 385,352 | |
Goldenbridge Acquisition Ltd. (a) | 7,095 | 69,460 | |
Greenpro Capital Corp. (a)(b) | 37,552 | 48,067 | |
Hamilton Lane, Inc. Class A | 19,775 | 1,787,067 | |
Harvest Capital Credit Corp. | 6,284 | 59,509 | |
Hennessy Advisors, Inc. (b) | 4,729 | 43,128 | |
Heritage Global, Inc. (a) | 28,350 | 80,231 | |
Holicity, Inc. Class A (a)(b) | 20,981 | 211,908 | |
Horizon Technology Finance Corp. | 7,992 | 131,708 | |
Hudson Executive Investment Corp. III Class A (a) | 3,317 | 32,507 | |
Hywin Holdings Ltd. ADR (a) | 6,913 | 51,709 | |
IG Acquisition Corp. Class A (a) | 14,764 | 143,654 | |
Interactive Brokers Group, Inc. | 51,234 | 3,445,999 | |
Investcorp Credit Management BDC, Inc. | 16,938 | 95,869 | |
Isleworth Healthcare Acquisition Corp. (a) | 17,107 | 166,451 | |
JOFF Fintech Acquisition Corp. Class A (a) | 23,850 | 229,914 | |
Kairos Acquisition Corp. Class A (a) | 19,781 | 192,469 | |
Kernel Group Holdings, Inc. (a) | 17,590 | 170,447 | |
Khosla Ventures Acquisition Co. (a) | 30,531 | 307,142 | |
KINS Technology Group, Inc. Class A (a) | 18,203 | 180,210 | |
KL Acquisition Corp. Class A (a) | 16,768 | 161,644 | |
Lion Group Holding Ltd. ADR (a)(b) | 7,384 | 17,279 | |
LPL Financial | 44,455 | 6,574,005 | |
MarketAxess Holdings, Inc. | 21,215 | 9,897,646 | |
Morningstar, Inc. | 24,152 | 5,699,630 | |
NASDAQ, Inc. | 92,482 | 15,487,036 | |
New Mountain Finance Corp. | 57,266 | 760,492 | |
Newtek Business Services Corp. (b) | 17,267 | 609,007 | |
North Mountain Merger Corp. Class A (a) | 6,334 | 61,947 | |
Northern Trust Corp. | 115,734 | 14,025,803 | |
Open Lending Corp. (a) | 70,944 | 2,737,020 | |
Panacea Acquisition Corp. II (a) | 10,372 | 103,720 | |
Patria Investments Ltd. | 27,689 | 468,221 | |
Petra Acquisition, Inc. (a) | 1,542 | 15,420 | |
PhenixFIN Corp. (a)(b) | 762 | 30,686 | |
Pioneer Merger Corp. Class A (a) | 23,866 | 235,796 | |
Poema Global Holdings Corp. Class A (a) | 23,140 | 223,301 | |
Property Solutions Acquisition Corp. (a)(b) | 14,569 | 184,152 | |
Puhui Wealth Investment Management Co. Ltd. (a)(b) | 11,943 | 43,353 | |
Puyi, Inc. ADR (a)(b) | 12,308 | 67,694 | |
Qell Acquisition Corp. (a)(b) | 25,933 | 256,477 | |
Rodgers Silicon Valley Acquisition Corp. (a)(b) | 17,303 | 258,853 | |
SEI Investments Co. | 79,812 | 5,063,273 | |
Senior Connect Acquisition Corp. I Class A (a) | 24,333 | 235,787 | |
Siebert Financial Corp. (a)(b) | 23,323 | 96,557 | |
Silvercrest Asset Management Group Class A | 8,360 | 133,091 | |
StepStone Group, Inc. Class A | 21,127 | 669,726 | |
StoneX Group, Inc. (a) | 10,378 | 702,591 | |
SVF Investment Corp. 2 (a) | 19,134 | 191,340 | |
SVF Investment Corp. 3 (a) | 24,143 | 240,223 | |
T. Rowe Price Group, Inc. | 126,560 | 24,217,256 | |
TCV Acquisition Corp. Class A (a) | 19,476 | 194,760 | |
Tradeweb Markets, Inc. Class A | 58,390 | 4,891,914 | |
Trinity Capital, Inc. | 14,443 | 207,979 | |
Twelve Seas Investment Co. II (a) | 900 | 8,694 | |
U.S. Global Investments, Inc. Class A (b) | 8,407 | 52,292 | |
Up Fintech Holdings Ltd. ADR (a)(b) | 43,904 | 1,000,572 | |
Value Line, Inc. | 5,984 | 184,906 | |
Victory Capital Holdings, Inc. | 7,768 | 233,195 | |
Vinci Partners Investments Ltd. | 30,832 | 446,447 | |
Virtu Financial, Inc. Class A (b) | 70,646 | 2,151,171 | |
Virtus Investment Partners, Inc. | 4,472 | 1,257,661 | |
VPC Impact Acquisition Holding Class A (a) | 15,369 | 156,764 | |
WisdomTree Investments, Inc. | 91,436 | 612,621 | |
XP, Inc. Class A (a) | 207,724 | 8,238,334 | |
203,057,775 | |||
Consumer Finance - 0.2% | |||
360 DigiTech, Inc. ADR (a) | 69,190 | 1,942,163 | |
7GC & Co. Holdings, Inc. Class A (a) | 16,089 | 156,546 | |
Atlanticus Holdings Corp. (a)(b) | 9,306 | 368,611 | |
Bit Digital, Inc. (a)(b) | 26,879 | 227,128 | |
Consumer Portfolio Services, Inc. (a) | 14,707 | 68,535 | |
Credit Acceptance Corp. (a)(b) | 9,385 | 4,199,412 | |
Encore Capital Group, Inc. (a)(b) | 18,287 | 846,505 | |
EZCORP, Inc. (non-vtg.) Class A (a) | 12,112 | 89,023 | |
First Cash Financial Services, Inc. | 22,700 | 1,809,644 | |
Jiayin Group, Inc. ADR (a) | 5,761 | 34,739 | |
LendingTree, Inc. (a) | 7,302 | 1,498,736 | |
LexinFintech Holdings Ltd. ADR (a)(b) | 60,982 | 557,375 | |
Medallion Financial Corp. (a) | 10,141 | 93,094 | |
Mogo, Inc. (a) | 17,146 | 138,197 | |
Navient Corp. | 99,396 | 1,815,965 | |
Nicholas Financial, Inc. (a) | 5,880 | 61,740 | |
Oportun Financial Corp. (a) | 16,861 | 321,708 | |
Pintec Technology Holdings Ltd. ADR (a)(b) | 7,937 | 7,108 | |
PRA Group, Inc. (a) | 24,555 | 955,926 | |
Senmiao Technology Ltd. (a)(b) | 16,727 | 13,549 | |
SLM Corp. | 189,714 | 3,841,709 | |
Upstart Holdings, Inc. (b) | 41,029 | 6,081,318 | |
World Acceptance Corp. (a)(b) | 3,875 | 622,364 | |
25,751,095 | |||
Diversified Financial Services - 0.2% | |||
10X Capital Venture Acquisition Corp. Class A (a)(b) | 15,296 | 152,042 | |
26 Capital Acquisition Corp. Class A (a) | 16,820 | 162,649 | |
5:01 Acquisition Corp. (a) | 400 | 3,972 | |
890 5th Avenue Partners, Inc. Class A (a) | 19,812 | 191,780 | |
A-Mark Precious Metals, Inc. | 4,846 | 258,389 | |
ACE Convergence Acquisition Corp. Class A (a) | 18,248 | 181,933 | |
Acies Acquisition Corp. Class A (a) | 18,373 | 183,546 | |
Aequi Acquisition Corp. Class A (a) | 13,710 | 132,302 | |
Agba Acquisition Ltd. (a) | 972 | 10,332 | |
Alerus Financial Corp. (b) | 7,192 | 236,976 | |
Alpha Healthcare Acquisition Corp. Class A (a) | 4,212 | 41,867 | |
Altitude Acquisition Corp. Class A (a) | 25,814 | 251,945 | |
Apex Technology Acquisition Corp. (a) | 19,331 | 199,303 | |
Arrowroot Acquisition Corp. Class A (a) | 1,530 | 14,765 | |
Athlon Acquisition Corp. (a) | 18,647 | 179,384 | |
BCLS Acquisition Corp. (a) | 6,186 | 63,407 | |
BCTG Acquisition Corp. (a) | 14,009 | 155,500 | |
Bespoke Capital Acquisition Corp. (a) | 18,987 | 191,959 | |
Big Cypress Acquisition Corp. (a) | 6,967 | 68,764 | |
Blade Air Mobility, Inc. (a)(b) | 18,704 | 181,803 | |
BowX Acquisition Corp. (a)(b) | 25,556 | 313,828 | |
Bridgetown 2 Holdings Ltd. (a)(b) | 24,222 | 240,282 | |
Bright Lights Acquisition Corp. (a) | 14,495 | 141,036 | |
Brookline Capital Acquisition Corp. (a) | 1,762 | 17,479 | |
Carney Technology Acquisition Corp. II Class A (a) | 23,359 | 226,816 | |
CF Acquisition Corp. IV Class A (a)(b) | 31,309 | 303,384 | |
CF Finance Acquisition Corp. III Class A (a)(b) | 16,671 | 166,543 | |
CHP Merger Corp. Class A (a) | 12,845 | 127,808 | |
CM Life Sciences, Inc. Class A (a)(b) | 26,015 | 329,350 | |
Corner Growth Acquisition Corp. (a) | 36,908 | 357,639 | |
COVA Acquisition Corp. Class A (a) | 14,122 | 136,842 | |
Crescent Acquisition Corp. (a) | 13,895 | 140,617 | |
Decarbonization Plus Acquisition Corp. Class A (a)(b) | 16,956 | 169,560 | |
Deerfield Healthcare Technology Acquisitions Corp. Class A (a)(b) | 11,520 | 148,032 | |
DiamondHead Holdings Corp. (a) | 17,651 | 170,862 | |
Dragoneer Growth Opportunities Corp. III (a) | 26,704 | 268,375 | |
Duddell Street Acquisition Corp. Class A (a) | 13,491 | 131,065 | |
Dune Acquisition Corp. (a) | 27,995 | 272,391 | |
E.Merge Technology Acquisition Corp. Class A (a) | 42,816 | 416,172 | |
Edify Acquisition Corp. (a) | 21,442 | 207,130 | |
EdtechX Holdings Acquisition Corp. II (a) | 600 | 5,940 | |
Environmental Impact Acquisition Corp. Class A (a) | 17,352 | 168,661 | |
Epiphany Technology Acquisition Corp. Class A (a) | 25,270 | 244,361 | |
Evo Acquisition Corp. Class A (a) | 2,089 | 20,096 | |
Falcon Capital Acquisition Corp. Class A (a)(b) | 16,919 | 169,021 | |
Fifth Wall Acquisition Corp. I (a) | 26,288 | 273,395 | |
FinServ Acquisition Corp. (a)(b) | 19,714 | 258,845 | |
Fintech Acquisition Corp. IV Class A (a) | 7,875 | 99,698 | |
FlexShopper, Inc. (a) | 5,973 | 16,127 | |
Flywire Corp. (a) | 50,800 | 1,744,472 | |
Foresight Acquisition Corp. Class A (a) | 9,021 | 89,488 | |
Fortistar Sustainable Solution Corp. Class A (a) | 16,708 | 163,404 | |
FoxWayne Enterprises Acquisition Corp. Class A (a) | 2,038 | 20,156 | |
Frazier Lifesciences Acquisition Corp. Class A (a) | 5,931 | 57,531 | |
Gaming & Hospitality Acquisition Corp. (a) | 564 | 5,499 | |
Global Partner Acquisition Corp. II Class A (a) | 7,062 | 69,137 | |
Global Synergy Acquisition Corp. Class A (a) | 13,599 | 132,046 | |
Globis Acquisition Corp. (a)(b) | 7,932 | 79,161 | |
Goal Acquisitions Corp. (a) | 26,248 | 252,768 | |
Gores Holdings V, Inc. Class A (a) | 28,757 | 290,446 | |
Gores Holdings VI, Inc. (a)(b) | 20,827 | 293,661 | |
Gores Holdings VII, Inc. Class A (a) | 1,641 | 16,049 | |
Gores Metropoulos II, Inc. (a)(b) | 28,128 | 277,342 | |
Greenrose Acquisition Corp. (a)(b) | 13,288 | 132,880 | |
Group Nine Acquisition Corp. Class A (a) | 13,930 | 135,818 | |
Growth Capital Acquisition Corp. (a) | 8,345 | 80,947 | |
GWG Holdings, Inc. (a)(b) | 9,632 | 65,979 | |
Hamilton Lane Alliance Holdings I, Inc. (a) | 3,752 | 36,507 | |
Health Sciences Acquisitions Corp. 2 (a) | 10,388 | 106,581 | |
Healthcare Services Acquisition Corp. (a) | 25,862 | 249,568 | |
HealthCor Catalio Acquisition Corp. (a) | 8,429 | 83,110 | |
Helix Acquisition Corp. (a) | 200 | 1,992 | |
Hennessy Capital Investment Corp. V Class A (a)(b) | 22,809 | 225,353 | |
Hudson Capital, Inc. (a)(b) | 16,721 | 49,160 | |
Hudson Executive Investment Corp. Class A (a) | 24,624 | 244,270 | |
HumanCo Acquisition Corp. (a) | 21,826 | 214,986 | |
Industrial Tech Acquisitions, Inc. (a) | 3,224 | 32,401 | |
INSU Acquisition Corp. III (a) | 13,519 | 130,594 | |
ITHAX Acquisition Corp. (a) | 11,626 | 111,958 | |
Khosla Ventures Acquisition Co. II (a) | 28,781 | 289,249 | |
Khosla Ventures Acquisition Co. III (a) | 40,777 | 406,954 | |
Kismet Acquisition One Corp. (a) | 19,644 | 193,886 | |
KludeIn I Acquisition Corp. (a) | 13,003 | 126,519 | |
Legato Merger Corp. (a)(b) | 21,831 | 215,690 | |
Leisure Acquisition Corp. (a)(b) | 800 | 11,112 | |
Lerer Hippeau Acquisition Corp. Class A (a) | 16,266 | 160,871 | |
Liberty Media Acquisition Corp. (a) | 30,083 | 306,847 | |
Lifesci Acquisition II Corp. (a)(b) | 3,695 | 37,024 | |
Lionheart Acquisition Corp. II Class A (a) | 12,061 | 118,680 | |
LM Funding America, Inc. (a)(b) | 6,078 | 27,108 | |
Lux Health Tech Acquisition Corp. (a) | 22,338 | 222,710 | |
Malacca Straits Acquisition Co. Ltd. Class A (a) | 6,813 | 67,381 | |
Marlin Business Services Corp. | 10,171 | 229,051 | |
Marlin Technology Corp. (a) | 24,047 | 230,851 | |
Marquee Raine Acquisition Corp. (a)(b) | 38,063 | 374,159 | |
Medicus Sciences Acquisition Corp. Class A (a) | 6,279 | 61,157 | |
MedTech Acquisition Corp. Class A (a) | 17,265 | 167,471 | |
Monument Circle Acquisition Corp. Class A (a) | 13,874 | 134,855 | |
Moringa Acquisition Corp. Class A (a) | 2,471 | 23,845 | |
Motion Acquisition Corp. Class A (a) | 9,842 | 98,026 | |
Mudrick Capital Acquisition Corp. II Class A (a) | 19,128 | 261,097 | |
Natural Order Acquisition Corp. (a) | 20,378 | 200,723 | |
Nebula Caravel Acquisition Corp. Class A (a) | 16,181 | 160,516 | |
NextGen Acquisition Corp. Class A (a) | 25,177 | 249,001 | |
Noble Rock Acquisition Corp. Class A (a) | 10,316 | 99,240 | |
NRX Pharmaceuticals, Inc. (a)(b) | 1,583 | 34,826 | |
OTR Acquisition Corp. Class A (a) | 4,256 | 42,347 | |
Population Health Investment Co., Inc. (a) | 10,758 | 105,536 | |
Power & Digital Infrastructure Acquisition I Corp. (a) | 4,804 | 46,695 | |
Powered Brands Class A (a) | 7,352 | 72,197 | |
PropTech Investment Corp. II (a)(b) | 12,250 | 120,050 | |
Prospector Capital Corp. Class A (a) | 26,293 | 256,094 | |
Provident Acquisition Corp. Class A (a) | 16,811 | 162,394 | |
PureCycle Technologies, Inc. (a)(b) | 64,980 | 1,131,952 | |
Queen's Gambit Growth Capital Class A (a) | 22,172 | 214,403 | |
Research Alliance Corp. II (a) | 5,975 | 59,929 | |
Revolution Acceleration Acquisition Corp. Class A (a) | 18,629 | 186,290 | |
RMG Acquisition Corp. II (a) | 24,688 | 245,152 | |
RMG Acquisition Corp. III Class A (a) | 13,160 | 128,705 | |
Roman DBDR Tech Acquisition Corp. (a) | 30,608 | 307,916 | |
Roth CH Acquisition II Co. (a) | 10,369 | 102,549 | |
Roth CH Acquisition III Co. (a) | 18,959 | 183,334 | |
ScION Tech Growth I Class A (a) | 37,911 | 368,495 | |
Seven Oaks Acquisition Corp. Class A (a) | 18,556 | 181,292 | |
Soaring Eagle Acquisition Corp. Class A (a) | 111,875 | 1,104,206 | |
Sports Ventures Acquisition Corp. Class A (a) | 15,350 | 148,895 | |
Stable Road Acquisition Corp. Class A (a)(b) | 16,207 | 170,174 | |
Starboard Value Acquisition Corp. Class A (a)(b) | 21,991 | 217,931 | |
Sustainable Development Acquisition I Corp. Class A (a) | 17,521 | 169,428 | |
SVF Investment Corp. (a) | 43,423 | 433,796 | |
SWK Holdings Corp. (a) | 4,294 | 69,090 | |
Tastemaker Acquisition Corp. Class A (a) | 19,139 | 185,648 | |
Tekkorp Digital Acquisition Corp. (a) | 19,009 | 185,718 | |
Thayer Ventures Acquisition Corp. (a) | 12,815 | 127,253 | |
Thimble Point Acquisition Corp. Class A (a) | 6,972 | 67,768 | |
Thunder Bridge Capital Partners III, Inc. Class A (a) | 10,637 | 103,285 | |
Trident Acquisitions Corp. (a)(b) | 12,219 | 152,738 | |
TS Innovation Acquisitions Corp. (a)(b) | 18,953 | 202,987 | |
Tuatara Capital Acquisition Corp. (a) | 11,671 | 112,508 | |
Tuscan Holdings Corp. II (a)(b) | 26,034 | 261,121 | |
TWC Tech Holdings II Corp. (a) | 55,063 | 544,022 | |
VectoIQ Acquisition Corp. II (a) | 18,670 | 181,939 | |
Vector Acquisition Corp. Class A (a) | 21,601 | 215,578 | |
Ventoux CCM Acquisition Corp. (a) | 11,540 | 114,592 | |
Vickers Vantage Corp. I (a) | 10,324 | 102,208 | |
View, Inc. Class A (a)(b) | 121,207 | 959,959 | |
Yellowstone Acquisition Co. (a) | 10,479 | 105,209 | |
28,157,469 | |||
Insurance - 0.7% | |||
American National Group, Inc. | 13,897 | 2,084,828 | |
Amerisafe, Inc. | 9,587 | 628,236 | |
Arch Capital Group Ltd. (a) | 223,762 | 8,925,866 | |
Atlantic American Corp. (b) | 8,809 | 38,143 | |
Brighthouse Financial, Inc. (a) | 49,712 | 2,418,986 | |
BRP Group, Inc. (a) | 28,126 | 691,337 | |
Cincinnati Financial Corp. | 89,882 | 10,939,538 | |
Conifer Holdings, Inc. (a) | 3,312 | 8,942 | |
Donegal Group, Inc. Class A | 18,229 | 278,721 | |
eHealth, Inc. (a) | 14,424 | 941,166 | |
Enstar Group Ltd. (a) | 10,255 | 2,603,642 | |
Erie Indemnity Co. Class A | 25,749 | 5,178,896 | |
Fanhua, Inc. ADR | 18,931 | 251,593 | |
Fednat Holding Co. | 14,952 | 71,620 | |
FG Financial Group, Inc. (a) | 3,213 | 26,154 | |
Global Indemnity Group LLC Class A | 7,184 | 229,457 | |
GoHealth, Inc. (a) | 53,860 | 612,388 | |
Goosehead Insurance | 10,135 | 910,832 | |
Greenlight Capital Re, Ltd. (a) | 10,467 | 96,820 | |
Hallmark Financial Services, Inc. (a) | 856 | 3,766 | |
Huize Holding Ltd. ADR (a)(b) | 11,981 | 75,480 | |
International General Insurance Holdings Ltd. (b) | 24,436 | 215,037 | |
Investors Title Co. | 1,165 | 207,184 | |
James River Group Holdings Ltd. | 16,877 | 589,345 | |
Kingstone Companies, Inc. | 5,340 | 42,880 | |
Kinsale Capital Group, Inc. | 12,932 | 2,152,661 | |
Maiden Holdings Ltd. (a) | 47,521 | 167,274 | |
MetroMile, Inc. (a)(b) | 67,472 | 572,163 | |
Midwest Holding, Inc. | 1,575 | 65,426 | |
National Western Life Group, Inc. | 1,558 | 381,741 | |
NI Holdings, Inc. (a) | 13,483 | 256,986 | |
Oxbridge Re Holdings Ltd. (a)(b) | 5,511 | 12,675 | |
Palomar Holdings, Inc. (a) | 14,396 | 1,050,908 | |
Principal Financial Group, Inc. | 151,479 | 9,905,212 | |
Protective Insurance Corp. Class B | 9,179 | 213,871 | |
Root, Inc. (b) | 30,343 | 276,728 | |
Safety Insurance Group, Inc. | 8,823 | 750,926 | |
Selective Insurance Group, Inc. | 35,449 | 2,668,246 | |
Sirius International Insurance rights 3/1/23 (a)(c) | 58,865 | 215,770 | |
State Auto Financial Corp. | 21,446 | 405,329 | |
Tian Ruixiang Holdings Ltd. (b) | 3,710 | 37,026 | |
Tiptree, Inc. | 21,813 | 234,926 | |
Trean Insurance Group, Inc. (a) | 28,354 | 476,347 | |
Trupanion, Inc. (a) | 22,228 | 2,004,299 | |
Unico American Corp. (a) | 851 | 3,974 | |
United Fire Group, Inc. | 12,395 | 379,907 | |
United Insurance Holdings Corp. | 21,548 | 121,531 | |
Vericity, Inc. | 6,650 | 60,249 | |
Watford Holdings Ltd. (a) | 10,260 | 358,484 | |
Willis Towers Watson PLC | 72,065 | 18,834,908 | |
79,678,424 | |||
Mortgage Real Estate Investment Trusts - 0.0% | |||
AGNC Investment Corp. | 289,915 | 5,375,024 | |
Manhattan Bridge Capital, Inc. (b) | 7,113 | 47,657 | |
New York Mortgage Trust, Inc. | 210,565 | 951,754 | |
6,374,435 | |||
Thrifts & Mortgage Finance - 0.2% | |||
America First Tax Exempt Investors LP | 39,141 | 245,805 | |
Bogota Financial Corp. (a)(b) | 8,810 | 88,541 | |
Bridgewater Bancshares, Inc. (a) | 11,181 | 194,102 | |
Broadway Financial Corp. (a) | 9,122 | 21,984 | |
Capitol Federal Financial, Inc. | 86,439 | 1,118,521 | |
Carver Bancorp, Inc. (a) | 1,018 | 8,714 | |
Columbia Financial, Inc. (a) | 72,096 | 1,281,146 | |
FS Bancorp, Inc. | 3,075 | 218,879 | |
Greene County Bancorp, Inc. (b) | 4,298 | 123,181 | |
Guaranty Federal Bancshares, Inc. | 453 | 10,985 | |
Hingham Institution for Savings | 1,454 | 422,024 | |
HMN Financial, Inc. (a) | 2,581 | 53,375 | |
Home Bancorp, Inc. | 7,434 | 288,811 | |
Home Point Capital, Inc. (b) | 75,896 | 484,975 | |
HomeStreet, Inc. | 11,829 | 532,542 | |
Kearny Financial Corp. | 36,521 | 478,790 | |
Luther Burbank Corp. | 20,688 | 251,152 | |
Merchants Bancorp | 14,760 | 633,942 | |
Meridian Bancorp, Inc. Maryland | 27,458 | 605,449 | |
Meta Financial Group, Inc. | 21,290 | 1,128,583 | |
MMA Capital Management, LLC (a) | 4,253 | 115,086 | |
Mr. Cooper Group, Inc. (a) | 52,465 | 1,814,764 | |
NMI Holdings, Inc. (a) | 48,402 | 1,170,844 | |
Northfield Bancorp, Inc. | 31,683 | 536,393 | |
Northwest Bancshares, Inc. | 89,823 | 1,271,894 | |
OP Bancorp | 2,211 | 22,928 | |
PCSB Financial Corp. | 16,016 | 294,374 | |
PDL Community Bancorp (a) | 2,467 | 34,538 | |
Pioneer Bancorp, Inc. (a) | 7,585 | 92,613 | |
Premier Financial Corp. | 24,001 | 732,031 | |
Provident Bancorp, Inc. | 14,544 | 245,503 | |
Prudential Bancorp, Inc. | 6,449 | 89,448 | |
Randolph Bancorp, Inc. (a) | 3,346 | 74,214 | |
Riverview Bancorp, Inc. | 15,015 | 103,153 | |
Severn Bancorp, Inc. | 3,614 | 43,838 | |
Southern Missouri Bancorp, Inc. | 6,368 | 281,466 | |
Standard AVB Financial Corp. | 585 | 19,305 | |
Sterling Bancorp, Inc. (a) | 20,345 | 97,859 | |
TFS Financial Corp. | 157,301 | 3,485,790 | |
Timberland Bancorp, Inc. | 5,704 | 166,329 | |
Trustco Bank Corp., New York | 10,680 | 417,908 | |
Washington Federal, Inc. | 48,680 | 1,622,991 | |
Waterstone Financial, Inc. | 20,236 | 400,268 | |
Western New England Bancorp, Inc. | 19,217 | 163,537 | |
WSFS Financial Corp. | 29,890 | 1,590,447 | |
23,079,022 | |||
TOTAL FINANCIALS | 597,485,443 | ||
HEALTH CARE - 10.1% | |||
Biotechnology - 5.3% | |||
180 Life Sciences Corp. (a)(b) | 11,196 | 95,614 | |
4D Molecular Therapeutics, Inc. | 14,497 | 385,040 | |
89Bio, Inc. (a)(b) | 11,203 | 211,737 | |
Abcam PLC ADR | 9,016 | 181,222 | |
Abeona Therapeutics, Inc. (a)(b) | 85,883 | 141,707 | |
AC Immune SA (a)(b) | 35,468 | 216,000 | |
ACADIA Pharmaceuticals, Inc. (a) | 90,773 | 2,027,869 | |
Acceleron Pharma, Inc. (a) | 33,864 | 4,432,459 | |
Achieve Life Sciences, Inc. (a) | 5,703 | 45,681 | |
Acorda Therapeutics, Inc. (a)(b) | 10,209 | 37,977 | |
Adagene, Inc. ADR | 3,007 | 42,639 | |
Adamas Pharmaceuticals, Inc. (a) | 18,481 | 102,200 | |
Adaptimmune Therapeutics PLC sponsored ADR (a) | 72,769 | 366,028 | |
Adicet Bio, Inc. (a) | 16,009 | 214,841 | |
Adicet Bio, Inc. rights (a)(c) | 3,438 | 0 | |
Aditx Therapeutics, Inc. (a)(b) | 2,896 | 8,138 | |
ADMA Biologics, Inc. (a) | 55,094 | 96,415 | |
Advaxis, Inc. (a) | 132,082 | 63,135 | |
Adverum Biotechnologies, Inc. (a) | 57,265 | 198,137 | |
Aeglea BioTherapeutics, Inc. (a) | 27,375 | 180,949 | |
Aeterna Zentaris, Inc. (a)(b) | 53,097 | 46,943 | |
Affimed NV (a) | 64,697 | 573,862 | |
Agenus, Inc. (a)(b) | 117,953 | 502,480 | |
Agios Pharmaceuticals, Inc. (a) | 38,425 | 2,143,347 | |
Aikido Pharma, Inc. (a) | 40,485 | 43,319 | |
Aileron Therapeutics, Inc. (a) | 66,955 | 82,355 | |
Akebia Therapeutics, Inc. (a)(b) | 75,712 | 265,749 | |
Akero Therapeutics, Inc. (a)(b) | 19,689 | 515,458 | |
Akouos, Inc. (a)(b) | 19,469 | 254,265 | |
Akoya Biosciences, Inc. (a) | 19,467 | 405,303 | |
Albireo Pharma, Inc. (a)(b) | 10,788 | 360,859 | |
Aldeyra Therapeutics, Inc. (a) | 27,263 | 341,333 | |
Alector, Inc. (a)(b) | 43,288 | 770,526 | |
Alexion Pharmaceuticals, Inc. (a) | 122,329 | 21,597,185 | |
Aligos Therapeutics, Inc. (b) | 20,224 | 563,845 | |
Alkermes PLC (a) | 90,053 | 2,041,502 | |
Allakos, Inc. (a) | 29,236 | 2,965,700 | |
Allena Pharmaceuticals, Inc. (a)(b) | 34,198 | 37,276 | |
Allogene Therapeutics, Inc. (a) | 79,583 | 2,045,283 | |
Allovir, Inc. (a)(b) | 36,743 | 861,256 | |
Alnylam Pharmaceuticals, Inc. (a) | 65,197 | 9,257,322 | |
Alpine Immune Sciences, Inc. (a)(b) | 16,822 | 179,323 | |
Alterity Therapeutics Ltd. ADR (a) | 12,128 | 16,252 | |
Altimmune, Inc. (a)(b) | 22,016 | 278,502 | |
ALX Oncology Holdings, Inc. (a) | 22,323 | 1,262,589 | |
Amarin Corp. PLC ADR (a)(b) | 214,385 | 973,308 | |
Amgen, Inc. | 319,480 | 76,017,071 | |
Amicus Therapeutics, Inc. (a) | 141,900 | 1,313,994 | |
AnaptysBio, Inc. (a) | 14,026 | 334,801 | |
Anavex Life Sciences Corp. (a)(b) | 39,848 | 496,108 | |
Anika Therapeutics, Inc. (a) | 7,769 | 362,424 | |
Anixa Biosciences, Inc. (a)(b) | 19,414 | 77,074 | |
Annexon, Inc. (a) | 20,751 | 438,261 | |
AnPac Bio-Medical Science Co. Ltd. ADR (a)(b) | 1,377 | 5,949 | |
Apellis Pharmaceuticals, Inc. (a) | 43,906 | 2,471,030 | |
Applied Genetic Technologies Corp. (a)(b) | 18,110 | 72,621 | |
Applied Molecular Transport, Inc. (b) | 19,852 | 951,705 | |
Applied Therapeutics, Inc. (a) | 13,218 | 254,182 | |
Aprea Therapeutics, Inc. (a)(b) | 12,259 | 51,733 | |
Aptevo Therapeutics, Inc. (a) | 3,386 | 88,442 | |
Aptinyx, Inc. (a) | 74,514 | 189,266 | |
Aptorum Group Ltd. (a)(b) | 16,827 | 47,116 | |
Aptose Biosciences, Inc. (a)(b) | 59,019 | 312,801 | |
AquaBounty Technologies, Inc. (a) | 43,964 | 239,164 | |
AquaMed Technologies, Inc. (a)(c) | 19,156 | 0 | |
Aravive, Inc. (a)(b) | 15,258 | 78,274 | |
Arbutus Biopharma Corp. (a) | 61,977 | 175,395 | |
ARCA Biopharma, Inc. (a)(b) | 17,417 | 60,785 | |
Arcturus Therapeutics Holdings, Inc. (a)(b) | 14,340 | 419,015 | |
Arcutis Biotherapeutics, Inc. (a) | 27,809 | 732,767 | |
Ardelyx, Inc. (a) | 56,480 | 403,832 | |
Arena Pharmaceuticals, Inc. (a) | 32,965 | 2,014,491 | |
Argenx SE ADR (a) | 13,852 | 3,864,569 | |
Aridis Pharmaceuticals, Inc. (a)(b) | 2,356 | 13,618 | |
Arrowhead Pharmaceuticals, Inc. (a) | 57,486 | 4,173,484 | |
Ascendis Pharma A/S sponsored ADR (a) | 29,656 | 3,985,173 | |
Aslan Pharmaceuticals Ltd. ADR (a)(b) | 21,036 | 62,477 | |
Atara Biotherapeutics, Inc. (a) | 45,129 | 611,949 | |
Athenex, Inc. (a)(b) | 57,314 | 268,803 | |
Athersys, Inc. (a)(b) | 109,566 | 182,975 | |
Atossa Therapeutics, Inc. (a)(b) | 60,434 | 194,597 | |
Atreca, Inc. (a)(b) | 14,448 | 130,321 | |
aTyr Pharma, Inc. (a)(b) | 14,422 | 65,476 | |
Aurinia Pharmaceuticals, Inc. (a)(b) | 70,118 | 1,018,113 | |
Autolus Therapeutics Ltd. ADR (a) | 15,783 | 104,641 | |
AVEO Pharmaceuticals, Inc. (a) | 17,528 | 127,954 | |
Avid Bioservices, Inc. (a) | 32,569 | 693,068 | |
Avidity Biosciences, Inc. (b) | 19,476 | 462,360 | |
Avita Therapeutics, Inc. (a) | 12,445 | 224,757 | |
AVROBIO, Inc. (a) | 22,707 | 204,136 | |
Axcella Health, Inc. (a)(b) | 20,100 | 64,119 | |
Ayala Pharmaceuticals, Inc. (b) | 5,436 | 51,642 | |
Aziyo Biologics, Inc. (b) | 860 | 10,793 | |
AzurRx BioPharma, Inc. (a)(b) | 43,450 | 36,933 | |
Beam Therapeutics, Inc. (a)(b) | 32,249 | 2,522,839 | |
BeiGene Ltd. ADR (a) | 27,448 | 9,840,382 | |
Bellicum Pharmaceuticals, Inc. (a)(b) | 12,201 | 36,359 | |
BELLUS Health, Inc. (a)(b) | 38,028 | 152,112 | |
Benitec Biopharma, Inc. (a)(b) | 9,459 | 44,552 | |
BeyondSpring, Inc. (a) | 18,694 | 193,857 | |
Bicycle Therapeutics PLC ADR (a) | 6,221 | 183,520 | |
Bio Path Holdings, Inc. (a) | 15,100 | 86,070 | |
BioAtla, Inc. (b) | 17,439 | 750,749 | |
BioCardia, Inc. (a)(b) | 5,162 | 21,113 | |
Biocept, Inc. (a)(b) | 9,806 | 44,323 | |
BioCryst Pharmaceuticals, Inc. (a)(b) | 100,594 | 1,586,367 | |
Biogen, Inc. (a) | 84,386 | 22,571,567 | |
BioLine RX Ltd. sponsored ADR (a) | 10,263 | 29,352 | |
BioMarin Pharmaceutical, Inc. (a) | 101,570 | 7,851,361 | |
Biomea Fusion, Inc. (a) | 14,338 | 248,191 | |
BioNTech SE ADR (a)(b) | 41,770 | 8,521,080 | |
BioVie, Inc. (b) | 8,676 | 119,295 | |
BioXcel Therapeutics, Inc. (a)(b) | 12,737 | 420,703 | |
Black Diamond Therapeutics, Inc. (a)(b) | 21,284 | 279,246 | |
bluebird bio, Inc. (a) | 36,848 | 1,146,710 | |
Blueprint Medicines Corp. (a) | 32,675 | 2,984,861 | |
Bolt Biotherapeutics, Inc. | 19,795 | 346,610 | |
BrainStorm Cell Therpeutic, Inc. (a)(b) | 20,843 | 74,618 | |
BriaCell Therapeutics Corp. (a)(b) | 4,862 | 15,899 | |
Brickell Biotech, Inc. (a)(b) | 72,285 | 58,927 | |
BridgeBio Pharma, Inc. (a)(b) | 83,610 | 4,949,712 | |
Burning Rock Biotech Ltd. ADR | 15,294 | 414,009 | |
C4 Therapeutics, Inc. (b) | 24,502 | 905,349 | |
Cabaletta Bio, Inc. (a)(b) | 13,397 | 151,922 | |
Calithera Biosciences, Inc. (a) | 11,132 | 25,381 | |
Calyxt, Inc. (a) | 18,775 | 80,920 | |
Capricor Therapeutics, Inc. (a) | 9,339 | 35,395 | |
Cardiff Oncology, Inc. (a) | 23,215 | 195,006 | |
CareDx, Inc. (a) | 28,186 | 2,266,154 | |
CASI Pharmaceuticals, Inc. (a)(b) | 59,795 | 95,672 | |
Catabasis Pharmaceuticals, Inc. (a) | 9,932 | 20,261 | |
Catalyst Biosciences, Inc. (a) | 7,029 | 30,014 | |
Catalyst Pharmaceutical Partners, Inc. (a) | 48,487 | 268,133 | |
Celcuity, Inc. (a) | 6,340 | 171,751 | |
Celldex Therapeutics, Inc. (a) | 23,079 | 645,058 | |
Cellectar Biosciences, Inc. (a)(b) | 14,707 | 24,119 | |
Cellectis SA sponsored ADR (a) | 10,776 | 168,860 | |
Celsion Corp. (a) | 51,243 | 60,467 | |
Centogene NV (a)(b) | 11,156 | 109,440 | |
Cerevel Therapeutics Holdings (a)(b) | 74,379 | 975,852 | |
Checkmate Pharmaceuticals, Inc. | 10,139 | 68,540 | |
Checkpoint Therapeutics, Inc. (a)(b) | 32,158 | 86,183 | |
ChemoCentryx, Inc. (a) | 38,907 | 394,906 | |
Chemomab Therapeutics Ltd. ADR (a)(b) | 1,444 | 25,559 | |
Chimerix, Inc. (a) | 52,138 | 407,719 | |
Chinook Therapeutics, Inc. (a) | 24,522 | 404,613 | |
Chinook Therapeutics, Inc. rights (a)(c) | 11,497 | 575 | |
Cidara Therapeutics, Inc. (a) | 25,129 | 50,761 | |
Clementia Pharmaceuticals, Inc. rights (a)(c) | 21,066 | 28,439 | |
Clene, Inc. (a)(b) | 32,147 | 366,476 | |
Cleveland Biolabs, Inc. (a) | 11,084 | 59,854 | |
Clovis Oncology, Inc. (a)(b) | 58,413 | 299,659 | |
Codiak Biosciences, Inc. (b) | 11,391 | 257,664 | |
Cogent Biosciences, Inc. (a) | 26,227 | 227,126 | |
Cogent Biosciences, Inc. rights (a)(c) | 12,548 | 0 | |
CohBar, Inc. (a)(b) | 15,928 | 19,910 | |
Coherus BioSciences, Inc. (a) | 43,446 | 571,749 | |
Collplant Biotechnologies Ltd. ADR (a)(b) | 3,242 | 55,681 | |
Compass Pathways PLC ADR | 5,782 | 200,635 | |
Concert Pharmaceuticals, Inc. (a) | 10,199 | 41,000 | |
Connect Biopharma Holdings Ltd. ADR (a)(b) | 4,035 | 60,041 | |
Constellation Pharmaceuticals, Inc. (a) | 26,786 | 530,631 | |
ContraFect Corp. (a)(b) | 10,656 | 43,050 | |
Corbus Pharmaceuticals Holdings, Inc. (a) | 58,993 | 128,015 | |
Cortexyme, Inc. (a)(b) | 16,512 | 683,101 | |
Corvus Pharmaceuticals, Inc. (a)(b) | 17,851 | 48,912 | |
Crinetics Pharmaceuticals, Inc. (a) | 19,529 | 342,734 | |
CRISPR Therapeutics AG (a)(b) | 42,155 | 4,981,878 | |
CTI BioPharma Corp. (a) | 59,493 | 142,188 | |
Cue Biopharma, Inc. (a) | 15,106 | 216,620 | |
Cullinan Oncology, Inc. | 23,980 | 712,925 | |
CureVac NV (a)(b) | 103,386 | 11,525,471 | |
Curis, Inc. (a) | 54,553 | 785,563 | |
Cyclacel Pharmaceuticals, Inc. (a)(b) | 3,131 | 22,449 | |
Cyclerion Therapeutics, Inc. (a) | 22,640 | 73,354 | |
Cyclo Therapeutics, Inc. (a) | 3,960 | 32,789 | |
Cytokinetics, Inc. (a) | 39,694 | 866,520 | |
CytomX Therapeutics, Inc. (a) | 35,387 | 253,371 | |
DBV Technologies SA sponsored ADR (a)(b) | 21,559 | 126,120 | |
Decibel Therapeutics, Inc. | 12,258 | 109,709 | |
Deciphera Pharmaceuticals, Inc. (a) | 32,567 | 1,098,811 | |
Denali Therapeutics, Inc. (a) | 67,159 | 4,270,641 | |
DermTech, Inc. (a)(b) | 16,192 | 662,577 | |
Design Therapeutics, Inc. (a)(b) | 29,432 | 771,118 | |
DiaMedica Therapeutics, Inc. (a) | 8,546 | 63,326 | |
Dicerna Pharmaceuticals, Inc. (a) | 46,326 | 1,510,228 | |
Diffusion Pharmaceuticals, Inc. (a) | 64,139 | 45,026 | |
Dyadic International, Inc. (a)(b) | 15,088 | 56,882 | |
Dynavax Technologies Corp. (a)(b) | 63,663 | 522,037 | |
Dyne Therapeutics, Inc. (b) | 27,351 | 522,678 | |
Eagle Pharmaceuticals, Inc. (a) | 5,542 | 219,574 | |
Edesa Biotech, Inc. (a) | 14,050 | 88,094 | |
Edgewise Therapeutics, Inc. (a) | 26,060 | 752,352 | |
Editas Medicine, Inc. (a)(b) | 38,353 | 1,302,084 | |
Eiger Biopharmaceuticals, Inc. (a) | 20,474 | 160,926 | |
Eledon Pharmaceuticals, Inc. (a) | 7,538 | 71,762 | |
Enanta Pharmaceuticals, Inc. (a) | 11,608 | 564,845 | |
Enlivex Therapeutics Ltd. (a) | 7,994 | 74,904 | |
Enochian Biosciences, Inc. (a)(b) | 23,627 | 96,162 | |
Entasis Therapeutics Holdings, Inc. (a) | 26,360 | 62,473 | |
Entera Bio Ltd. (a) | 17,597 | 56,838 | |
Epizyme, Inc. (a) | 58,277 | 479,620 | |
Equillium, Inc. (a) | 15,098 | 99,043 | |
Esperion Therapeutics, Inc. (a)(b) | 14,765 | 293,971 | |
Essa Pharma, Inc. (a) | 18,395 | 581,650 | |
Evelo Biosciences, Inc. (a)(b) | 28,127 | 377,464 | |
Evogene Ltd. (a)(b) | 26,731 | 93,024 | |
Exact Sciences Corp. (a) | 94,013 | 10,391,257 | |
Exelixis, Inc. (a) | 173,130 | 3,904,082 | |
Exicure, Inc. (a) | 46,150 | 77,071 | |
F-star Therapeutics, Inc. (a) | 3,746 | 27,870 | |
F-star Therapeutics, Inc.: | |||
rights (a)(c) | 1,855 | 0 | |
rights (a)(c) | 1,855 | 0 | |
Fate Therapeutics, Inc. (a) | 52,071 | 3,988,639 | |
Fennec Pharmaceuticals, Inc. (a)(b) | 17,500 | 128,975 | |
FibroGen, Inc. (a) | 51,710 | 1,098,838 | |
Finch Therapeutics Group, Inc. (a)(b) | 25,491 | 371,914 | |
Flexion Therapeutics, Inc. (a)(b) | 29,385 | 245,952 | |
Foghorn Therapeutics, Inc. | 18,696 | 194,625 | |
Forma Therapeutics Holdings, Inc. | 23,976 | 673,006 | |
Forte Biosciences, Inc. (a) | 7,239 | 257,274 | |
Fortress Biotech, Inc. (a) | 60,011 | 241,844 | |
Forward Pharma A/S sponsored ADR (a)(b) | 499 | 3,638 | |
Freeline Therapeutics Holdings PLC ADR (a) | 17,109 | 188,199 | |
Frequency Therapeutics, Inc. (a)(b) | 19,874 | 175,885 | |
Fusion Pharmaceuticals, Inc. (a)(b) | 23,089 | 189,561 | |
G1 Therapeutics, Inc. (a)(b) | 21,859 | 474,777 | |
Gain Therapeutics, Inc. (a) | 5,115 | 54,526 | |
Galapagos Genomics NV sponsored ADR (a) | 3,377 | 257,125 | |
Galectin Therapeutics, Inc. (a)(b) | 32,120 | 127,516 | |
Galecto, Inc. | 7,426 | 39,432 | |
Galera Therapeutics, Inc. (a) | 11,144 | 95,504 | |
Galmed Pharmaceuticals Ltd. (a)(b) | 19,960 | 51,896 | |
Gamida Cell Ltd. (a)(b) | 31,257 | 202,858 | |
Gemini Therapeutics, Inc. | 21,173 | 260,428 | |
Generation Bio Co. (b) | 30,848 | 1,056,852 | |
Genetron Holdings Ltd. ADR | 10,525 | 222,814 | |
Genfit ADR (a)(b) | 3,215 | 12,796 | |
Genmab A/S ADR (a)(b) | 26,405 | 1,072,571 | |
Genocea Biosciences, Inc. (a)(b) | 31,346 | 73,977 | |
Genprex, Inc. (a)(b) | 21,698 | 81,151 | |
GeoVax Labs, Inc. (a) | 6,138 | 33,268 | |
Geron Corp. (a) | 167,155 | 230,674 | |
Gilead Sciences, Inc. | 696,087 | 46,018,312 | |
Global Blood Therapeutics, Inc. (a)(b) | 34,207 | 1,314,575 | |
GlycoMimetics, Inc. (a)(b) | 16,635 | 42,419 | |
Gossamer Bio, Inc. (a)(b) | 44,064 | 373,222 | |
Gracell Biotechnologies, Inc. ADR (b) | 3,209 | 48,328 | |
Greenwich Lifesciences, Inc. | 6,960 | 258,077 | |
Grifols SA ADR | 66,711 | 1,166,775 | |
Gritstone Bio, Inc. (a)(b) | 27,675 | 254,610 | |
Gt Biopharma, Inc. (a)(b) | 15,252 | 262,944 | |
Halozyme Therapeutics, Inc. (a) | 75,562 | 3,129,022 | |
Harpoon Therapeutics, Inc. (a) | 17,898 | 369,057 | |
Heat Biologics, Inc. (a)(b) | 12,934 | 85,494 | |
Heron Therapeutics, Inc. (a)(b) | 52,372 | 694,976 | |
Histogen, Inc. (a)(b) | 28,748 | 28,463 | |
Homology Medicines, Inc. (a) | 26,885 | 178,516 | |
Hookipa Pharma, Inc. (a)(b) | 13,294 | 221,877 | |
Humanigen, Inc. (a)(b) | 32,218 | 651,770 | |
I-Mab ADR (a) | 10,492 | 850,586 | |
Ideaya Biosciences, Inc. (a) | 17,450 | 351,618 | |
Idera Pharmaceuticals, Inc. (a)(b) | 20,059 | 23,469 | |
IGM Biosciences, Inc. (a) | 14,073 | 1,050,549 | |
Immatics NV (a) | 33,359 | 374,622 | |
Immunic, Inc. (a) | 10,417 | 140,734 | |
ImmunityBio, Inc. (a)(b) | 213,855 | 3,753,155 | |
Immunocore Holdings PLC ADR | 4,716 | 193,356 | |
ImmunoGen, Inc. (a) | 102,165 | 631,380 | |
Immunome, Inc. | 5,349 | 111,901 | |
Immunovant, Inc. (a) | 55,308 | 838,469 | |
Immutep Ltd. ADR (a) | 12,131 | 61,140 | |
IMV, Inc. (a)(b) | 26,492 | 64,376 | |
Incyte Corp. (a) | 122,466 | 10,260,201 | |
Infinity Pharmaceuticals, Inc. (a) | 53,051 | 176,660 | |
InflaRx NV (a) | 4,464 | 13,615 | |
Inhibrx, Inc. (a) | 21,784 | 460,949 | |
Inmune Bio, Inc. (a) | 8,543 | 115,843 | |
Inovio Pharmaceuticals, Inc. (a)(b) | 115,838 | 874,577 | |
Inozyme Pharma, Inc. (a)(b) | 11,206 | 183,330 | |
Insmed, Inc. (a) | 55,664 | 1,369,334 | |
Instil Bio, Inc. (a) | 67,746 | 1,205,879 | |
Intec Pharma Ltd. (a)(b) | 8,545 | 32,215 | |
Intellia Therapeutics, Inc. (a) | 37,725 | 2,827,112 | |
Intercept Pharmaceuticals, Inc. (a)(b) | 18,707 | 311,097 | |
Inventiva SA ADR (a)(b) | 2,231 | 30,475 | |
Ionis Pharmaceuticals, Inc. (a)(b) | 78,414 | 2,920,922 | |
Iovance Biotherapeutics, Inc. (a) | 82,683 | 1,535,423 | |
Ironwood Pharmaceuticals, Inc. Class A (a) | 94,574 | 1,094,221 | |
iTeos Therapeutics, Inc. (a) | 19,095 | 392,211 | |
Iveric Bio, Inc. (a) | 50,254 | 355,296 | |
Jounce Therapeutics, Inc. (a) | 23,043 | 180,888 | |
Kadmon Holdings, Inc. (a) | 112,596 | 432,369 | |
Kalvista Pharmaceuticals, Inc. (a)(b) | 14,657 | 395,739 | |
Kamada (a)(b) | 24,022 | 141,009 | |
Karuna Therapeutics, Inc. (a) | 14,740 | 1,648,227 | |
Karyopharm Therapeutics, Inc. (a)(b) | 41,184 | 382,188 | |
Kazia Therapeutics Ltd. sponsored ADR (a)(b) | 3,881 | 36,908 | |
Keros Therapeutics, Inc. (a) | 12,482 | 681,018 | |
Kezar Life Sciences, Inc. (a) | 17,659 | 101,009 | |
Kindred Biosciences, Inc. (a) | 19,079 | 92,152 | |
Kiniksa Pharmaceuticals Ltd. (a)(b) | 21,394 | 291,600 | |
Kinnate Biopharma, Inc. (b) | 23,511 | 552,038 | |
Kintara Therapeutics, Inc. (a)(b) | 15,368 | 24,742 | |
Kodiak Sciences, Inc. (a)(b) | 28,155 | 2,354,321 | |
Kronos Bio, Inc. (b) | 31,134 | 759,981 | |
Krystal Biotech, Inc. (a) | 12,300 | 802,452 | |
Kura Oncology, Inc. (a) | 35,945 | 799,776 | |
Kymera Therapeutics, Inc. (a)(b) | 24,633 | 1,184,601 | |
La Jolla Pharmaceutical Co. (a)(b) | 17,647 | 75,882 | |
Lantern Pharma, Inc. (a) | 5,274 | 79,743 | |
Larimar Therapeutics, Inc. (a)(b) | 8,246 | 68,524 | |
LAVA Therapeutics NV (a) | 12,997 | 147,256 | |
Leap Therapeutics, Inc. (a) | 28,305 | 45,854 | |
Legend Biotech Corp. ADR (b) | 15,769 | 620,826 | |
Lexicon Pharmaceuticals, Inc. (a)(b) | 78,924 | 346,476 | |
Ligand Pharmaceuticals, Inc.: | |||
Class B (a) | 9,030 | 1,062,831 | |
General CVR (a)(c) | 1,518 | 23 | |
Glucagon CVR (a) | 1,518 | 17 | |
rights (a) | 1,518 | 21 | |
TR Beta CVR (a) | 1,518 | 258 | |
Liminal BioSciences, Inc. (a) | 14,301 | 63,210 | |
LogicBio Therapeutics, Inc. (a)(b) | 19,478 | 85,119 | |
Lumos Pharma, Inc. (a) | 4,873 | 51,069 | |
Macrogenics, Inc. (a) | 30,755 | 990,003 | |
Madrigal Pharmaceuticals, Inc. (a)(b) | 9,320 | 1,046,636 | |
Magenta Therapeutics, Inc. (a) | 23,655 | 292,139 | |
MannKind Corp. (a)(b) | 133,586 | 590,450 | |
Marker Therapeutics, Inc. (a) | 38,560 | 112,210 | |
Medicenna Therapeutics Corp. (a)(b) | 19,762 | 76,874 | |
MediciNova, Inc. (a)(b) | 25,966 | 109,577 | |
MEI Pharma, Inc. (a) | 53,702 | 154,662 | |
MeiraGTx Holdings PLC (a) | 27,678 | 381,680 | |
Mereo Biopharma Group PLC ADR (a)(b) | 32,987 | 107,867 | |
Merrimack Pharmaceuticals, Inc. (a) | 2,337 | 14,957 | |
Mersana Therapeutics, Inc. (a) | 38,414 | 550,088 | |
Merus BV (a) | 20,484 | 433,237 | |
Mesoblast Ltd. sponsored ADR (a)(b) | 7,548 | 58,346 | |
Metacrine, Inc. | 7,941 | 32,717 | |
Midatech Pharma PLC ADR (a)(b) | 7,397 | 14,128 | |
Millendo Therapeutics, Inc. (a) | 22,083 | 26,279 | |
MiMedx Group, Inc. (a)(b) | 59,575 | 636,857 | |
Minerva Neurosciences, Inc. (a) | 7,475 | 22,051 | |
Mirati Therapeutics, Inc. (a) | 28,158 | 4,453,188 | |
Mirum Pharmaceuticals, Inc. (a) | 14,847 | 245,569 | |
Moderna, Inc. (a) | 221,215 | 40,926,987 | |
Molecular Templates, Inc. (a) | 32,716 | 292,481 | |
Moleculin Biotech, Inc. (a) | 7,535 | 27,880 | |
Monopar Therapeutics, Inc. (a)(b) | 4,962 | 28,333 | |
Morphic Holding, Inc. (a) | 19,704 | 972,589 | |
Morphosys AG sponsored ADR (a) | 7,201 | 158,998 | |
Mustang Bio, Inc. (a) | 37,461 | 125,494 | |
Myriad Genetics, Inc. (a) | 42,298 | 1,211,838 | |
Nanobiotix SA ADR (b) | 1,588 | 27,123 | |
Natera, Inc. (a) | 48,551 | 4,570,591 | |
Neoleukin Therapeutics, Inc. (a) | 22,529 | 225,966 | |
Neubase Therapeutics, Inc. (a)(b) | 13,736 | 71,015 | |
Neurobo Pharmaceuticals, Inc. (a) | 9,229 | 26,026 | |
Neurobo Pharmaceuticals, Inc. rights (a)(c) | 612 | 0 | |
Neurocrine Biosciences, Inc. (a) | 52,583 | 5,059,536 | |
Neximmune, Inc. | 11,947 | 221,975 | |
NextCure, Inc. (a) | 9,878 | 77,542 | |
Nkarta, Inc. (a)(b) | 18,643 | 453,957 | |
Novavax, Inc. (a) | 40,913 | 6,039,577 | |
NuCana PLC ADR (a) | 14,498 | 44,364 | |
Nurix Therapeutics, Inc. (a)(b) | 24,268 | 677,077 | |
Nymox Pharmaceutical Corp. (a)(b) | 41,592 | 63,220 | |
ObsEva SA (a) | 24,966 | 72,901 | |
Ocugen, Inc. (a)(b) | 105,158 | 918,029 | |
Olema Pharmaceuticals, Inc. (b) | 22,009 | 615,372 | |
OncoCyte Corp. (a) | 49,349 | 218,123 | |
Oncolytics Biotech, Inc. (a) | 24,545 | 74,862 | |
Oncorus, Inc. (a) | 13,846 | 238,151 | |
OncoSec Medical, Inc. (a) | 23,035 | 92,370 | |
Oncternal Therapeutics, Inc. (a) | 28,548 | 162,438 | |
Oncternal Therapeutics, Inc. rights (a)(c) | 4,319 | 0 | |
OpGen, Inc. (a) | 8,401 | 18,398 | |
Opko Health, Inc. (a)(b) | 378,730 | 1,446,749 | |
Opthea Ltd. ADR (a) | 1,175 | 10,751 | |
Orchard Therapeutics PLC ADR (a) | 30,672 | 160,415 | |
Organogenesis Holdings, Inc. Class A (a)(b) | 71,506 | 1,274,952 | |
Organovo Holdings, Inc. (a)(b) | 3,745 | 35,203 | |
Orgenesis, Inc. (a)(b) | 11,563 | 55,849 | |
ORIC Pharmaceuticals, Inc. (a)(b) | 21,924 | 500,963 | |
Outlook Therapeutics, Inc. (a) | 98,465 | 263,886 | |
Ovid Therapeutics, Inc. (a)(b) | 34,929 | 144,955 | |
Oyster Point Pharma, Inc. (a)(b) | 13,535 | 242,547 | |
Palisade Bio, Inc. (a)(b) | 4,937 | 18,810 | |
Palisade Bio, Inc. rights (a)(c) | 29,628 | 0 | |
Passage Bio, Inc. (a)(b) | 29,798 | 394,824 | |
PDS Biotechnology Corp. (a) | 17,716 | 216,135 | |
Pharming Group NV ADR (a) | 2,093 | 25,430 | |
PhaseBio Pharmaceuticals, Inc. (a)(b) | 10,575 | 35,744 | |
Phio Pharmaceuticals Corp. (a) | 20,152 | 44,737 | |
Pieris Pharmaceuticals, Inc. (a) | 27,125 | 93,310 | |
Pluristem Therapeutics, Inc. (a)(b) | 12,690 | 46,699 | |
Plus Therapeutics, Inc. (a)(b) | 17,778 | 42,134 | |
PMV Pharmaceuticals, Inc. (b) | 25,512 | 877,613 | |
Polarityte, Inc. (a)(b) | 77,220 | 88,031 | |
Portage Biotech, Inc. (a)(b) | 5,892 | 165,565 | |
Poseida Therapeutics, Inc. (a)(b) | 35,266 | 297,998 | |
Praxis Precision Medicines, Inc. | 21,955 | 430,098 | |
Precigen, Inc. (a)(b) | 110,895 | 731,907 | |
Precision BioSciences, Inc. (a)(b) | 32,101 | 338,024 | |
Prelude Therapeutics, Inc. (b) | 26,166 | 909,530 | |
Prometheus Biosciences, Inc. (a) | 18,805 | 437,968 | |
ProQR Therapeutics BV (a)(b) | 23,054 | 143,857 | |
Protagonist Therapeutics, Inc. (a) | 23,216 | 815,114 | |
Protara Therapeutics, Inc. (a) | 4,515 | 42,802 | |
Prothena Corp. PLC (a) | 20,939 | 610,791 | |
PTC Therapeutics, Inc. (a) | 39,121 | 1,536,282 | |
Puma Biotechnology, Inc. (a) | 25,036 | 264,130 | |
PureTech Health PLC ADR (a)(b) | 566 | 32,251 | |
Qualigen Therapeutics, Inc. (a)(b) | 10,616 | 20,277 | |
Radius Health, Inc. (a) | 26,855 | 518,033 | |
Rain Therapeutics, Inc. (a)(b) | 10,662 | 211,854 | |
RAPT Therapeutics, Inc. (a)(b) | 12,217 | 235,788 | |
Recro Pharma, Inc. (a) | 15,366 | 35,188 | |
Recursion Pharmaceuticals, Inc. (a)(b) | 81,269 | 2,142,251 | |
Regeneron Pharmaceuticals, Inc. (a) | 58,384 | 29,333,873 | |
REGENXBIO, Inc. (a) | 22,282 | 785,886 | |
Regulus Therapeutics, Inc. (a)(b) | 67,351 | 66,428 | |
Relay Therapeutics, Inc. (a) | 50,544 | 1,623,473 | |
Repare Therapeutics, Inc. (b) | 21,402 | 691,713 | |
Repligen Corp. (a) | 30,439 | 5,558,466 | |
Replimune Group, Inc. (a) | 25,355 | 988,084 | |
Revolution Medicines, Inc. (a)(b) | 40,970 | 1,225,413 | |
Rhythm Pharmaceuticals, Inc. (a) | 26,615 | 521,920 | |
Rigel Pharmaceuticals, Inc. (a) | 90,653 | 337,229 | |
Rocket Pharmaceuticals, Inc. (a)(b) | 34,922 | 1,484,185 | |
Rubius Therapeutics, Inc. (a)(b) | 44,722 | 1,092,558 | |
Sage Therapeutics, Inc. (a) | 32,434 | 2,257,406 | |
Salarius Pharmaceuticals, Inc. (a)(b) | 35,070 | 44,890 | |
Salarius Pharmaceuticals, Inc. rights (a)(c) | 122,366 | 15,051 | |
Sana Biotechnology, Inc. (b) | 104,431 | 2,189,918 | |
Sangamo Therapeutics, Inc. (a) | 79,495 | 856,956 | |
Sarepta Therapeutics, Inc. (a) | 44,000 | 3,328,600 | |
Savara, Inc. (a) | 54,580 | 98,244 | |
Scholar Rock Holding Corp. (a)(b) | 18,710 | 502,738 | |
Scopus Biopharma, Inc. (b) | 9,794 | 69,342 | |
Seagen, Inc. (a) | 100,584 | 15,625,724 | |
Selecta Biosciences, Inc. (a) | 55,947 | 242,810 | |
Sellas Life Sciences Group, Inc. (a) | 12,014 | 143,687 | |
Sensei Biotherapeutics, Inc. | 15,533 | 193,075 | |
Seres Therapeutics, Inc. (a) | 52,432 | 1,106,840 | |
Sesen Bio, Inc. (a) | 104,301 | 349,408 | |
Shattuck Labs, Inc. | 23,856 | 647,452 | |
Sierra Oncology, Inc. (a)(b) | 5,958 | 105,576 | |
Sigilon Therapeutics, Inc. | 16,929 | 197,561 | |
Silverback Therapeutics, Inc. (b) | 19,230 | 529,402 | |
Sinovac Biotech Ltd. (a)(c) | 27,717 | 179,329 | |
Sio Gene Therapies, Inc. (a)(b) | 47,869 | 109,141 | |
Soleno Therapeutics, Inc. (a) | 41,457 | 42,701 | |
Solid Biosciences, Inc. (a) | 60,067 | 228,255 | |
Soligenix, Inc. (a)(b) | 8,820 | 8,996 | |
Sonnet Biotherapeutics Holding (a)(b) | 15,344 | 23,783 | |
Sorrento Therapeutics, Inc. (a)(b) | 156,858 | 1,179,572 | |
Spectrum Pharmaceuticals, Inc. (a)(b) | 101,297 | 349,475 | |
Spero Therapeutics, Inc. (a)(b) | 13,597 | 197,157 | |
Springworks Therapeutics, Inc. (a)(b) | 27,008 | 2,202,232 | |
Spruce Biosciences, Inc. (b) | 13,434 | 189,822 | |
Stealth BioTherapeutics Corp. ADR (a)(b) | 9,599 | 13,151 | |
Stoke Therapeutics, Inc. (a)(b) | 19,882 | 788,520 | |
Summit Therapeutics, Inc. (a)(b) | 53,018 | 414,601 | |
Surface Oncology, Inc. (a)(b) | 19,090 | 172,574 | |
Sutro Biopharma, Inc. (a) | 24,478 | 455,536 | |
Syndax Pharmaceuticals, Inc. (a)(b) | 25,794 | 473,836 | |
Synlogic, Inc. (a) | 40,292 | 150,692 | |
Syros Pharmaceuticals, Inc. (a) | 30,872 | 199,124 | |
T2 Biosystems, Inc. (a)(b) | 103,876 | 144,388 | |
Taysha Gene Therapies, Inc. (b) | 22,814 | 513,315 | |
TCR2 Therapeutics, Inc. (a) | 20,704 | 396,482 | |
Tenax Therapeutics, Inc. (a) | 30,408 | 59,296 | |
TG Therapeutics, Inc. (a) | 77,601 | 2,705,947 | |
Theratechnologies, Inc. (a) | 44,667 | 157,228 | |
Tiziana Life Sciences PLC ADR (a)(b) | 14,852 | 34,902 | |
Tobira Therapeutics, Inc. rights (a)(c) | 6,103 | 0 | |
TONIX Pharmaceuticals Holding (a) | 174,073 | 205,406 | |
TRACON Pharmaceuticals, Inc. (a)(b) | 12,879 | 77,660 | |
Translate Bio, Inc. (a) | 41,077 | 739,797 | |
Travere Therapeutics, Inc. (a) | 30,901 | 468,768 | |
Trevena, Inc. (a) | 95,478 | 166,132 | |
Trillium Therapeutics, Inc. (a)(b) | 56,388 | 449,412 | |
Turning Point Therapeutics, Inc. (a) | 27,202 | 1,800,228 | |
Twist Bioscience Corp. (a) | 27,050 | 2,902,736 | |
Tyme Technologies, Inc. (a)(b) | 86,426 | 133,096 | |
Ultragenyx Pharmaceutical, Inc. (a) | 36,984 | 3,761,643 | |
uniQure B.V. (a) | 25,416 | 882,698 | |
United Therapeutics Corp. (a) | 24,857 | 4,620,916 | |
UNITY Biotechnology, Inc. (a) | 23,540 | 105,459 | |
UroGen Pharma Ltd. (a)(b) | 11,336 | 199,740 | |
Vaccinex, Inc. (a)(b) | 17,705 | 42,138 | |
Vanda Pharmaceuticals, Inc. (a) | 35,576 | 629,339 | |
Vaxart, Inc. (a)(b) | 65,370 | 432,749 | |
Vaxcyte, Inc. | 27,477 | 578,940 | |
VBI Vaccines, Inc. (a)(b) | 137,102 | 442,839 | |
VBL Therapeutics (a)(b) | 24,873 | 58,700 | |
VectivBio Holding AG (a) | 17,780 | 264,922 | |
Veracyte, Inc. (a) | 37,092 | 1,448,443 | |
Verastem, Inc. (a) | 111,497 | 431,493 | |
Vericel Corp. (a) | 25,530 | 1,442,445 | |
Vertex Pharmaceuticals, Inc. (a) | 144,397 | 30,125,546 | |
Viking Therapeutics, Inc. (a)(b) | 46,434 | 243,314 | |
Vincerx Pharma, Inc. (a)(b) | 5,053 | 70,136 | |
Vir Biotechnology, Inc. (a)(b) | 71,142 | 2,981,561 | |
Viracta Therapeutics, Inc. (a)(b) | 7,200 | 74,736 | |
Viridian Therapeutics, Inc. (a) | 3,556 | 64,044 | |
Viridian Therapeutics, Inc. rights (a)(c) | 30,380 | 0 | |
VistaGen Therapeutics, Inc. (a) | 88,620 | 229,526 | |
Vor Biopharma, Inc. (a)(b) | 20,299 | 428,309 | |
Voyager Therapeutics, Inc. (a)(b) | 9,718 | 41,399 | |
vTv Therapeutics, Inc. Class A (a)(b) | 39,477 | 97,113 | |
Vyant Bio, Inc. (a)(b) | 13,429 | 49,553 | |
Windtree Therapeutics, Inc. (a)(b) | 7,883 | 13,953 | |
X4 Pharmaceuticals, Inc. (a) | 14,730 | 139,935 | |
Xbiotech, Inc. (a) | 15,395 | 265,564 | |
Xencor, Inc. (a) | 34,932 | 1,343,485 | |
Xenetic Biosciences, Inc. (a) | 20,698 | 39,740 | |
Xenon Pharmaceuticals, Inc. (a) | 21,650 | 399,876 | |
XOMA Corp. (a) | 4,906 | 144,580 | |
Y-mAbs Therapeutics, Inc. (a) | 25,116 | 899,906 | |
Yield10 Bioscience, Inc. (a) | 5,455 | 44,949 | |
Yumanity Therapeutics, Inc. (a)(b) | 3,571 | 54,922 | |
Yumanity Therapeutics, Inc. rights (a)(c) | 39,785 | 0 | |
Zai Lab Ltd. ADR (a) | 33,205 | 5,899,200 | |
Zealand Pharma A/S sponsored ADR (a)(b) | 3,611 | 106,777 | |
Zentalis Pharmaceuticals, Inc. (a) | 22,504 | 1,256,848 | |
ZIOPHARM Oncology, Inc. (a)(b) | 133,508 | 405,864 | |
Zymergen, Inc. (a)(b) | 54,364 | 1,760,306 | |
644,258,978 | |||
Health Care Equipment & Supplies - 2.1% | |||
Abiomed, Inc. (a) | 25,243 | 7,183,653 | |
Accelerate Diagnostics, Inc. (a) | 32,605 | 247,472 | |
Accuray, Inc. (a) | 42,355 | 180,432 | |
Acutus Medical, Inc. (a)(b) | 13,707 | 223,013 | |
Aethlon Medical, Inc. (a) | 2,749 | 4,783 | |
Align Technology, Inc. (a) | 43,820 | 25,860,373 | |
Allied Healthcare Products, Inc. (a)(b) | 1,352 | 5,056 | |
Alphatec Holdings, Inc.(a) | 51,997 | 753,957 | |
Angiodynamics, Inc. (a) | 19,263 | 445,361 | |
Antares Pharma, Inc. (a) | 98,062 | 389,306 | |
Apollo Endosurgery, Inc. (a) | 15,720 | 113,184 | |
Apyx Medical Corp. (a) | 18,122 | 177,414 | |
Aspira Women's Health, Inc. (a)(b) | 64,182 | 358,777 | |
Atricure, Inc. (a) | 24,789 | 1,852,482 | |
Atrion Corp. | 958 | 594,918 | |
Avinger, Inc. (a) | 61,116 | 64,172 | |
AxoGen, Inc. (a) | 20,701 | 420,230 | |
Axonics Modulation Technologies, Inc. (a) | 22,638 | 1,305,986 | |
Bellerophon Therapeutics, Inc. (a) | 4,969 | 20,572 | |
Beyond Air, Inc. (a)(b) | 9,537 | 47,208 | |
BioLase Technology, Inc. (a) | 104,396 | 75,687 | |
BioLife Solutions, Inc. (a) | 20,731 | 690,550 | |
Biomerica, Inc. (a)(b) | 5,860 | 21,389 | |
BioSig Technologies, Inc. (a) | 11,418 | 41,333 | |
Bioventus, Inc. | 22,014 | 391,409 | |
Cardiovascular Systems, Inc. (a) | 23,790 | 932,330 | |
Cerus Corp. (a) | 93,501 | 541,371 | |
Check Capital Ltd. (a)(b) | 58,636 | 93,818 | |
Chembio Diagnostics, Inc. (a)(b) | 16,477 | 52,562 | |
ClearPoint Neuro, Inc. (a) | 13,370 | 246,275 | |
Co-Diagnostics, Inc. (a)(b) | 17,214 | 138,917 | |
ConforMis, Inc. (a) | 88,612 | 78,298 | |
CryoPort, Inc. (a)(b) | 24,925 | 1,393,806 | |
Cutera, Inc. (a)(b) | 9,184 | 352,482 | |
CytoSorbents Corp. (a)(b) | 20,343 | 164,575 | |
Dare Bioscience, Inc. (a)(b) | 29,994 | 38,392 | |
DarioHealth Corp. (a)(b) | 7,922 | 128,891 | |
Delcath Systems, Inc. (a)(b) | 1,414 | 15,130 | |
Dentsply Sirona, Inc. | 121,331 | 8,119,471 | |
DexCom, Inc. (a) | 53,224 | 19,660,413 | |
Eargo, Inc. (a)(b) | 21,526 | 732,315 | |
EDAP TMS SA sponsored ADR (a)(b) | 22,764 | 153,657 | |
Ekso Bionics Holdings, Inc. (a) | 5,843 | 33,188 | |
electroCore, Inc. (a) | 32,345 | 54,340 | |
ENDRA Life Sciences, Inc. (a)(b) | 35,458 | 75,171 | |
Establishment Labs Holdings, Inc. (a) | 13,987 | 1,116,163 | |
Fonar Corp. (a) | 3,366 | 60,925 | |
GBS, Inc. (a)(b) | 2,664 | 8,019 | |
Hancock Jaffe Laboratories, Inc. (a)(b) | 3,269 | 19,320 | |
Helius Medical Technologies, Inc. (U.S.) (a)(b) | 1,605 | 21,684 | |
Heska Corp. (a) | 5,548 | 1,099,336 | |
Hologic, Inc. (a) | 143,478 | 9,047,723 | |
ICU Medical, Inc. (a) | 11,909 | 2,477,787 | |
IDEXX Laboratories, Inc. (a) | 47,426 | 26,468,925 | |
Impel Neuropharma, Inc. (a)(b) | 7,532 | 84,132 | |
Inari Medical, Inc. | 27,483 | 2,389,647 | |
InMode Ltd. (a) | 20,616 | 1,759,782 | |
Inogen, Inc. (a) | 13,301 | 822,135 | |
Insulet Corp. (a) | 36,639 | 9,880,439 | |
Integra LifeSciences Holdings Corp. (a) | 47,834 | 3,302,938 | |
Intersect ENT, Inc. (a) | 22,132 | 390,630 | |
IntriCon Corp. (a) | 5,239 | 116,987 | |
Intuitive Surgical, Inc. (a) | 65,123 | 54,845,288 | |
InVivo Therapeutics Holdings Corp. (a)(b) | 43,910 | 29,529 | |
INVO Bioscience, Inc. (a)(b) | 2,637 | 11,550 | |
IRadimed Corp. (a) | 7,542 | 209,743 | |
iRhythm Technologies, Inc. (a) | 16,455 | 1,241,694 | |
Iridex Corp. (a)(b) | 7,305 | 57,417 | |
Itamar Medical Ltd. ADR (a) | 3,458 | 70,820 | |
Kewaunee Scientific Corp. (a) | 1,782 | 21,259 | |
Lantheus Holdings, Inc. (a) | 36,857 | 893,782 | |
Lantheus Holdings, Inc. rights (a)(c) | 50,063 | 1 | |
LeMaitre Vascular, Inc. | 13,069 | 669,263 | |
LENSAR, Inc. (a) | 5,527 | 45,708 | |
LivaNova PLC (a) | 27,107 | 2,264,519 | |
Lucira Health, Inc. (b) | 20,144 | 99,511 | |
Masimo Corp. (a) | 31,002 | 6,684,031 | |
Medigus Ltd. ADR (a) | 7,664 | 13,259 | |
Meridian Bioscience, Inc. (a) | 24,681 | 512,378 | |
Merit Medical Systems, Inc. (a) | 31,052 | 1,873,678 | |
Mesa Laboratories, Inc. | 2,822 | 694,381 | |
Microbot Medical, Inc. (a)(b) | 2,681 | 20,590 | |
Misonix, Inc. (a) | 8,900 | 170,791 | |
Motus GI Holdings, Inc. (a)(b) | 42,952 | 43,811 | |
MyMD Pharmaceuticals, Inc. (a)(b) | 19,378 | 84,682 | |
Nano-X Imaging Ltd. (a)(b) | 26,181 | 654,525 | |
NanoVibronix, Inc. (a) | 25,676 | 21,352 | |
Natus Medical, Inc. (a) | 17,191 | 460,719 | |
Nemaura Medical, Inc. (a)(b) | 11,700 | 159,237 | |
Neogen Corp. (a) | 29,523 | 2,725,268 | |
Neovasc, Inc. (a) | 21,359 | 19,437 | |
Neuronetics, Inc. (a) | 15,647 | 212,330 | |
Newegg Commerce, Inc. (a) | 4,371 | 43,929 | |
Novocure Ltd. (a) | 56,745 | 11,575,980 | |
NuVasive, Inc. (a) | 28,056 | 1,913,419 | |
Nuwellis, Inc. (a) | 6,913 | 27,790 | |
Obalon Therapeutics, Inc.(a)(b) | 17,647 | 55,059 | |
OraSure Technologies, Inc. (a) | 41,450 | 398,335 | |
Ortho Clinical Diagnostics Holdings PLC | 130,391 | 2,679,535 | |
Orthofix International NV (a) | 9,251 | 376,516 | |
OrthoPediatrics Corp. (a) | 10,461 | 590,942 | |
Outset Medical, Inc. | 23,989 | 1,157,949 | |
PAVmed, Inc. (a)(b) | 43,839 | 232,347 | |
Predictive Oncology, Inc. (a)(b) | 38,220 | 45,100 | |
Pro-Dex, Inc. (a) | 3,523 | 120,416 | |
Profound Medical Corp. (a) | 8,921 | 157,634 | |
Pulmonx Corp. | 19,855 | 852,177 | |
Pulse Biosciences, Inc. (a)(b) | 15,897 | 286,782 | |
Quidel Corp. (a)(b) | 23,611 | 2,788,695 | |
Quotient Ltd. (a) | 62,085 | 258,274 | |
Repro Medical Systems, Inc. (a)(b) | 20,163 | 86,096 | |
ReWalk Robotics Ltd. (a) | 29,639 | 55,425 | |
Rockwell Medical Technologies, Inc. (a)(b) | 24,209 | 21,064 | |
Sanara Medtech, Inc. (a) | 3,924 | 115,562 | |
Seaspine Holdings Corp. (a) | 16,598 | 338,267 | |
Second Sight Medical Products, Inc. (a) | 14,858 | 88,851 | |
Shockwave Medical, Inc. (a) | 19,835 | 3,568,317 | |
SI-BONE, Inc. (a) | 16,689 | 503,507 | |
Sientra, Inc. (a)(b) | 31,005 | 215,795 | |
Silk Road Medical, Inc. (a) | 19,105 | 928,121 | |
Sintx Technologies, Inc. (a)(b) | 21,155 | 30,675 | |
SmileDirectClub, Inc. (a)(b) | 63,011 | 517,320 | |
Soliton, Inc. (a) | 10,936 | 243,654 | |
Staar Surgical Co. (a) | 26,042 | 3,802,913 | |
STRATA Skin Sciences, Inc. (a) | 17,447 | 24,426 | |
Surgalign Holdings, Inc. (a) | 51,564 | 101,065 | |
SurModics, Inc. (a) | 7,764 | 411,880 | |
Tactile Systems Technology, Inc. (a) | 12,519 | 673,147 | |
Talis Biomedical Corp. | 13,579 | 132,259 | |
Tandem Diabetes Care, Inc. (a) | 35,095 | 2,996,762 | |
Tela Bio, Inc. (a) | 6,966 | 95,713 | |
Thermogenesis Holdings, Inc. (a)(b) | 2,264 | 6,203 | |
Titan Medical, Inc. (a)(b) | 54,356 | 104,364 | |
TransMedics Group, Inc. (a) | 15,332 | 393,112 | |
Treace Medical Concepts, Inc. (a) | 26,776 | 868,881 | |
Trinity Biotech PLC sponsored ADR (a)(b) | 13,909 | 43,535 | |
Utah Medical Products, Inc. | 3,090 | 264,844 | |
Varex Imaging Corp. (a) | 23,722 | 595,185 | |
Venus Concept, Inc. (a) | 24,506 | 49,992 | |
ViewRay, Inc. (a) | 84,065 | 494,302 | |
Viveve Medical, Inc. (a) | 62 | 171 | |
Zosano Pharma Corp. (a) | 87,573 | 70,058 | |
Zynex, Inc. (a)(b) | 19,173 | 291,813 | |
250,045,402 | |||
Health Care Providers & Services - 0.6% | |||
1Life Healthcare, Inc. (a) | 75,460 | 2,792,020 | |
Acadia Healthcare Co., Inc. (a) | 48,947 | 3,150,229 | |
Accolade, Inc. (a) | 32,486 | 1,640,218 | |
AdaptHealth Corp. (a)(b) | 63,834 | 1,671,812 | |
Addus HomeCare Corp. (a) | 8,720 | 838,602 | |
Akumin, Inc. (a)(b) | 32,538 | 91,106 | |
Alignment Healthcare, Inc. (a)(b) | 103,822 | 2,619,429 | |
Amedisys, Inc. (a) | 18,005 | 4,651,952 | |
Apollo Medical Holdings, Inc. (a) | 30,440 | 1,061,747 | |
Apria, Inc. | 19,041 | 579,798 | |
Avalon GloboCare Corp. (a)(b) | 32,090 | 36,583 | |
Aveanna Healthcare Holdings, Inc. (a) | 95,400 | 1,106,640 | |
Biodesix, Inc. (a) | 14,278 | 206,317 | |
Caladrius Biosciences, Inc. (a) | 14,883 | 22,622 | |
Castle Biosciences, Inc. (a) | 13,466 | 807,017 | |
Clover Health Investments Corp. (a)(b) | 78,635 | 600,771 | |
Corvel Corp. (a) | 9,803 | 1,221,454 | |
Covetrus, Inc. (a) | 75,082 | 2,082,775 | |
Cross Country Healthcare, Inc. (a) | 18,850 | 295,003 | |
Exagen, Inc. (a) | 7,907 | 112,675 | |
Five Star Senior Living, Inc. (a)(b) | 17,017 | 102,272 | |
Fulgent Genetics, Inc. (a)(b) | 16,010 | 1,185,861 | |
Great Elm Group, Inc. (a) | 7,056 | 18,628 | |
Guardant Health, Inc. (a) | 55,596 | 6,900,576 | |
HealthEquity, Inc. (a) | 45,526 | 3,784,121 | |
Henry Schein, Inc. (a) | 78,144 | 5,942,070 | |
Ikena Oncology, Inc. (a)(b) | 16,267 | 292,806 | |
IMAC Holdings, Inc. (a)(b) | 117,207 | 219,177 | |
Innovage Holding Corp. (a) | 75,461 | 1,614,865 | |
LHC Group, Inc. (a) | 17,460 | 3,437,001 | |
Magellan Health Services, Inc. (a) | 14,171 | 1,334,766 | |
Modivcare, Inc. (a) | 7,758 | 1,142,210 | |
National Research Corp. Class A | 13,880 | 663,880 | |
Novo Integrated Sciences, Inc. (a) | 8,005 | 17,771 | |
Ontrak, Inc. (a) | 10,232 | 310,848 | |
Option Care Health, Inc. (a) | 99,534 | 1,825,454 | |
Patterson Companies, Inc. (b) | 54,157 | 1,762,269 | |
Pennant Group, Inc. (a) | 15,432 | 528,855 | |
PetIQ, Inc. Class A (a)(b) | 13,773 | 566,070 | |
Precipio, Inc. (a) | 16,994 | 56,250 | |
Premier, Inc. | 68,489 | 2,260,137 | |
Progenity, Inc. (b) | 35,463 | 91,849 | |
Progyny, Inc. (a) | 48,053 | 3,077,314 | |
Psychemedics Corp. (a) | 3,315 | 21,879 | |
R1 RCM, Inc. (a) | 144,032 | 3,334,341 | |
RadNet, Inc. (a) | 28,166 | 745,554 | |
Sharps Compliance Corp. (a)(b) | 8,144 | 110,921 | |
SOC Telemed, Inc. Class A (a)(b) | 49,797 | 298,782 | |
Star Equity Holdings, Inc. (a)(b) | 11,004 | 30,371 | |
Surgery Partners, Inc. (a) | 32,632 | 1,909,951 | |
The Ensign Group, Inc. | 29,826 | 2,481,523 | |
The Joint Corp. (a)(b) | 9,246 | 657,206 | |
Tivity Health, Inc. (a) | 27,823 | 728,963 | |
Viemed Healthcare, Inc. (a) | 19,429 | 151,740 | |
Vivos Therapeutics, Inc. | 8,417 | 45,283 | |
73,240,334 | |||
Health Care Technology - 0.3% | |||
Allscripts Healthcare Solutions, Inc. (a) | 84,902 | 1,476,446 | |
CareCloud, Inc. (a)(b) | 13,011 | 109,423 | |
Cerner Corp. | 170,730 | 13,359,623 | |
Certara, Inc. (b) | 85,985 | 2,262,265 | |
Change Healthcare, Inc. (a) | 169,932 | 3,983,206 | |
Computer Programs & Systems, Inc. | 10,872 | 351,927 | |
Forian, Inc. (a)(b) | 18,658 | 186,020 | |
GoodRx Holdings, Inc. (b) | 35,618 | 1,321,784 | |
Health Catalyst, Inc. (a)(b) | 23,320 | 1,252,051 | |
HealthStream, Inc. (a) | 16,614 | 434,955 | |
HTG Molecular Diagnostics (a)(b) | 12,929 | 48,096 | |
iCAD, Inc. (a) | 15,927 | 261,999 | |
Inovalon Holdings, Inc. Class A (a) | 41,582 | 1,304,012 | |
NantHealth, Inc. (a) | 57,733 | 150,683 | |
NeuroPace, Inc. (a) | 12,283 | 281,649 | |
Nextgen Healthcare, Inc. (a) | 35,416 | 581,531 | |
Omnicell, Inc. (a) | 23,837 | 3,313,343 | |
OptimizeRx Corp. (a) | 10,957 | 538,208 | |
Renalytix AI PLC ADR (a)(b) | 4,156 | 136,982 | |
Schrodinger, Inc. (a)(b) | 33,990 | 2,385,418 | |
SCWorx, Corp. (a)(b) | 13,282 | 20,321 | |
Simulations Plus, Inc. (b) | 10,611 | 560,049 | |
Streamline Health Solutions, Inc. (a) | 14,467 | 28,211 | |
Tabula Rasa HealthCare, Inc. (a)(b) | 13,654 | 589,989 | |
Telemynd, Inc. (a)(c) | 92 | 0 | |
34,938,191 | |||
Life Sciences Tools & Services - 0.9% | |||
10X Genomics, Inc. (a) | 47,857 | 8,614,260 | |
AbCellera Biologics, Inc. (b) | 150,046 | 4,025,734 | |
Adaptive Biotechnologies Corp. (a) | 77,332 | 2,923,923 | |
Applied DNA Sciences, Inc. (a)(b) | 2,126 | 12,310 | |
Berkeley Lights, Inc. (a) | 37,172 | 1,616,982 | |
Bio-Techne Corp. | 21,387 | 8,850,582 | |
BioNano Genomics, Inc. (a)(b) | 154,210 | 951,476 | |
Bruker Corp. | 84,617 | 5,875,804 | |
Cellect Biotechnology Ltd. ADR (a)(b) | 10,200 | 31,926 | |
Champions Oncology, Inc. (a) | 10,958 | 103,115 | |
ChromaDex, Inc. (a)(b) | 42,495 | 352,709 | |
Codexis, Inc. (a) | 35,046 | 718,443 | |
Compugen Ltd. (a)(b) | 42,343 | 325,194 | |
Fluidigm Corp. (a)(b) | 37,771 | 219,072 | |
Genetic Technologies Ltd. ADR (a)(b) | 2,511 | 11,614 | |
Harvard Bioscience, Inc. (a) | 25,302 | 177,114 | |
ICON PLC (a) | 29,478 | 6,595,997 | |
Illumina, Inc. (a) | 80,644 | 32,712,432 | |
ImmunoPrecise Antibodies Ltd. (a)(b) | 6,816 | 53,301 | |
Inotiv, Inc. (a) | 5,553 | 138,159 | |
Luminex Corp. | 28,121 | 1,037,384 | |
Maravai LifeSciences Holdings, Inc. | 63,264 | 2,374,931 | |
Medpace Holdings, Inc. (a) | 19,854 | 3,316,809 | |
Nanostring Technologies, Inc. (a) | 23,996 | 1,331,538 | |
NeoGenomics, Inc. (a) | 64,799 | 2,658,703 | |
Olink Holding AB ADR (a) | 9,441 | 333,551 | |
Pacific Biosciences of California, Inc. (a) | 107,009 | 2,894,593 | |
Personalis, Inc. (a) | 22,588 | 508,004 | |
PPD, Inc. (a) | 194,022 | 8,948,295 | |
PRA Health Sciences, Inc. (a) | 36,038 | 6,159,615 | |
Quanterix Corp. (a) | 19,890 | 1,024,136 | |
Seer, Inc. (b) | 31,644 | 936,030 | |
Sotera Health Co. | 157,250 | 3,789,725 | |
Syneos Health, Inc. (a) | 57,814 | 5,081,851 | |
114,705,312 | |||
Pharmaceuticals - 0.9% | |||
4D Pharma PLC ADR (a)(b) | 1,165 | 13,013 | |
9 Meters Biopharma, Inc. (a)(b) | 116,420 | 149,018 | |
A Menarini Industrie Farmaceut rights (a)(c) | 32,407 | 11,481 | |
Acasti Pharma, Inc. (a)(b) | 146,784 | 73,289 | |
AcelRx Pharmaceuticals, Inc. (a) | 69,185 | 96,167 | |
Acer Therapeutics, Inc. (a)(b) | 7,869 | 23,056 | |
Achilles Therapeutics PLC ADR (a)(b) | 4,669 | 58,969 | |
Aclaris Therapeutics, Inc. (a) | 30,259 | 672,960 | |
Adamis Pharmaceuticals Corp. (a)(b) | 103,311 | 71,119 | |
Adial Pharmaceuticals, Inc. (a)(b) | 13,581 | 33,545 | |
Aerie Pharmaceuticals, Inc. (a)(b) | 28,131 | 458,254 | |
Aerpio Pharmaceuticals, Inc. (a) | 22,410 | 38,097 | |
Agile Therapeutics, Inc. (a)(b) | 61,745 | 99,409 | |
Akari Therapeutics PLC sponsored ADR (a)(b) | 30,264 | 54,324 | |
Alimera Sciences, Inc. (a) | 5,507 | 57,824 | |
Amphastar Pharmaceuticals, Inc. (a) | 43,435 | 821,790 | |
Amryt Pharma PLC ADR (a)(b) | 6,776 | 79,618 | |
Angion Biomedica Corp. | 15,840 | 244,570 | |
ANI Pharmaceuticals, Inc. (a) | 9,565 | 328,558 | |
ANI Pharmaceuticals, Inc. rights (a)(c) | 1,389 | 0 | |
Aquestive Therapeutics, Inc. (a)(b) | 39,828 | 147,762 | |
Artelo Biosciences, Inc. (a) | 38,032 | 47,160 | |
Arvinas Holding Co. LLC (a) | 26,953 | 1,960,561 | |
Assertio Holdings, Inc. (a) | 39,380 | 71,278 | |
AstraZeneca PLC: | |||
rights (a)(c) | 3,011 | 0 | |
sponsored ADR (b) | 259,008 | 14,703,884 | |
Atea Pharmaceuticals, Inc. (b) | 47,154 | 962,885 | |
Athira Pharma, Inc. | 22,163 | 441,930 | |
Auris Medical Holding AG (a) | 18,871 | 67,747 | |
Avadel Pharmaceuticals PLC sponsored ADR (a)(b) | 40,528 | 311,660 | |
Avenue Therapeutics, Inc. (a)(b) | 12,483 | 61,916 | |
Axsome Therapeutics, Inc. (a)(b) | 22,242 | 1,350,312 | |
Aytu BioScience, Inc. (a)(b) | 14,838 | 75,377 | |
Baudax Bio, Inc. (a) | 35,933 | 32,448 | |
Biodelivery Sciences International, Inc. (a) | 89,535 | 316,059 | |
Biondvax Pharmaceuticals Ltd. ADR (a)(b) | 13,768 | 41,717 | |
Calliditas Therapeutics AB ADR (a)(b) | 5,831 | 173,414 | |
Cara Therapeutics, Inc. (a) | 34,753 | 472,293 | |
Cassava Sciences, Inc. (a) | 22,322 | 1,203,602 | |
Cerecor, Inc. (a) | 43,412 | 114,608 | |
Chiasma, Inc. (a)(b) | 50,091 | 211,885 | |
China SXT Pharmaceuticals, Inc. (a)(b) | 26,642 | 34,635 | |
Citius Pharmaceuticals, Inc. (a)(b) | 75,361 | 171,823 | |
Clearside Biomedical, Inc. (a) | 38,079 | 97,673 | |
Clever Leaves Holdings, Inc. (a)(b) | 13,315 | 162,842 | |
CNS Pharmaceuticals, Inc. (a)(b) | 11,876 | 21,971 | |
Cocrystal Pharma, Inc. (a)(b) | 39,771 | 44,941 | |
Collegium Pharmaceutical, Inc. (a) | 24,854 | 593,762 | |
Corcept Therapeutics, Inc. (a) | 71,775 | 1,550,340 | |
CorMedix, Inc. (a)(b) | 20,194 | 146,003 | |
Cronos Group, Inc. (a)(b) | 206,950 | 1,864,620 | |
Cumberland Pharmaceuticals, Inc. (a) | 11,327 | 33,415 | |
CymaBay Therapeutics, Inc. (a)(b) | 58,261 | 246,444 | |
Dova Pharmaceuticals, Inc. rights (a)(c) | 23,572 | 12,729 | |
Durect Corp. (a) | 139,062 | 229,452 | |
Elanco Animal Health, Inc. rights (a)(c) | 45,364 | 0 | |
Eloxx Pharmaceuticals, Inc. (a)(b) | 24,062 | 37,537 | |
Endo International PLC (a) | 136,064 | 798,696 | |
Enveric Biosciences, Inc. (a)(b) | 6,768 | 15,093 | |
Eton Pharmaceuticals, Inc. (a)(b) | 19,371 | 136,759 | |
Evofem Biosciences, Inc. (a) | 82,798 | 71,206 | |
Evoke Pharma, Inc.(a)(b) | 26,645 | 32,773 | |
Evolus, Inc. (a) | 24,994 | 270,435 | |
EyeGate Pharmaceuticals, Inc. (a) | 2,167 | 9,513 | |
Eyenovia, Inc. (a) | 18,093 | 86,485 | |
Eyepoint Pharmaceuticals, Inc. (a) | 16,085 | 158,116 | |
Fulcrum Therapeutics, Inc. (a)(b) | 18,817 | 168,036 | |
Graybug Vision, Inc. (b) | 12,609 | 50,184 | |
Harmony Biosciences Holdings, Inc. (a) | 33,782 | 1,079,673 | |
Harrow Health, Inc. (a)(b) | 22,525 | 207,230 | |
Hepion Pharmaceuticals, Inc. (a)(b) | 33,141 | 56,340 | |
Horizon Therapeutics PLC (a) | 124,580 | 11,419,003 | |
Hoth Therapeutics, Inc. (a) | 2,601 | 3,771 | |
Hutchison China Meditech Ltd. sponsored ADR (a) | 33,593 | 999,392 | |
IMARA, Inc. (a) | 11,348 | 82,500 | |
InMed Pharmaceuticals, Inc. (a)(b) | 4,383 | 12,930 | |
Innoviva, Inc. (a) | 74,629 | 1,003,760 | |
Intra-Cellular Therapies, Inc. (a) | 47,541 | 1,873,591 | |
Iterum Therapeutics PLC (a) | 96,173 | 139,451 | |
Jaguar Health, Inc. (a)(b) | 83,167 | 133,067 | |
Jazz Pharmaceuticals PLC (a) | 32,431 | 5,776,934 | |
Kala Pharmaceuticals, Inc. (a)(b) | 31,202 | 176,291 | |
Kaleido Biosciences, Inc. (a)(b) | 22,138 | 158,951 | |
KemPharm, Inc. (a)(b) | 16,829 | 172,329 | |
Landos Biopharma, Inc. | 22,141 | 243,108 | |
Lexaria Bioscience Corp. (a)(b) | 2,740 | 16,659 | |
Lipocine, Inc. (a) | 61,226 | 74,696 | |
Liquidia Technologies, Inc. (a) | 21,967 | 66,121 | |
Longboard Pharmaceuticals, Inc. (a) | 6,573 | 54,293 | |
Lyra Therapeutics, Inc. | 9,646 | 69,258 | |
Marinus Pharmaceuticals, Inc. (a)(b) | 20,303 | 341,496 | |
MediWound Ltd. (a) | 23,801 | 80,923 | |
Milestone Pharmaceuticals, Inc. (a) | 20,859 | 126,197 | |
Mind Medicine MindMed, Inc. (a)(b) | 184,120 | 626,008 | |
Nabriva Therapeutics PLC (a)(b) | 13,225 | 18,251 | |
Nektar Therapeutics (a) | 108,591 | 1,962,239 | |
NGM Biopharmaceuticals, Inc. (a) | 43,512 | 655,291 | |
NLS Pharmaceutics Ltd. (a)(b) | 5,844 | 20,162 | |
Novan, Inc. (a)(b) | 10,162 | 79,314 | |
Ocular Therapeutix, Inc. (a) | 42,919 | 624,901 | |
Ocuphire Pharma, Inc. (a)(b) | 9,487 | 43,071 | |
Odonate Therapeutics, Inc. (a) | 25,693 | 88,898 | |
Omeros Corp. (a)(b) | 40,138 | 609,696 | |
Onconova Therapeutics, Inc. (a) | 12,224 | 81,779 | |
Opiant Pharmaceuticals, Inc. (a) | 3,728 | 47,159 | |
OptiNose, Inc. (a) | 28,477 | 90,842 | |
Oramed Pharmaceuticals, Inc. (a)(b) | 16,957 | 195,345 | |
Osmotica Pharmaceuticals PLC (a)(b) | 40,948 | 119,159 | |
Otonomy, Inc. (a) | 34,460 | 80,292 | |
Pacira Biosciences, Inc. (a) | 26,655 | 1,617,159 | |
PainReform Ltd. (b) | 5,250 | 15,750 | |
Paratek Pharmaceuticals, Inc. (a)(b) | 29,676 | 243,937 | |
Petros Pharmaceuticals, Inc. (a)(b) | 6,734 | 20,404 | |
Pharvaris BV | 16,824 | 344,892 | |
Phathom Pharmaceuticals, Inc. (a)(b) | 17,323 | 612,368 | |
Phibro Animal Health Corp. Class A | 18,319 | 516,413 | |
Pliant Therapeutics, Inc. | 21,561 | 648,124 | |
PLx Pharma PLC (a)(b) | 15,915 | 235,860 | |
PolyPid Ltd. (a) | 9,757 | 92,692 | |
Processa Pharmaceuticals, Inc. (b) | 7,546 | 46,408 | |
ProPhase Labs, Inc. | 7,224 | 34,675 | |
Provention Bio, Inc. (a)(b) | 40,087 | 305,062 | |
Pulmatrix, Inc. (a)(b) | 28,209 | 26,248 | |
Purple Biotech Ltd. ADR (a)(b) | 9,695 | 52,935 | |
Qilian International Holding Group Ltd. (b) | 23,641 | 111,113 | |
Reata Pharmaceuticals, Inc. (a)(b) | 18,420 | 2,518,751 | |
RedHill Biopharma Ltd. sponsored ADR (a)(b) | 23,879 | 173,123 | |
Relmada Therapeutics, Inc. (a)(b) | 12,198 | 421,929 | |
Reneo Pharmaceuticals, Inc. (a) | 11,991 | 120,510 | |
Revance Therapeutics, Inc. (a) | 42,674 | 1,263,577 | |
Reviva Pharmaceuticals Holdings, Inc. (a)(b) | 3,238 | 16,190 | |
Royalty Pharma PLC (b) | 218,296 | 8,758,036 | |
Sanofi SA sponsored ADR | 115,425 | 6,167,158 | |
Satsuma Pharmaceuticals, Inc. (a) | 15,079 | 78,712 | |
scPharmaceuticals, Inc. (a) | 18,268 | 103,397 | |
SCYNEXIS, Inc. (a) | 7,435 | 71,227 | |
Seelos Therapeutics, Inc. (a) | 47,271 | 145,595 | |
Seelos Therapeutics, Inc. rights (a)(b)(c) | 2,932 | 0 | |
SenesTech, Inc. (a)(b) | 20,064 | 32,504 | |
SIGA Technologies, Inc. (a) | 74,518 | 525,352 | |
Sol-Gel Technologies Ltd. (a)(b) | 13,406 | 138,484 | |
Strongbridge Biopharma PLC (a) | 39,901 | 100,551 | |
Supernus Pharmaceuticals, Inc. (a)(b) | 32,482 | 969,588 | |
Tarsus Pharmaceuticals, Inc. (a) | 12,561 | 418,533 | |
Teligent, Inc. (a) | 69,134 | 37,132 | |
Terns Pharmaceuticals, Inc. (b) | 14,756 | 252,475 | |
TFF Pharmaceuticals, Inc. (a) | 14,144 | 150,068 | |
TherapeuticsMD, Inc. (a)(b) | 223,639 | 270,603 | |
Theravance Biopharma, Inc. (a) | 36,348 | 628,093 | |
Tilray, Inc. Class 2 (a)(b) | 100,306 | 1,672,101 | |
Titan Pharmaceuticals, Inc. (a)(b) | 19,257 | 46,987 | |
Trevi Therapeutics, Inc. (a) | 7,164 | 15,259 | |
Tricida, Inc. (a)(b) | 34,018 | 156,823 | |
Universe Pharmaceuticals, Inc. (a) | 8,802 | 28,254 | |
Vallon Pharamceuticals, Inc. (b) | 4,817 | 19,268 | |
Verona Pharma PLC ADR (a)(b) | 7,472 | 45,206 | |
Verrica Pharmaceuticals, Inc. (a)(b) | 16,292 | 183,448 | |
Viatris, Inc. | 672,726 | 10,252,344 | |
Vyne Therapeutics, Inc. (a)(b) | 30,249 | 119,484 | |
WAVE Life Sciences (a) | 32,769 | 224,140 | |
Xeris Pharmaceuticals, Inc. (a)(b) | 45,418 | 141,704 | |
Zogenix, Inc. (a) | 35,750 | 627,413 | |
Zynerba Pharmaceuticals, Inc. (a) | 16,974 | 96,412 | |
104,823,884 | |||
TOTAL HEALTH CARE | 1,222,012,101 | ||
INDUSTRIALS - 4.4% | |||
Aerospace & Defense - 0.1% | |||
AeroVironment, Inc. (a) | 13,397 | 1,468,713 | |
AerSale Corp. (a) | 22,165 | 266,202 | |
Astronics Corp. (a) | 10,063 | 170,668 | |
Astrotech Corp. (a)(b) | 36,874 | 43,143 | |
Axon Enterprise, Inc. (a) | 35,725 | 5,022,578 | |
EHang Holdings Ltd. ADR (a)(b) | 14,795 | 399,613 | |
Elbit Systems Ltd. (b) | 23,780 | 3,148,472 | |
Innovative Solutions & Support, Inc. | 5,109 | 28,610 | |
Kratos Defense & Security Solutions, Inc. (a) | 68,797 | 1,720,613 | |
Mercury Systems, Inc. (a) | 30,699 | 2,009,250 | |
PAE, Inc. (a) | 49,577 | 402,565 | |
RADA Electronic Industries Ltd. (a) | 29,760 | 351,168 | |
Sigma Labs, Inc. (a)(b) | 14,199 | 51,968 | |
TAT Technologies Ltd. (a)(b) | 4,899 | 27,385 | |
15,110,948 | |||
Air Freight & Logistics - 0.2% | |||
Air T, Inc. (a) | 931 | 21,636 | |
Air Transport Services Group, Inc. (a) | 32,945 | 818,354 | |
Atlas Air Worldwide Holdings, Inc. (a) | 14,813 | 1,109,938 | |
C.H. Robinson Worldwide, Inc. | 74,559 | 7,233,714 | |
Echo Global Logistics, Inc. (a) | 16,109 | 550,283 | |
Expeditors International of Washington, Inc. | 94,806 | 11,916,166 | |
Forward Air Corp. | 17,002 | 1,647,324 | |
Hub Group, Inc. Class A (a) | 18,343 | 1,280,525 | |
24,577,940 | |||
Airlines - 0.3% | |||
Allegiant Travel Co. (a) | 9,270 | 2,052,934 | |
American Airlines Group, Inc. (a)(b) | 360,003 | 8,726,473 | |
Frontier Group Holdings, Inc. (a) | 120,000 | 2,558,400 | |
Hawaiian Holdings, Inc. (a) | 23,524 | 606,919 | |
JetBlue Airways Corp. (a) | 168,787 | 3,392,619 | |
Mesa Air Group, Inc. (a) | 19,225 | 186,867 | |
Ryanair Holdings PLC sponsored ADR (a) | 54,260 | 6,334,855 | |
SkyWest, Inc. (a) | 27,552 | 1,350,875 | |
Sun Country Airlines Holdings, Inc. (a)(b) | 30,637 | 1,139,696 | |
United Airlines Holdings, Inc. (a) | 176,394 | 10,292,590 | |
36,642,228 | |||
Building Products - 0.1% | |||
AAON, Inc. | 28,630 | 1,896,738 | |
American Woodmark Corp. (a) | 8,946 | 777,586 | |
Antelope Enterprise Holdings L (a)(b) | 10,431 | 27,538 | |
Apogee Enterprises, Inc. | 14,762 | 561,104 | |
Applied UV, Inc. | 4,305 | 35,516 | |
Builders FirstSource, Inc. (a) | 112,573 | 5,014,001 | |
Caesarstone Sdot-Yam Ltd. | 14,609 | 241,049 | |
CSW Industrials, Inc. | 8,215 | 1,000,751 | |
DIRTT Environmental Solutions Ltd. (a)(b) | 41,699 | 142,611 | |
Gibraltar Industries, Inc. (a) | 18,047 | 1,433,834 | |
Tecnoglass, Inc. | 23,615 | 519,294 | |
UFP Industries, Inc. | 32,976 | 2,622,252 | |
14,272,274 | |||
Commercial Services & Supplies - 0.5% | |||
Aqua Metals, Inc. (a)(b) | 36,541 | 103,411 | |
Casella Waste Systems, Inc. Class A (a) | 27,982 | 1,886,826 | |
CECO Environmental Corp. (a) | 21,695 | 165,533 | |
China Customer Relations Centers, Inc. (a)(b) | 11,412 | 68,016 | |
China Recycling Energy Corp. (a)(b) | 2,863 | 26,941 | |
Cimpress PLC (a) | 14,202 | 1,410,401 | |
Cintas Corp. | 57,666 | 20,387,238 | |
Copart, Inc. (a) | 130,518 | 16,838,127 | |
Driven Brands Holdings, Inc. | 92,792 | 2,748,499 | |
Fuel Tech, Inc. (a) | 7,428 | 15,525 | |
Healthcare Services Group, Inc. (b) | 42,504 | 1,274,695 | |
Heritage-Crystal Clean, Inc. (a) | 13,663 | 420,820 | |
Herman Miller, Inc. | 33,262 | 1,589,924 | |
Interface, Inc. | 29,819 | 487,242 | |
Kimball International, Inc. Class B | 14,231 | 189,557 | |
Matthews International Corp. Class A | 14,831 | 579,447 | |
Odyssey Marine Exploration, Inc. (a)(b) | 6,411 | 42,313 | |
Performant Financial Corp. (a)(b) | 26,404 | 84,493 | |
Perma-Fix Environmental Services, Inc. (a) | 9,998 | 72,486 | |
PICO Holdings, Inc. (a) | 19,423 | 203,942 | |
PyroGenesis Canada, Inc. (a)(b) | 65,636 | 359,029 | |
Recycling Asset Holdings, Inc. (a)(c) | 694 | 24 | |
SP Plus Corp. (a) | 13,740 | 449,161 | |
Stericycle, Inc. (a) | 49,751 | 3,908,439 | |
Tetra Tech, Inc. | 29,586 | 3,534,639 | |
Thunder Bridge Acquisition II Ltd. Class A (a)(b) | 22,344 | 225,674 | |
TOMI Environmental Solutions, Inc. (a)(b) | 8,765 | 22,964 | |
U.S. Ecology, Inc. (a) | 16,302 | 646,048 | |
Virco Manufacturing Co. (a) | 950 | 2,955 | |
VSE Corp. | 7,604 | 361,722 | |
58,106,091 | |||
Construction & Engineering - 0.1% | |||
Concrete Pumping Holdings, Inc. (a) | 28,584 | 229,244 | |
Construction Partners, Inc. Class A (a) | 17,350 | 558,844 | |
Great Lakes Dredge & Dock Corp. (a) | 35,442 | 517,808 | |
IES Holdings, Inc. (a) | 11,098 | 588,860 | |
Infrastructure and Energy Alternatives, Inc. (a)(b) | 11,087 | 128,387 | |
iSun, Inc. (a)(b) | 4,788 | 42,134 | |
Latham Group, Inc. (a)(b) | 64,700 | 2,009,582 | |
Limbach Holdings, Inc. (a) | 6,648 | 62,957 | |
Matrix Service Co. (a) | 12,262 | 133,656 | |
MYR Group, Inc. (a) | 9,722 | 846,203 | |
Northwest Pipe Co. (a) | 5,851 | 185,243 | |
NV5 Global, Inc. (a) | 7,838 | 715,845 | |
Orbital Energy Group, Inc. (a) | 27,556 | 97,824 | |
Primoris Services Corp. | 28,950 | 920,321 | |
Sterling Construction Co., Inc. (a) | 15,145 | 340,763 | |
Willscot Mobile Mini Holdings (a) | 126,245 | 3,661,105 | |
11,038,776 | |||
Electrical Equipment - 0.3% | |||
Advent Technologies Holdings, Inc. Class A (a)(b) | 23,862 | 251,505 | |
Allied Motion Technologies, Inc. | 8,863 | 313,750 | |
American Superconductor Corp. (a) | 13,822 | 206,915 | |
Array Technologies, Inc. | 71,241 | 1,161,228 | |
Asia Pacific Wire & Cable Corp. Ltd. (a)(b) | 76,311 | 322,796 | |
Ballard Power Systems, Inc. (a)(b) | 163,130 | 2,825,412 | |
Beam Global (a)(b) | 4,471 | 130,508 | |
Broadwind, Inc. (a) | 9,566 | 45,152 | |
Capstone Turbine Corp. (a) | 2,102 | 15,218 | |
CBAK Energy Technology, Inc. (a)(b) | 48,117 | 201,610 | |
Encore Wire Corp. | 10,986 | 903,049 | |
Energous Corp. (a)(b) | 23,137 | 63,164 | |
Energy Focus, Inc. (a)(b) | 617 | 2,554 | |
Eos Energy Enterprises, Inc. (a)(b) | 29,970 | 607,792 | |
Flux Power Holdings, Inc. (b) | 6,183 | 64,551 | |
FuelCell Energy, Inc. (a)(b) | 179,365 | 1,761,364 | |
Fusion Fuel Green PLC Class A (a)(b) | 4,794 | 69,657 | |
Ideal Power, Inc. (a) | 1,812 | 20,602 | |
LSI Industries, Inc. | 17,145 | 159,449 | |
Nuvve Holding Corp. (a)(b) | 17,297 | 175,219 | |
Ocean Power Technologies, Inc. (a)(b) | 22,341 | 53,395 | |
Orion Energy Systems, Inc. (a) | 14,347 | 91,964 | |
Pioneer Power Solutions, Inc. | 9,793 | 38,976 | |
Plug Power, Inc. (a) | 313,519 | 9,625,033 | |
Polar Power, Inc. (a)(b) | 8,285 | 80,033 | |
Powell Industries, Inc. | 6,368 | 218,804 | |
Preformed Line Products Co. | 3,095 | 230,330 | |
Shoals Technologies Group, Inc. | 51,848 | 1,431,005 | |
Sunrun, Inc. (a) | 111,542 | 4,988,158 | |
Sunworks, Inc. (a) | 14,202 | 122,989 | |
TPI Composites, Inc. (a) | 19,766 | 954,698 | |
Ultralife Corp. (a) | 11,042 | 100,813 | |
Vicor Corp. (a) | 17,324 | 1,560,546 | |
28,798,239 | |||
Industrial Conglomerates - 0.8% | |||
Honeywell International, Inc. | 387,800 | 89,546,898 | |
Icahn Enterprises LP | 133,505 | 7,525,677 | |
Raven Industries, Inc. | 18,361 | 810,271 | |
97,882,846 | |||
Machinery - 0.5% | |||
Agrify Corp. | 10,193 | 95,508 | |
Altra Industrial Motion Corp. | 35,733 | 2,347,301 | |
Astec Industries, Inc. | 13,267 | 909,188 | |
Blue Bird Corp. (a) | 16,718 | 437,343 | |
Columbus McKinnon Corp. (NY Shares) | 12,799 | 648,909 | |
Commercial Vehicle Group, Inc. (a) | 21,200 | 244,436 | |
Eastern Co. | 4,547 | 144,958 | |
Energy Recovery, Inc. (a) | 35,074 | 666,757 | |
ExOne Co. (a)(b) | 12,897 | 274,964 | |
Franklin Electric Co., Inc. | 25,745 | 2,159,748 | |
FreightCar America, Inc. (a)(b) | 11,480 | 70,372 | |
Gencor Industries, Inc. (a) | 8,433 | 105,918 | |
Greenland Technologies Holding Corp. (a)(b) | 5,467 | 46,251 | |
GreenPower Motor Co., Inc. (b) | 11,083 | 182,537 | |
Helios Technologies, Inc. | 18,734 | 1,331,051 | |
Hurco Companies, Inc. | 4,416 | 151,866 | |
Hydrofarm Holdings Group, Inc. (b) | 18,775 | 1,169,495 | |
Kornit Digital Ltd. (a) | 25,353 | 2,641,783 | |
L.B. Foster Co. Class A (a) | 5,419 | 97,488 | |
Lincoln Electric Holdings, Inc. | 32,763 | 4,212,667 | |
LiqTech International, Inc. (a)(b) | 14,828 | 109,727 | |
Manitex International, Inc. (a) | 14,236 | 102,926 | |
Middleby Corp. (a) | 30,871 | 5,071,488 | |
Nikola Corp. (a)(b) | 216,728 | 3,242,251 | |
Nisun International Enterprise (a)(b) | 9,549 | 120,508 | |
NN, Inc. (a) | 17,861 | 134,136 | |
Nordson Corp. | 32,168 | 7,131,324 | |
Omega Flex, Inc. (b) | 5,646 | 830,244 | |
PACCAR, Inc. | 191,364 | 17,521,288 | |
Park-Ohio Holdings Corp. | 5,074 | 187,180 | |
Perma-Pipe International Holdings, Inc. (a) | 5,390 | 35,951 | |
RBC Bearings, Inc. (a) | 13,892 | 2,719,915 | |
Taylor Devices, Inc. (a) | 1,759 | 20,950 | |
The Shyft Group, Inc. | 20,942 | 816,319 | |
TriMas Corp. (a) | 25,565 | 828,817 | |
Twin Disc, Inc. (a) | 9,749 | 134,341 | |
voxeljet AG ADR (a) | 2,769 | 40,870 | |
Westport Fuel Systems, Inc. (a)(b) | 72,395 | 453,193 | |
Woodward, Inc. | 34,713 | 4,414,799 | |
61,854,767 | |||
Marine - 0.0% | |||
Capital Product Partners LP | 6,724 | 84,050 | |
Castor Maritime, Inc. (a) | 49,703 | 151,594 | |
Eagle Bulk Shipping, Inc. (a)(b) | 6,979 | 330,316 | |
EuroDry Ltd. (a) | 30,103 | 549,380 | |
Euroseas Ltd. (a)(b) | 2,629 | 41,328 | |
Globus Maritime Ltd. (a)(b) | 9,253 | 39,973 | |
Golden Ocean Group Ltd. (b) | 99,171 | 988,735 | |
Grindrod Shipping Holdings Ltd. (a)(b) | 5,040 | 43,924 | |
Performance Shipping, Inc. (b) | 40,265 | 179,985 | |
Pyxis Tankers, Inc. (a)(b) | 42,562 | 35,565 | |
Seanergy Martime Holdings Corp. (a)(b) | 72,085 | 72,806 | |
Star Bulk Carriers Corp. (b) | 49,906 | 973,666 | |
3,491,322 | |||
Professional Services - 0.4% | |||
51job, Inc. sponsored ADR (a) | 22,264 | 1,595,884 | |
Acacia Research Corp. (a) | 26,315 | 140,785 | |
ATIF Holdings Ltd. (a) | 26,801 | 26,635 | |
Atlas Technical Consultants, Inc. (a) | 12,998 | 143,758 | |
Barrett Business Services, Inc. | 3,985 | 296,763 | |
China Index Holdings Ltd. ADR (a) | 30,315 | 56,689 | |
CoStar Group, Inc. (a) | 21,883 | 18,688,082 | |
CRA International, Inc. | 4,701 | 384,824 | |
DLH Holdings Corp. (a) | 3,987 | 45,372 | |
Exponent, Inc. | 28,889 | 2,635,543 | |
Forrester Research, Inc. (a) | 10,756 | 461,540 | |
Global Internet of People, Inc. (a)(b) | 8,860 | 25,517 | |
Headhunter Group PLC ADR | 13,600 | 559,912 | |
Heidrick & Struggles International, Inc. | 8,594 | 369,886 | |
Hirequest, Inc. (b) | 5,866 | 104,473 | |
Hudson Global, Inc. (a) | 1,375 | 25,878 | |
Huron Consulting Group, Inc. (a) | 11,971 | 654,933 | |
ICF International, Inc. | 11,326 | 995,555 | |
Kelly Services, Inc. Class A (non-vtg.) (a) | 21,044 | 540,199 | |
Kforce, Inc. | 10,845 | 680,090 | |
Lightbridge Corp. (a)(b) | 9,119 | 50,610 | |
ManTech International Corp. Class A | 15,383 | 1,338,475 | |
RCM Technologies, Inc. (a) | 4,323 | 16,427 | |
Red Violet, Inc. (a)(b) | 8,743 | 192,171 | |
Rekor Systems, Inc. (a)(b) | 22,727 | 255,451 | |
Resources Connection, Inc. (b) | 22,810 | 332,570 | |
ShiftPixy, Inc. (a)(b) | 8,773 | 22,547 | |
Upwork, Inc. (a) | 69,392 | 3,266,281 | |
Verisk Analytics, Inc. | 90,571 | 15,653,386 | |
Willdan Group, Inc. (a) | 7,167 | 260,592 | |
49,820,828 | |||
Road & Rail - 0.9% | |||
AMERCO | 10,972 | 6,309,339 | |
ArcBest Corp. | 12,968 | 1,009,429 | |
Avis Budget Group, Inc. (a) | 38,458 | 3,377,382 | |
Covenant Transport Group, Inc. Class A (a) | 5,779 | 130,085 | |
CSX Corp. | 422,435 | 42,294,192 | |
Daseke, Inc. (a) | 32,783 | 237,349 | |
Ezgo Technologies Ltd. (b) | 2,944 | 12,571 | |
Heartland Express, Inc. | 44,050 | 799,508 | |
HyreCar, Inc. (a) | 9,338 | 153,237 | |
J.B. Hunt Transport Services, Inc. | 59,047 | 10,128,922 | |
Landstar System, Inc. | 21,474 | 3,661,317 | |
Lyft, Inc. (a) | 172,080 | 9,824,047 | |
Marten Transport Ltd. | 47,473 | 809,889 | |
MingZhu Logistics Holdings Ltd. (b) | 5,623 | 26,147 | |
Old Dominion Freight Lines, Inc. | 65,471 | 17,379,277 | |
P.A.M. Transportation Services, Inc. (a) | 3,501 | 203,198 | |
Patriot Transportation Holding, Inc. | 1,759 | 19,542 | |
Saia, Inc. (a) | 14,496 | 3,336,399 | |
Td Holdings, Inc. (a)(b) | 38,567 | 39,724 | |
TuSimple Holdings, Inc. (a)(b) | 104,883 | 4,021,214 | |
U.S.A. Truck, Inc. (a) | 5,235 | 80,619 | |
Universal Logistics Holdings, Inc. | 17,590 | 439,750 | |
Werner Enterprises, Inc. | 37,001 | 1,775,678 | |
Yellow Corp. (a) | 25,553 | 162,517 | |
106,231,332 | |||
Trading Companies & Distributors - 0.2% | |||
Beacon Roofing Supply, Inc. (a) | 37,931 | 2,148,412 | |
Code Chain New Continent Ltd. (a)(b) | 17,695 | 47,777 | |
DXP Enterprises, Inc. (a) | 8,484 | 262,071 | |
Fastenal Co. | 317,732 | 16,852,505 | |
H&E Equipment Services, Inc. | 19,766 | 739,248 | |
Houston Wire & Cable Co. (a) | 7,080 | 37,453 | |
Hudson Technologies, Inc. (a) | 40,436 | 114,030 | |
Huttig Building Products, Inc. (a) | 17,487 | 108,944 | |
Lawson Products, Inc. (a) | 5,086 | 307,703 | |
McGrath RentCorp. | 12,871 | 1,103,431 | |
Rush Enterprises, Inc.: | |||
Class A | 24,910 | 1,190,698 | |
Class B | 6,706 | 290,772 | |
Titan Machinery, Inc. (a) | 11,661 | 357,759 | |
Transcat, Inc. (a) | 4,527 | 239,207 | |
Willis Lease Finance Corp. (a) | 3,418 | 151,588 | |
23,951,598 | |||
Transportation Infrastructure - 0.0% | |||
Grupo Aeroportuario Norte S.A.B. de CV ADR (a) | 3,405 | 173,723 | |
Sino-Global Shipping America Ltd. (a)(b) | 11,251 | 42,079 | |
215,802 | |||
TOTAL INDUSTRIALS | 531,994,991 | ||
INFORMATION TECHNOLOGY - 40.4% | |||
Communications Equipment - 1.3% | |||
ADTRAN, Inc. | 23,497 | 465,476 | |
Applied Optoelectronics, Inc. (a)(b) | 20,141 | 165,760 | |
AudioCodes Ltd. | 17,081 | 551,545 | |
Aviat Networks, Inc. (a) | 6,448 | 238,318 | |
CalAmp Corp. (a) | 13,453 | 186,593 | |
Cambium Networks Corp. (a) | 13,989 | 807,305 | |
Casa Systems, Inc. (a) | 43,056 | 373,726 | |
Ceragon Networks Ltd. (a)(b) | 40,973 | 136,850 | |
Cisco Systems, Inc. | 2,331,371 | 123,329,526 | |
Clearfield, Inc. (a) | 9,087 | 343,670 | |
ClearOne, Inc. (a) | 10,289 | 24,591 | |
CommScope Holding Co., Inc. (a) | 110,149 | 2,237,126 | |
Communications Systems, Inc. | 4,332 | 28,894 | |
COMSovereign Holding Corp. (b) | 34,013 | 79,590 | |
Comtech Telecommunications Corp. | 10,821 | 273,663 | |
Digi International, Inc. (a) | 19,090 | 361,946 | |
DZS, Inc. (a) | 11,703 | 193,685 | |
EchoStar Holding Corp. Class A (a)(b) | 23,662 | 626,806 | |
EMCORE Corp. (a) | 20,355 | 197,444 | |
Ericsson (B Shares) sponsored ADR | 208,281 | 2,797,214 | |
EXFO, Inc. (a) | 13,715 | 50,677 | |
Extreme Networks, Inc. (a) | 71,064 | 812,972 | |
F5 Networks, Inc. (a) | 34,371 | 6,373,415 | |
Franklin Wireless Corp. (a) | 5,335 | 51,216 | |
Genasys, Inc. (a) | 20,513 | 111,796 | |
Gilat Satellite Networks Ltd. | 28,312 | 285,668 | |
Harmonic, Inc. (a) | 60,290 | 420,221 | |
Infinera Corp. (a)(b) | 109,028 | 1,046,669 | |
Inseego Corp. (a)(b) | 55,229 | 474,969 | |
Ituran Location & Control Ltd. | 10,985 | 265,947 | |
KVH Industries, Inc. (a) | 10,763 | 153,803 | |
Lantronix, Inc. (a)(b) | 15,008 | 83,444 | |
Lumentum Holdings, Inc. (a) | 42,344 | 3,445,531 | |
NETGEAR, Inc. (a) | 18,625 | 724,140 | |
NetScout Systems, Inc. (a) | 41,313 | 1,214,602 | |
Ondas Holdings, Inc. (b) | 13,139 | 116,937 | |
PC-Tel, Inc. | 11,312 | 74,546 | |
Radcom Ltd. (a)(b) | 13,668 | 137,637 | |
Radware Ltd. (a) | 27,517 | 803,496 | |
Resonant, Inc. (a) | 25,234 | 82,263 | |
Ribbon Communications, Inc. (a) | 79,551 | 591,859 | |
Sierra Wireless, Inc. (a)(b) | 17,296 | 269,126 | |
Silicom Ltd. (a) | 4,848 | 198,671 | |
Siyata Mobile, Inc. (a)(b) | 5,656 | 44,682 | |
Tessco Technologies, Inc. (a) | 10,061 | 74,854 | |
UTStarcom Holdings Corp. (a)(b) | 48,947 | 64,610 | |
ViaSat, Inc. (a)(b) | 38,584 | 2,051,897 | |
Viavi Solutions, Inc. (a) | 136,569 | 2,394,055 | |
Vislink Technologies, Inc. (a)(b) | 25,373 | 60,134 | |
Westell Technologies, Inc. Class A (a) | 5,356 | 4,230 | |
155,903,795 | |||
Electronic Equipment & Components - 0.8% | |||
908 Devices, Inc. (b) | 15,054 | 634,225 | |
Airgain, Inc. (a)(b) | 3,450 | 68,483 | |
Akoustis Technologies, Inc. (a) | 23,599 | 226,078 | |
Avnet, Inc. | 52,649 | 2,319,715 | |
Bel Fuse, Inc.: | |||
Class A | 1,125 | 19,564 | |
Class B (non-vtg.) | 5,258 | 86,652 | |
CDW Corp. | 78,074 | 12,915,001 | |
Cemtrex, Inc. (a)(b) | 30,161 | 42,527 | |
ClearSign Combustion Corp. (a) | 16,057 | 79,000 | |
Coda Octopus Group, Inc. (a)(b) | 2,615 | 22,411 | |
Cognex Corp. | 98,054 | 7,784,507 | |
Coherent, Inc. (a) | 13,614 | 3,575,173 | |
CPS Technologies Corp. (a) | 6,351 | 40,519 | |
Daktronics, Inc. (a) | 31,984 | 216,212 | |
Data I/O Corp. (a) | 15,054 | 88,216 | |
Deswell Industries, Inc. | 1,758 | 6,909 | |
Digital Ally, Inc. (a)(b) | 23,185 | 40,342 | |
ePlus, Inc. (a) | 7,090 | 670,501 | |
FARO Technologies, Inc. (a) | 11,137 | 842,514 | |
Flex Ltd. (a) | 275,758 | 5,038,099 | |
Frequency Electronics, Inc. (a) | 5,274 | 52,529 | |
Hollysys Automation Technologies Ltd. (b) | 30,748 | 415,098 | |
Identiv, Inc. (a) | 10,328 | 160,910 | |
IEC Electronics Corp. (a) | 3,892 | 43,590 | |
II-VI, Inc. (a)(b) | 58,179 | 3,919,519 | |
Insight Enterprises, Inc. (a) | 19,164 | 2,002,255 | |
Intellicheck, Inc. (a)(b) | 10,166 | 76,245 | |
Interlink Electronics, Inc. (a) | 405 | 4,232 | |
IPG Photonics Corp. (a) | 29,805 | 6,236,994 | |
Iteris, Inc. (a) | 22,008 | 162,199 | |
Itron, Inc. (a) | 24,868 | 2,371,164 | |
KEY Tronic Corp. (a) | 6,057 | 41,369 | |
Kimball Electronics, Inc. (a) | 15,945 | 356,849 | |
LightPath Technologies, Inc. Class A (a) | 12,016 | 28,598 | |
Littelfuse, Inc. | 13,581 | 3,547,900 | |
Luna Innovations, Inc. (a) | 21,826 | 221,534 | |
Magal Security Systems Ltd. (b) | 12,188 | 53,262 | |
Mechanical Technology, Inc. (a)(b) | 3,965 | 31,641 | |
MicroVision, Inc. (a)(b) | 87,687 | 1,367,917 | |
MICT, Inc. (a) | 60,111 | 126,834 | |
Napco Security Technolgies, Inc. (a) | 11,834 | 385,078 | |
National Instruments Corp. | 72,866 | 2,972,933 | |
Neonode, Inc. (a)(b) | 3,287 | 21,168 | |
nLIGHT, Inc. (a) | 23,656 | 693,594 | |
Novanta, Inc. (a) | 19,813 | 2,753,413 | |
OSI Systems, Inc. (a) | 9,960 | 959,746 | |
PC Connection, Inc. | 15,743 | 768,101 | |
Plexus Corp. (a) | 16,687 | 1,648,842 | |
Powerfleet, Inc. (a) | 19,674 | 132,603 | |
Research Frontiers, Inc. (a)(b) | 18,055 | 42,971 | |
Richardson Electronics Ltd. | 7,825 | 66,904 | |
Sanmina Corp. (a) | 37,941 | 1,597,696 | |
ScanSource, Inc. (a) | 12,803 | 390,876 | |
SGOCO Technology Ltd. (a)(b) | 47,686 | 90,603 | |
Supercom Ltd. (a)(b) | 8,931 | 11,432 | |
Trimble, Inc. (a) | 139,442 | 10,847,193 | |
TTM Technologies, Inc. (a) | 56,839 | 861,111 | |
UTime Ltd. (a)(b) | 4,556 | 217,549 | |
Velodyne Lidar, Inc. (a)(b) | 104,840 | 1,011,706 | |
Wayside Technology Group, Inc. | 3,243 | 93,561 | |
Wrap Technologies, Inc. (a)(b) | 19,549 | 175,159 | |
Zebra Technologies Corp. Class A (a) | 29,750 | 14,787,238 | |
96,466,764 | |||
IT Services - 3.5% | |||
21Vianet Group, Inc. ADR (a) | 60,471 | 1,349,713 | |
Affirm Holdings, Inc. (b) | 71,828 | 4,367,861 | |
Akamai Technologies, Inc. (a) | 90,568 | 10,343,771 | |
Alithya Group, Inc. (a)(b) | 36,580 | 76,086 | |
ALJ Regional Holdings, Inc. (a)(b) | 36,145 | 53,856 | |
Amdocs Ltd. | 73,258 | 5,721,450 | |
American Virtual Cloud Technologies, Inc. (a)(b) | 11,030 | 66,842 | |
Automatic Data Processing, Inc. | 236,849 | 46,427,141 | |
BigCommerce Holdings, Inc. (a)(b) | 38,362 | 2,086,509 | |
Brightcove, Inc. (a) | 26,601 | 385,715 | |
Cantaloupe, Inc. (a) | 39,215 | 478,815 | |
Cardtronics PLC (a) | 24,580 | 956,899 | |
Cass Information Systems, Inc. | 9,021 | 411,628 | |
Chindata Group Holdings Ltd. ADR (a) | 24,899 | 403,364 | |
CLPS, Inc. (a)(b) | 5,050 | 21,109 | |
Cognizant Technology Solutions Corp. Class A | 293,756 | 21,021,179 | |
Computer Task Group, Inc. (a) | 17,316 | 176,104 | |
Concentrix Corp. (a) | 28,764 | 4,392,838 | |
Conduent, Inc. (a) | 116,630 | 884,055 | |
Crexendo, Inc. (a)(b) | 8,006 | 43,873 | |
CSG Systems International, Inc. | 17,233 | 758,941 | |
CSP, Inc. (a) | 2,765 | 28,618 | |
Euronet Worldwide, Inc. (a) | 29,081 | 4,351,681 | |
EVO Payments, Inc. Class A (a) | 24,859 | 711,962 | |
Exela Technologies, Inc. (a)(b) | 24,688 | 38,266 | |
ExlService Holdings, Inc. (a) | 18,501 | 1,886,732 | |
Fiserv, Inc. (a) | 369,569 | 42,574,349 | |
Formula Systems (1985) Ltd. ADR | 25 | 2,155 | |
GDS Holdings Ltd. ADR (a) | 60,045 | 4,516,585 | |
GreenBox POS (a)(b) | 19,483 | 209,442 | |
GreenSky, Inc. Class A (a) | 39,568 | 231,868 | |
Grid Dynamics Holdings, Inc. (a) | 33,150 | 509,516 | |
Hackett Group, Inc. | 16,264 | 289,662 | |
i3 Verticals, Inc. Class A (a) | 11,599 | 360,381 | |
IBEX Ltd. (a) | 9,134 | 198,573 | |
Information Services Group, Inc. | 25,958 | 152,114 | |
Innodata, Inc. (a) | 11,764 | 73,643 | |
Inpixon (a)(b) | 51,648 | 54,747 | |
International Money Express, Inc. (a) | 22,487 | 343,376 | |
Jack Henry & Associates, Inc. | 42,610 | 6,568,332 | |
Kingsoft Cloud Holdings Ltd. ADR (b) | 52,242 | 2,040,573 | |
Limelight Networks, Inc. (a) | 65,096 | 201,798 | |
Marathon Digital Holdings, Inc. (a)(b) | 54,748 | 1,356,108 | |
MoneyGram International, Inc. (a) | 41,296 | 404,701 | |
MongoDB, Inc. Class A (a) | 33,340 | 9,733,280 | |
Net 1 UEPS Technologies, Inc. (a)(b) | 28,433 | 141,596 | |
Okta, Inc. (a) | 67,098 | 14,925,279 | |
Paya Holdings, Inc. (a) | 62,024 | 615,278 | |
Paychex, Inc. | 200,325 | 20,260,871 | |
PayPal Holdings, Inc. (a) | 647,260 | 168,300,545 | |
Paysign, Inc. (a)(b) | 23,327 | 77,212 | |
Perficient, Inc. (a) | 17,809 | 1,274,946 | |
PFSweb, Inc. (a) | 12,193 | 91,813 | |
Priority Technology Holdings, Inc. (a) | 36,694 | 284,379 | |
QIWI PLC Class B sponsored ADR | 23,534 | 258,639 | |
Rackspace Technology, Inc. (a)(b) | 114,778 | 2,316,220 | |
Repay Holdings Corp. (a) | 43,394 | 985,478 | |
Research Solutions, Inc. (a) | 4,834 | 11,553 | |
Sabre Corp. (a)(b) | 175,407 | 2,429,387 | |
ServiceSource International, Inc. (a) | 61,161 | 75,840 | |
Steel Connect, Inc. (a) | 32,364 | 64,728 | |
StoneCo Ltd. Class A (a) | 146,362 | 9,655,501 | |
Sykes Enterprises, Inc. (a) | 22,354 | 937,080 | |
Taoping, Inc. (a) | 3,739 | 20,041 | |
Ttec Holdings, Inc. | 25,710 | 2,787,221 | |
Tucows, Inc. (a) | 6,556 | 512,024 | |
Usio, Inc. (a) | 11,199 | 65,290 | |
VeriSign, Inc. (a) | 62,452 | 13,734,444 | |
Verra Mobility Corp. (a) | 86,859 | 1,237,741 | |
Wix.com Ltd. (a) | 30,831 | 8,011,744 | |
426,341,061 | |||
Semiconductors & Semiconductor Equipment - 10.2% | |||
ACM Research, Inc. (a) | 9,291 | 705,930 | |
Advanced Energy Industries, Inc. | 21,060 | 2,148,331 | |
Advanced Micro Devices, Inc. (a) | 670,547 | 53,697,404 | |
Allegro MicroSystems LLC (a) | 104,788 | 2,746,493 | |
Alpha & Omega Semiconductor Ltd. (a) | 13,400 | 431,614 | |
Ambarella, Inc. (a) | 19,752 | 1,982,706 | |
Amkor Technology, Inc. | 133,371 | 2,814,128 | |
Amtech Systems, Inc. (a) | 9,588 | 100,099 | |
Analog Devices, Inc. (b) | 204,712 | 33,695,595 | |
Applied Materials, Inc. | 507,106 | 70,046,552 | |
ASML Holding NV | 42,814 | 28,919,573 | |
Atomera, Inc. (a)(b) | 13,904 | 244,015 | |
Axcelis Technologies, Inc. (a) | 19,430 | 805,179 | |
AXT, Inc. (a) | 21,623 | 220,122 | |
Broadcom, Inc. | 225,439 | 106,481,603 | |
Brooks Automation, Inc. | 40,836 | 4,168,947 | |
Camtek Ltd. (a) | 23,975 | 874,368 | |
Canadian Solar, Inc. (a)(b) | 33,213 | 1,314,571 | |
CEVA, Inc. (a) | 12,199 | 547,369 | |
ChipMOS TECHNOLOGIES, Inc. sponsored ADR | 3,922 | 126,445 | |
Cirrus Logic, Inc. (a) | 32,816 | 2,561,945 | |
CMC Materials, Inc. | 16,067 | 2,479,620 | |
Cohu, Inc. (a) | 26,067 | 970,214 | |
Cree, Inc. (a)(b) | 61,576 | 6,158,216 | |
CVD Equipment Corp. (a)(b) | 4,263 | 17,947 | |
CyberOptics Corp. (a) | 5,253 | 156,539 | |
Diodes, Inc. (a) | 25,857 | 1,956,599 | |
DSP Group, Inc. (a) | 16,168 | 254,161 | |
Enphase Energy, Inc. (a) | 71,429 | 10,217,918 | |
Entegris, Inc. | 75,108 | 8,596,111 | |
Everspin Technologies, Inc. (a)(b) | 13,033 | 80,153 | |
First Solar, Inc. (a) | 58,857 | 4,479,606 | |
FormFactor, Inc. (a) | 42,159 | 1,486,105 | |
GSI Technology, Inc. (a) | 15,609 | 97,556 | |
Himax Technologies, Inc. sponsored ADR (b) | 59,577 | 781,054 | |
Ichor Holdings Ltd. (a) | 14,956 | 841,425 | |
Impinj, Inc. (a)(b) | 13,149 | 684,405 | |
Intel Corp. | 2,245,629 | 128,270,328 | |
KLA Corp. | 85,096 | 26,966,071 | |
Kopin Corp. (a) | 49,279 | 399,160 | |
Kulicke & Soffa Industries, Inc. | 35,634 | 1,849,405 | |
Lam Research Corp. | 78,948 | 51,304,358 | |
Lattice Semiconductor Corp. (a) | 75,683 | 4,016,497 | |
MACOM Technology Solutions Holdings, Inc. (a) | 38,228 | 2,263,098 | |
Marvell Technology, Inc. | 375,021 | 18,113,514 | |
Maxeon Solar Technologies Ltd. (a)(b) | 18,202 | 284,315 | |
Maxim Integrated Products, Inc. | 149,293 | 15,229,379 | |
Microchip Technology, Inc. | 148,325 | 23,279,609 | |
Micron Technology, Inc. (a) | 618,449 | 52,036,299 | |
MKS Instruments, Inc. | 30,438 | 5,729,345 | |
Monolithic Power Systems, Inc. | 25,186 | 8,641,820 | |
Nova Measuring Instruments Ltd. (a)(b) | 15,378 | 1,541,183 | |
NVE Corp. | 2,373 | 165,778 | |
NVIDIA Corp. | 342,804 | 222,747,183 | |
NXP Semiconductors NV | 153,033 | 32,354,237 | |
O2Micro International Ltd. sponsored ADR (a)(b) | 16,202 | 120,381 | |
ON Semiconductor Corp. (a) | 228,320 | 9,141,933 | |
PDF Solutions, Inc. (a) | 23,680 | 412,979 | |
Photronics, Inc. (a) | 36,838 | 498,787 | |
Pixelworks, Inc. (a) | 37,111 | 129,517 | |
Power Integrations, Inc. | 32,986 | 2,711,119 | |
Qorvo, Inc. (a) | 62,935 | 11,499,483 | |
Qualcomm, Inc. | 627,570 | 84,433,268 | |
QuickLogic Corp. (a) | 5,932 | 36,719 | |
Rambus, Inc. (a) | 63,437 | 1,240,828 | |
Rubicon Technology, Inc. (a) | 443 | 4,359 | |
SemiLEDs Corp. (a)(b) | 4,500 | 62,190 | |
Semtech Corp. (a) | 36,094 | 2,273,922 | |
Silicon Laboratories, Inc. (a) | 24,354 | 3,325,782 | |
Silicon Motion Tech Corp. sponsored ADR | 18,403 | 1,214,046 | |
SiTime Corp. (a) | 9,292 | 913,682 | |
SkyWater Technology, Inc. (a) | 20,062 | 522,414 | |
Skyworks Solutions, Inc. | 91,388 | 15,535,960 | |
SMART Global Holdings, Inc. (a) | 12,953 | 613,972 | |
SolarEdge Technologies, Inc. (a) | 28,516 | 7,357,413 | |
SPI Energy Co. Ltd. sponsored ADR (a) | 11,554 | 64,702 | |
Summit Wireless Technologies, Inc. (a) | 27,872 | 117,062 | |
SunPower Corp. (a)(b) | 94,340 | 2,206,613 | |
Synaptics, Inc. (a) | 19,301 | 2,438,295 | |
Teradyne, Inc. | 92,307 | 12,216,831 | |
Texas Instruments, Inc. | 507,766 | 96,384,142 | |
Tower Semiconductor Ltd. (a) | 61,304 | 1,684,021 | |
Ultra Clean Holdings, Inc. (a) | 21,918 | 1,234,641 | |
Universal Display Corp. | 26,374 | 5,693,092 | |
Veeco Instruments, Inc. (a) | 28,870 | 687,683 | |
Xilinx, Inc. | 135,810 | 17,247,870 | |
1,231,105,903 | |||
Software - 14.6% | |||
2U, Inc. (a)(b) | 40,526 | 1,475,957 | |
Absolute Software Corp. (b) | 23,903 | 332,252 | |
ACI Worldwide, Inc. (a) | 64,620 | 2,472,361 | |
ACV Auctions, Inc. Class A (a) | 8,524 | 220,942 | |
Adobe, Inc. (a) | 264,523 | 133,473,015 | |
Agilysys, Inc. (a) | 14,089 | 715,580 | |
Agora, Inc. ADR (a)(b) | 28,319 | 1,265,576 | |
Alarm.com Holdings, Inc. (a) | 27,342 | 2,238,763 | |
Alkami Technology, Inc. (a) | 45,862 | 1,525,829 | |
Allot Ltd. (a) | 21,262 | 409,931 | |
Altair Engineering, Inc. Class A (a) | 23,917 | 1,611,288 | |
American Software, Inc. Class A | 20,292 | 408,275 | |
ANSYS, Inc. (a) | 47,996 | 16,219,768 | |
AppFolio, Inc. (a) | 10,392 | 1,401,777 | |
Appian Corp. Class A (a)(b) | 21,665 | 1,960,249 | |
Aspen Technology, Inc. (a) | 37,769 | 5,154,335 | |
Asure Software, Inc. (a)(b) | 12,380 | 104,611 | |
Atlassian Corp. PLC (a) | 73,913 | 17,242,425 | |
AudioEye, Inc. (a)(b) | 4,910 | 90,049 | |
Aurora Mobile Ltd. ADR (a)(b) | 21,727 | 71,699 | |
Autodesk, Inc. (a) | 121,248 | 34,659,953 | |
Aware, Inc. (a) | 13,849 | 52,626 | |
Benefitfocus, Inc. (a) | 14,604 | 215,993 | |
Bentley Systems, Inc. Class B (b) | 146,143 | 8,382,762 | |
Bio-Key International, Inc. (a)(b) | 10,259 | 41,344 | |
Blackbaud, Inc. (a) | 28,221 | 1,994,942 | |
BlackLine, Inc. (a) | 32,196 | 3,347,418 | |
Bottomline Technologies, Inc. (a) | 24,745 | 924,968 | |
BSQUARE Corp. (a) | 7,925 | 17,594 | |
BTRS Holdings, Inc. (a) | 82,523 | 1,180,079 | |
Cadence Design Systems, Inc. (a) | 154,811 | 19,659,449 | |
CDK Global, Inc. | 67,309 | 3,522,953 | |
Cerence, Inc. (a)(b) | 20,732 | 1,972,235 | |
Check Point Software Technologies Ltd. (a)(b) | 78,387 | 9,169,711 | |
Citrix Systems, Inc. | 68,201 | 7,840,387 | |
Cleanspark, Inc. (a) | 17,932 | 300,540 | |
Cognyte Software Ltd. (a) | 35,965 | 925,739 | |
Color Star Technology Co. Ltd. (a)(b) | 55,164 | 56,267 | |
CommVault Systems, Inc. (a) | 26,788 | 2,040,442 | |
Cornerstone OnDemand, Inc. (a) | 36,694 | 1,613,435 | |
Coupa Software, Inc. (a) | 40,038 | 9,537,052 | |
Crowdstrike Holdings, Inc. (a) | 104,498 | 23,214,231 | |
CyberArk Software Ltd. (a) | 21,654 | 2,740,097 | |
Cyren Ltd. (a)(b) | 13,132 | 7,991 | |
Datadog, Inc. Class A (a) | 129,931 | 11,830,218 | |
Datasea, Inc. (a)(b) | 10,484 | 26,315 | |
Descartes Systems Group, Inc. (a) | 47,469 | 2,774,088 | |
Digimarc Corp. (a)(b) | 8,852 | 307,784 | |
Digital Turbine, Inc. (a) | 49,479 | 3,274,025 | |
Docebo, Inc. | 17,300 | 896,486 | |
DocuSign, Inc. (a) | 103,287 | 20,824,725 | |
Domo, Inc. Class B (a) | 15,133 | 1,006,345 | |
Dropbox, Inc. Class A (a) | 186,095 | 5,089,698 | |
Duck Creek Technologies, Inc. (a) | 74,029 | 2,910,080 | |
Ebix, Inc. (b) | 17,007 | 465,992 | |
eGain Communications Corp. (a) | 19,235 | 193,119 | |
Everbridge, Inc. (a) | 20,941 | 2,460,568 | |
Evolving Systems, Inc. (a)(b) | 8,488 | 15,873 | |
FireEye, Inc. (a) | 132,160 | 2,956,419 | |
Five9, Inc. (a) | 36,884 | 6,532,156 | |
Fortinet, Inc. (a) | 90,590 | 19,797,539 | |
GTY Technology Holdings, Inc. (a) | 38,628 | 231,768 | |
Ideanomics, Inc. (a)(b) | 228,858 | 659,111 | |
Infobird Co. Ltd. (a) | 11,582 | 44,012 | |
Innoviz Technologies Ltd. (a)(b) | 72,685 | 771,188 | |
InterDigital, Inc. | 18,354 | 1,482,636 | |
Intrusion, Inc. (a)(b) | 9,227 | 137,113 | |
Intuit, Inc. | 151,313 | 66,440,025 | |
j2 Global, Inc. (a)(b) | 25,296 | 3,150,111 | |
Jamf Holding Corp. (a) | 65,286 | 2,264,118 | |
JFrog Ltd. (b) | 51,911 | 2,167,284 | |
Karooooo Ltd. (a) | 11,529 | 421,039 | |
Kaspien Holdings, Inc. (a)(b) | 477 | 11,066 | |
KnowBe4, Inc. (a) | 4,867 | 90,770 | |
LivePerson, Inc. (a) | 36,995 | 2,032,875 | |
Magic Software Enterprises Ltd. | 31,025 | 510,051 | |
Manhattan Associates, Inc. (a) | 35,271 | 4,796,151 | |
Marin Software, Inc. (a)(b) | 14,390 | 22,880 | |
Materialise NV ADR (a)(b) | 11,968 | 323,016 | |
McAfee Corp. | 91,878 | 2,308,894 | |
Mercurity Fintech Holding, Inc. sponsored ADR (a)(b) | 3,066 | 17,813 | |
Microsoft Corp. | 4,170,351 | 1,041,253,238 | |
MicroStrategy, Inc. Class A (a)(b) | 4,324 | 2,032,280 | |
Mimecast Ltd. (a) | 35,134 | 1,756,349 | |
Mitek Systems, Inc. (a) | 28,300 | 479,968 | |
MMTEC, Inc. (a)(b) | 12,794 | 22,006 | |
nCino, Inc. (a)(b) | 52,955 | 3,236,610 | |
Net Element International, Inc. (a) | 2,849 | 29,430 | |
NetSol Technologies, Inc. (a) | 6,495 | 30,072 | |
NICE Systems Ltd. sponsored ADR (a) | 28,012 | 6,228,748 | |
NortonLifeLock, Inc. | 325,865 | 9,013,426 | |
Nuance Communications, Inc. (a) | 158,586 | 8,389,199 | |
Nutanix, Inc. Class A (a) | 106,851 | 3,366,875 | |
NXT-ID, Inc. (a) | 34,241 | 28,927 | |
Oblong, Inc. (a) | 11,971 | 43,215 | |
Onespan, Inc. (a) | 24,175 | 632,176 | |
Open Text Corp. | 151,171 | 7,102,014 | |
Opera Ltd. ADR (a) | 15,592 | 184,921 | |
Park City Group, Inc. (a) | 11,886 | 71,197 | |
Paylocity Holding Corp. (a) | 30,228 | 5,133,621 | |
Pegasystems, Inc. | 44,859 | 5,299,642 | |
Phunware, Inc. (a)(b) | 56,490 | 76,826 | |
Powerbridge Technologies Co. Ltd. (a)(b) | 18,068 | 23,669 | |
Privia Health Group, Inc. (a) | 55,690 | 1,822,734 | |
Progress Software Corp. | 24,678 | 1,099,898 | |
Proofpoint, Inc. (a) | 31,996 | 5,529,229 | |
PTC, Inc. (a) | 64,731 | 8,683,016 | |
QAD, Inc. Class A | 12,057 | 861,593 | |
Qualtrics International, Inc. | 50,590 | 1,742,320 | |
Qualys, Inc. (a)(b) | 22,000 | 2,126,960 | |
Qumu Corp. (a) | 9,115 | 42,749 | |
Rapid7, Inc. (a) | 28,819 | 2,410,709 | |
RealNetworks, Inc. (a) | 17,847 | 42,476 | |
Rimini Street, Inc. (a) | 47,719 | 310,651 | |
Riot Blockchain, Inc. (a)(b) | 46,859 | 1,271,285 | |
Safe-T Group Ltd. ADR (a)(b) | 24,878 | 35,327 | |
Sapiens International Corp. NV | 29,656 | 851,424 | |
SeaChange International, Inc. (a) | 35,372 | 41,032 | |
SecureWorks Corp. (a) | 11,955 | 168,326 | |
SharpSpring, Inc. (a) | 7,519 | 102,634 | |
ShotSpotter, Inc. (a)(b) | 7,107 | 289,326 | |
Smith Micro Software, Inc. (a) | 26,575 | 143,239 | |
Splunk, Inc. (a) | 90,249 | 10,938,179 | |
Sprout Social, Inc. (a) | 24,259 | 1,684,060 | |
SPS Commerce, Inc. (a) | 19,702 | 1,849,230 | |
SS&C Technologies Holdings, Inc. | 142,981 | 10,562,006 | |
Sumo Logic, Inc. | 57,543 | 1,081,808 | |
Support.com, Inc. (a)(b) | 16,704 | 47,105 | |
SVMK, Inc. (a) | 77,628 | 1,509,865 | |
Synchronoss Technologies, Inc. (a)(b) | 16,433 | 47,820 | |
Synopsys, Inc. (a) | 84,460 | 21,481,556 | |
Talend SA ADR (a) | 17,339 | 1,126,515 | |
Telos Corp. | 35,661 | 1,172,534 | |
Tenable Holdings, Inc. (a) | 58,467 | 2,443,921 | |
The Trade Desk, Inc. (a) | 23,612 | 13,887,162 | |
Triterras, Inc. (a)(b) | 45,458 | 281,385 | |
Upland Software, Inc. (a) | 17,288 | 708,635 | |
Varonis Systems, Inc. (a) | 58,534 | 2,827,192 | |
Verb Technology Co., Inc. (a)(b) | 21,055 | 25,477 | |
Verint Systems, Inc. (a) | 35,965 | 1,658,346 | |
Veritone, Inc. (a)(b) | 17,092 | 327,654 | |
Vertex, Inc. Class A (a)(b) | 14,677 | 281,945 | |
Viant Technology, Inc. | 5,920 | 172,805 | |
Workday, Inc. Class A (a) | 99,713 | 22,806,357 | |
Xperi Holding Corp. | 60,469 | 1,295,246 | |
Xunlei Ltd. sponsored ADR (a) | 19,615 | 95,133 | |
Zix Corp. (a) | 26,304 | 183,339 | |
Zoom Video Communications, Inc. Class A (a) | 129,760 | 43,019,333 | |
Zscaler, Inc. (a) | 74,811 | 14,528,296 | |
1,769,108,482 | |||
Technology Hardware, Storage & Peripherals - 10.0% | |||
Apple, Inc. | 9,283,655 | 1,156,836,230 | |
Astro-Med, Inc. (a) | 3,663 | 59,524 | |
Avid Technology, Inc. (a) | 21,504 | 664,044 | |
Borqs Technologies, Inc. (a)(b) | 40,146 | 36,890 | |
Boxlight Corp. (a)(b) | 32,673 | 81,683 | |
Canaan, Inc. ADR (a)(b) | 68,932 | 579,029 | |
Corsair Gaming, Inc. (b) | 50,700 | 1,582,854 | |
Ebang International Holdings, Inc. Class A (a)(b) | 66,036 | 190,844 | |
Immersion Corp. (a) | 18,807 | 160,800 | |
Intevac, Inc. (a) | 22,851 | 158,814 | |
Logitech International SA (b) | 94,153 | 11,590,234 | |
Movano, Inc. (a) | 16,621 | 83,105 | |
Nano Dimension Ltd. ADR (a)(b) | 95,395 | 677,305 | |
NetApp, Inc. | 123,251 | 9,535,930 | |
One Stop Systems, Inc. (a) | 4,926 | 28,571 | |
Quantum Corp. (a) | 25,956 | 194,930 | |
Seagate Technology Holdings PLC | 131,938 | 12,633,064 | |
Socket Mobile, Inc. (a) | 1,296 | 7,659 | |
Sonim Technologies, Inc. (a) | 70,787 | 35,953 | |
Stratasys Ltd. (a)(b) | 30,018 | 693,116 | |
Super Micro Computer, Inc. (a) | 28,899 | 1,003,951 | |
Transact Technologies, Inc. (a) | 6,575 | 91,853 | |
Western Digital Corp. (a) | 169,685 | 12,765,403 | |
1,209,691,786 | |||
TOTAL INFORMATION TECHNOLOGY | 4,888,617,791 | ||
MATERIALS - 0.4% | |||
Chemicals - 0.1% | |||
Advanced Emissions Solutions, Inc. (a) | 9,725 | 77,217 | |
AgroFresh Solutions, Inc. (a) | 34,342 | 75,896 | |
Amyris, Inc. (a) | 146,537 | 2,085,222 | |
Balchem Corp. | 17,562 | 2,300,622 | |
CN Energy Group, Inc. (b) | 4,799 | 22,651 | |
Diversey Holdings Ltd. (a) | 168,328 | 2,841,377 | |
Fuwei Films Holdings Co. Ltd. (a) | 3,842 | 31,697 | |
Gulf Resources, Inc. (a) | 8,302 | 51,555 | |
Hawkins, Inc. | 11,982 | 407,628 | |
Innospec, Inc. | 15,113 | 1,528,075 | |
Loop Industries, Inc. (a)(b) | 22,788 | 210,333 | |
Marrone Bio Innovations, Inc. (a) | 100,070 | 140,098 | |
Methanex Corp. | 43,441 | 1,544,328 | |
Northern Technologies International Corp. | 5,689 | 93,755 | |
11,410,454 | |||
Construction Materials - 0.0% | |||
Forterra, Inc. (a) | 35,757 | 835,999 | |
U.S. Concrete, Inc. (a) | 10,755 | 612,927 | |
United States Lime & Minerals, Inc. | 3,255 | 452,933 | |
1,901,859 | |||
Containers & Packaging - 0.1% | |||
Karat Packaging, Inc. (a) | 10,117 | 192,223 | |
Pactiv Evergreen, Inc. | 96,857 | 1,437,358 | |
Silgan Holdings, Inc. | 60,123 | 2,532,982 | |
UFP Technologies, Inc. (a) | 5,073 | 276,174 | |
4,438,737 | |||
Metals & Mining - 0.2% | |||
Century Aluminum Co. (a) | 47,905 | 651,987 | |
China Natural Resources, Inc. (a)(b) | 12,136 | 17,112 | |
Corvus Gold, Inc. (a)(b) | 55,356 | 172,157 | |
Ferroglobe PLC (a) | 90,623 | 467,615 | |
Ferroglobe Representation & Warranty Insurance (a)(c) | 23,476 | 0 | |
Haynes International, Inc. | 3,064 | 106,627 | |
Huadi International Group Co. Ltd. (a)(b) | 1,902 | 9,700 | |
Hycroft Mining Holding Corp. (a)(b) | 31,072 | 124,909 | |
Kaiser Aluminum Corp. | 10,015 | 1,295,841 | |
Largo Resources Ltd. (a) | 7,447 | 109,024 | |
Olympic Steel, Inc. | 8,257 | 295,188 | |
Pan American Silver Corp. | 118,840 | 3,997,778 | |
Perpetua Resources Corp. (a) | 24,662 | 190,391 | |
Piedmont Lithium, Inc. (a)(b) | 4,409 | 286,144 | |
Ramaco Resources, Inc. (a)(b) | 21,088 | 121,256 | |
Royal Gold, Inc. | 37,519 | 4,643,727 | |
Schnitzer Steel Industries, Inc. Class A | 12,350 | 672,828 | |
SSR Mining, Inc. (b) | 123,685 | 2,294,357 | |
Steel Dynamics, Inc. | 118,191 | 7,378,664 | |
Synalloy Corp. (a) | 6,143 | 60,631 | |
U.S. Gold Corp. (a) | 1,706 | 20,899 | |
Universal Stainless & Alloy Products, Inc. (a) | 7,722 | 83,012 | |
ZK International Group Co. Ltd. (a)(b) | 9,529 | 41,928 | |
23,041,775 | |||
Paper & Forest Products - 0.0% | |||
Mercer International, Inc. (SBI) | 32,688 | 485,090 | |
TOTAL MATERIALS | 41,277,915 | ||
REAL ESTATE - 1.0% | |||
Equity Real Estate Investment Trusts (REITs) - 0.8% | |||
American Finance Trust, Inc. | 70,901 | 645,199 | |
Brookfield Property REIT, Inc. Class A | 26,801 | 502,251 | |
CareTrust (REIT), Inc. | 57,669 | 1,342,534 | |
CIM Commercial Trust Corp. | 10,595 | 126,928 | |
CyrusOne, Inc. | 66,691 | 4,918,461 | |
Diversified Healthcare Trust (SBI) | 125,534 | 455,688 | |
East Stone Acquisition Corp. (a) | 10,409 | 104,610 | |
Equinix, Inc. | 49,592 | 36,535,418 | |
Gaming & Leisure Properties | 128,731 | 5,967,969 | |
Gladstone Commercial Corp. | 18,518 | 401,285 | |
Gladstone Land Corp. | 13,642 | 315,539 | |
Global Self Storage, Inc. | 5,948 | 32,655 | |
Host Hotels & Resorts, Inc. (a) | 391,220 | 6,717,247 | |
Indus Realty Trust, Inc. | 3,499 | 230,444 | |
Industrial Logistics Properties Trust | 36,786 | 921,857 | |
Lamar Advertising Co. Class A | 48,162 | 5,048,341 | |
Medalist Diversified (REIT), Inc. (a) | 12,929 | 18,488 | |
Office Properties Income Trust | 15,065 | 440,350 | |
Potlatch Corp. | 38,372 | 2,309,994 | |
Regency Centers Corp. | 96,389 | 6,226,729 | |
Retail Opportunity Investments Corp. | 70,063 | 1,251,325 | |
Sabra Health Care REIT, Inc. | 122,517 | 2,140,372 | |
SBA Communications Corp. Class A | 60,813 | 18,129,572 | |
Service Properties Trust | 89,889 | 1,129,006 | |
Uniti Group, Inc. | 130,929 | 1,421,889 | |
Wheeler REIT, Inc. (a) | 15,634 | 65,037 | |
97,399,188 | |||
Real Estate Management & Development - 0.2% | |||
Alset Ehome International, Inc. (b) | 3,984 | 16,215 | |
Altisource Portfolio Solutions SA (a) | 7,869 | 53,745 | |
Brookfield Property Partners LP | 243,998 | 4,584,722 | |
China HGS Real Estate, Inc. (a)(b) | 6,970 | 13,382 | |
Colliers International Group, Inc. | 20,510 | 2,276,405 | |
Cresud S.A.C.I.F. y A. sponsored ADR (a)(b) | 21,742 | 136,757 | |
eXp World Holdings, Inc. (a)(b) | 77,233 | 2,491,537 | |
Fathom Holdings, Inc. (a)(b) | 7,329 | 242,004 | |
FirstService Corp. | 24,577 | 3,991,059 | |
FRP Holdings, Inc. (a) | 6,217 | 356,421 | |
Gyrodyne LLC (a) | 1,080 | 13,500 | |
IRSA Propiedades Comerciales SA sponsored ADR (b) | 3,524 | 31,857 | |
Landmark Infrastructure Partners LP | 12,077 | 157,243 | |
Newmark Group, Inc. | 88,360 | 1,139,844 | |
Opendoor Technologies, Inc. (a)(b) | 317,867 | 4,977,797 | |
Redfin Corp. (a) | 56,727 | 3,348,595 | |
Stratus Properties, Inc. (a) | 4,684 | 127,264 | |
The RMR Group, Inc. | 6,892 | 269,615 | |
Ucommune International Ltd. (a)(b) | 38,568 | 88,706 | |
24,316,668 | |||
TOTAL REAL ESTATE | 121,715,856 | ||
UTILITIES - 0.7% | |||
Electric Utilities - 0.7% | |||
Alliant Energy Corp. | 139,857 | 7,992,828 | |
American Electric Power Co., Inc. | 276,770 | 23,802,220 | |
Exelon Corp. | 534,076 | 24,097,509 | |
MGE Energy, Inc. | 19,112 | 1,433,782 | |
Otter Tail Corp. | 23,594 | 1,131,804 | |
Spark Energy, Inc. Class A, (b) | 7,308 | 75,930 | |
Xcel Energy, Inc. | 299,868 | 21,254,644 | |
79,788,717 | |||
Gas Utilities - 0.0% | |||
RGC Resources, Inc. | 5,446 | 124,604 | |
Independent Power and Renewable Electricity Producers - 0.0% | |||
Atlantica Sustainable Infrastructure PLC (b) | 59,816 | 2,174,312 | |
FTC Solar, Inc. (a) | 43,800 | 471,288 | |
Montauk Renewables, Inc. (b) | 78,659 | 762,992 | |
VivoPower International PLC (a)(b) | 8,836 | 60,968 | |
3,469,560 | |||
Multi-Utilities - 0.0% | |||
NorthWestern Energy Corp. | 29,004 | 1,837,403 | |
Water Utilities - 0.0% | |||
Artesian Resources Corp. Class A | 6,205 | 255,894 | |
Cadiz, Inc. (a)(b) | 22,934 | 315,572 | |
Consolidated Water Co., Inc. (b) | 7,912 | 97,397 | |
Global Water Resources, Inc. | 13,586 | 232,049 | |
Middlesex Water Co. | 10,525 | 904,729 | |
Pure Cycle Corp. (a) | 13,933 | 197,013 | |
York Water Co. | 8,284 | 416,934 | |
2,419,588 | |||
TOTAL UTILITIES | 87,639,872 | ||
TOTAL COMMON STOCKS | |||
(Cost $5,123,986,297) | 12,064,644,258 | ||
Nonconvertible Preferred Stocks - 0.0% | |||
CONSUMER DISCRETIONARY - 0.0% | |||
Hotels, Restaurants & Leisure - 0.0% | |||
FAT Brands, Inc. | |||
(Cost $16,402) | 1,005 | 24,522 | |
Money Market Funds - 4.6% | |||
Fidelity Cash Central Fund 0.06% (e) | 31,205,673 | 31,211,914 | |
Fidelity Securities Lending Cash Central Fund 0.06% (e)(f) | 524,746,607 | 524,799,082 | |
TOTAL MONEY MARKET FUNDS | |||
(Cost $556,010,996) | 556,010,996 | ||
TOTAL INVESTMENT IN SECURITIES - 104.4% | |||
(Cost $5,680,013,695) | 12,620,679,776 | ||
NET OTHER ASSETS (LIABILITIES) - (4.4)% | (527,450,980) | ||
NET ASSETS - 100% | $12,093,228,796 |
Futures Contracts | |||||
Number of contracts | Expiration Date | Notional Amount | Value | Unrealized Appreciation/(Depreciation) | |
Purchased | |||||
Equity Index Contracts | |||||
CME E-mini NASDAQ 100 Index Contracts (United States) | 108 | June 2021 | $29,562,840 | $1,239,113 | $1,239,113 |
The notional amount of futures purchased as a percentage of Net Assets is 0.2%
Legend
(a) Non-income producing
(b) Security or a portion of the security is on loan at period end.
(c) Level 3 security
(d) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $0 or 0.0% of net assets.
(e) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.
(f) Investment made with cash collateral received from securities on loan.
Affiliated Central Funds
Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:
Fund | Income earned |
Fidelity Cash Central Fund | $14,501 |
Fidelity Securities Lending Cash Central Fund | 6,417,671 |
Total | $6,432,172 |
Amounts in the income column in the above table include any capital gain distributions from underlying funds, which are presented in the corresponding line-item in the Statement of Operations, if applicable. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investment Valuation
The following is a summary of the inputs used, as of May 31, 2021, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. For more information on valuation inputs, and their aggregation into the levels used below, please refer to the Investment Valuation section in the accompanying Notes to Financial Statements.
Valuation Inputs at Reporting Date: | ||||
Description | Total | Level 1 | Level 2 | Level 3 |
Investments in Securities: | ||||
Equities: | ||||
Communication Services | $2,128,361,246 | $2,128,350,001 | $-- | $11,245 |
Consumer Discretionary | 1,966,636,964 | 1,966,635,617 | -- | 1,347 |
Consumer Staples | 431,369,481 | 431,369,481 | -- | -- |
Energy | 47,557,120 | 47,557,120 | -- | -- |
Financials | 597,485,443 | 597,269,673 | -- | 215,770 |
Health Care | 1,222,012,101 | 1,221,752,859 | 11,614 | 247,628 |
Industrials | 531,994,991 | 531,994,967 | -- | 24 |
Information Technology | 4,888,617,791 | 4,888,617,791 | -- | -- |
Materials | 41,277,915 | 41,277,915 | -- | -- |
Real Estate | 121,715,856 | 121,715,856 | -- | -- |
Utilities | 87,639,872 | 87,639,872 | -- | -- |
Money Market Funds | 556,010,996 | 556,010,996 | -- | -- |
Total Investments in Securities: | $12,620,679,776 | $12,620,192,148 | $11,614 | $476,014 |
Derivative Instruments: | ||||
Assets | ||||
Futures Contracts | $1,239,113 | $1,239,113 | $-- | $-- |
Total Assets | $1,239,113 | $1,239,113 | $-- | $-- |
Total Derivative Instruments: | $1,239,113 | $1,239,113 | $-- | $-- |
Value of Derivative Instruments
The following table is a summary of the Fund's value of derivative instruments by primary risk exposure as of May 31, 2021. For additional information on derivative instruments, please refer to the Derivative Instruments section in the accompanying Notes to Financial Statements.
Primary Risk Exposure / Derivative Type | Value | |
Asset | Liability | |
Equity Risk | ||
Futures Contracts(a) | $1,239,113 | $0 |
Total Equity Risk | 1,239,113 | 0 |
Total Value of Derivatives | $1,239,113 | $0 |
(a) Reflects gross cumulative appreciation (depreciation) on futures contracts as presented in the Schedule of Investments. In the Statement of Assets and Liabilities, the period end daily variation margin is included in receivable or payable for daily variation margin on futures contracts, and the net cumulative appreciation (depreciation) is included in Total accumulated earnings (loss).
See accompanying notes which are an integral part of the financial statements.
Financial Statements
Statement of Assets and Liabilities
May 31, 2021 (Unaudited) | ||
Assets | ||
Investment in securities, at value (including securities loaned of $509,324,319) — See accompanying schedule: Unaffiliated issuers (cost $5,124,002,699) | $12,064,668,780 | |
Fidelity Central Funds (cost $556,010,996) | 556,010,996 | |
Total Investment in Securities (cost $5,680,013,695) | $12,620,679,776 | |
Segregated cash with brokers for derivative instruments | 2,080,000 | |
Cash | 1,789,624 | |
Foreign currency held at value (cost $313) | 354 | |
Receivable for fund shares sold | 7,348,105 | |
Dividends receivable | 7,260,907 | |
Distributions receivable from Fidelity Central Funds | 1,069,220 | |
Receivable for daily variation margin on futures contracts | 57,061 | |
Prepaid expenses | 1,804 | |
Receivable from investment adviser for expense reductions | 527,018 | |
Total assets | 12,640,813,869 | |
Liabilities | ||
Payable for investments purchased | $4,388,876 | |
Payable for fund shares redeemed | 15,012,547 | |
Accrued management fee | 2,377,251 | |
Other affiliated payables | 998,854 | |
Other payables and accrued expenses | 84,097 | |
Collateral on securities loaned | 524,723,448 | |
Total liabilities | 547,585,073 | |
Net Assets | $12,093,228,796 | |
Net Assets consist of: | ||
Paid in capital | $5,126,978,340 | |
Total accumulated earnings (loss) | 6,966,250,456 | |
Net Assets | $12,093,228,796 | |
Net Asset Value, offering price and redemption price per share ($12,093,228,796 ÷ 69,893,222 shares) | $173.02 |
See accompanying notes which are an integral part of the financial statements.
Statement of Operations
Six months ended May 31, 2021 (Unaudited) | ||
Investment Income | ||
Dividends | $42,771,729 | |
Income from Fidelity Central Funds (including $6,417,671 from security lending) | 6,432,172 | |
Total income | 49,203,901 | |
Expenses | ||
Management fee | $13,828,878 | |
Transfer agent fees | 5,762,033 | |
Accounting fees | 50,000 | |
Custodian fees and expenses | 68,574 | |
Independent trustees' fees and expenses | 102,272 | |
Registration fees | 156,287 | |
Audit | 41,235 | |
Legal | 17,404 | |
Miscellaneous | 21,743 | |
Total expenses before reductions | 20,048,426 | |
Expense reductions | (3,260,667) | |
Total expenses after reductions | 16,787,759 | |
Net investment income (loss) | 32,416,142 | |
Realized and Unrealized Gain (Loss) | ||
Net realized gain (loss) on: | ||
Investment securities: | ||
Unaffiliated issuers | 36,765,843 | |
Fidelity Central Funds | 995 | |
Foreign currency transactions | 548,210 | |
Futures contracts | 6,095,468 | |
Total net realized gain (loss) | 43,410,516 | |
Change in net unrealized appreciation (depreciation) on: | ||
Investment securities: | ||
Unaffiliated issuers | 1,269,621,732 | |
Assets and liabilities in foreign currencies | (379,997) | |
Futures contracts | (1,388,257) | |
Total change in net unrealized appreciation (depreciation) | 1,267,853,478 | |
Net gain (loss) | 1,311,263,994 | |
Net increase (decrease) in net assets resulting from operations | $1,343,680,136 |
See accompanying notes which are an integral part of the financial statements.
Statement of Changes in Net Assets
Six months ended May 31, 2021 (Unaudited) | Year ended November 30, 2020 | |
Increase (Decrease) in Net Assets | ||
Operations | ||
Net investment income (loss) | $32,416,142 | $69,157,497 |
Net realized gain (loss) | 43,410,516 | 38,522,896 |
Change in net unrealized appreciation (depreciation) | 1,267,853,478 | 2,873,388,510 |
Net increase (decrease) in net assets resulting from operations | 1,343,680,136 | 2,981,068,903 |
Distributions to shareholders | (72,649,348) | (314,082,075) |
Share transactions | ||
Proceeds from sales of shares | 1,842,982,817 | 3,001,514,559 |
Reinvestment of distributions | 68,602,714 | 298,187,514 |
Cost of shares redeemed | (1,255,286,543) | (2,955,078,158) |
Net increase (decrease) in net assets resulting from share transactions | 656,298,988 | 344,623,915 |
Total increase (decrease) in net assets | 1,927,329,776 | 3,011,610,743 |
Net Assets | ||
Beginning of period | 10,165,899,020 | 7,154,288,277 |
End of period | $12,093,228,796 | $10,165,899,020 |
Other Information | ||
Shares | ||
Sold | 11,016,840 | 24,570,358 |
Issued in reinvestment of distributions | 425,312 | 2,637,194 |
Redeemed | (7,521,768) | (24,222,462) |
Net increase (decrease) | 3,920,384 | 2,985,090 |
See accompanying notes which are an integral part of the financial statements.
Financial Highlights
Fidelity Nasdaq Composite Index Fund
Six months ended (Unaudited) May 31, | Years endedNovember 30, | |||||
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
Selected Per–Share Data | ||||||
Net asset value, beginning of period | $154.09 | $113.58 | $96.86 | $90.92 | $70.45 | $67.89 |
Income from Investment Operations | ||||||
Net investment income (loss)A | .47 | 1.04 | 1.12 | .89 | .76 | .78 |
Net realized and unrealized gain (loss) | 19.55 | 44.44 | 17.26 | 5.71 | 20.38 | 2.80 |
Total from investment operations | 20.02 | 45.48 | 18.38 | 6.60 | 21.14 | 3.58 |
Distributions from net investment income | (1.09) | (1.11)B | (.81) | (.64) | (.65) | (.55) |
Distributions from net realized gain | – | (3.86)B | (.85) | (.02) | (.03) | (.48) |
Total distributions | (1.09) | (4.97) | (1.66) | (.66) | (.67)C | (1.03) |
Redemption fees added to paid in capitalA | – | – | – | – | –D | .01 |
Net asset value, end of period | $173.02 | $154.09 | $113.58 | $96.86 | $90.92 | $70.45 |
Total ReturnE,F | 13.04% | 41.63% | 19.55% | 7.30% | 30.26% | 5.43% |
Ratios to Average Net AssetsG,H | ||||||
Expenses before reductions | .35%I | .35% | .35% | .40% | .41% | .42% |
Expenses net of fee waivers, if any | .29%I | .29% | .29% | .29% | .29% | .29% |
Expenses net of all reductions | .29%I | .29% | .29% | .29% | .29% | .29% |
Net investment income (loss) | .56%I | .84% | 1.10% | .90% | .94% | 1.20% |
Supplemental Data | ||||||
Net assets, end of period (000 omitted) | $12,093,229 | $10,165,899 | $7,154,288 | $6,002,333 | $4,899,784 | $2,715,137 |
Portfolio turnover rateJ | 9%I | 17% | 6% | 15% | 11% | 4% |
A Calculated based on average shares outstanding during the period.
B The amounts shown reflect certain reclassifications related to book to tax differences that were made in the year shown.
C Total distributions per share do not sum due to rounding.
D Amount represents less than $.005 per share.
E Total returns for periods of less than one year are not annualized.
F Total returns would have been lower if certain expenses had not been reduced during the applicable periods shown.
G Fees and expenses of any underlying mutual funds or exchange-traded funds (ETFs) are not included in the Fund's expense ratio. The Fund indirectly bears its proportionate share of these expenses. For additional expense information related to investments in Fidelity Central Funds, please refer to the "Investments in Fidelity Central Funds" note found in the Notes to Financial Statements section of the most recent Annual or Semi-Annual report.
H Expense ratios reflect operating expenses of the class. Expenses before reductions do not reflect amounts reimbursed, waived, or reduced through arrangements with the investment advisor, brokerage services, or other offset arrangements, if applicable, and do not represent the amount paid by the class during periods when reimbursements, waivers or reductions occur.
I Annualized
J Amount does not include the portfolio activity of any underlying mutual funds or exchange-traded funds (ETFs).
See accompanying notes which are an integral part of the financial statements.
Notes to Financial Statements (Unaudited)
For the period ended May 31, 2021
1. Organization.
Fidelity Nasdaq Composite Index Fund (the Fund) is a fund of Fidelity Concord Street Trust (the Trust) and is authorized to issue an unlimited number of shares. Share transactions on the Statement of Changes in Net Assets may contain exchanges between affiliated funds. The Trust is registered under the Investment Company Act of 1940, as amended (the 1940 Act), as an open-end management investment company organized as a Massachusetts business trust. The Fund may operate as a non-diversified fund, as defined under the 1940 Act, to the approximate extent the Index is non-diversified.
2. Investments in Fidelity Central Funds.
Funds may invest in Fidelity Central Funds, which are open-end investment companies generally available only to other investment companies and accounts managed by the investment adviser and its affiliates. The Schedule of Investments lists any Fidelity Central Funds held as an investment as of period end, but does not include the underlying holdings of each Fidelity Central Fund. An investing fund indirectly bears its proportionate share of the expenses of the underlying Fidelity Central Funds.
Based on its investment objective, each Fidelity Central Fund may invest or participate in various investment vehicles or strategies that are similar to those of the investing fund. These strategies are consistent with the investment objectives of the investing fund and may involve certain economic risks which may cause a decline in value of each of the Fidelity Central Funds and thus a decline in the value of the investing fund.
Fidelity Central Fund | Investment Manager | Investment Objective | Investment Practices | Expense Ratio(a) |
Fidelity Money Market Central Funds | Fidelity Management & Research Company LLC (FMR) | Each fund seeks to obtain a high level of current income consistent with the preservation of capital and liquidity. | Short-term Investments | Less than .005% to .01% |
(a) Expenses expressed as a percentage of average net assets and are as of each underlying Central Fund's most recent annual or semi-annual shareholder report.
A complete unaudited list of holdings for each Fidelity Central Fund is available upon request or at the Securities and Exchange Commission website at www.sec.gov. In addition, the financial statements of the Fidelity Central Funds which contain the significant accounting policies (including investment valuation policies) of those funds, and are not covered by the Report of Independent Registered Public Accounting Firm, are available on the Securities and Exchange Commission website or upon request.
3. Significant Accounting Policies.
The Fund is an investment company and applies the accounting and reporting guidance of the Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic 946 Financial Services - Investment Companies. The financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (GAAP), which require management to make certain estimates and assumptions at the date of the financial statements. Actual results could differ from those estimates. Subsequent events, if any, through the date that the financial statements were issued have been evaluated in the preparation of the financial statements. The Fund's Schedule of Investments lists any underlying mutual funds or exchange-traded funds (ETFs) but does not include the underlying holdings of these funds. The following summarizes the significant accounting policies of the Fund:
Investment Valuation. Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund's valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee.
The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels as shown below:
- Level 1 – quoted prices in active markets for identical investments
- Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
- Level 3 – unobservable inputs (including the Fund's own assumptions based on the best information available)
Valuation techniques used to value the Fund's investments by major category are as follows:
Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.
Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy. Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. The aggregate value of investments by input level as of May 31, 2021 is included at the end of the Fund's Schedule of Investments.
Foreign Currency. Certain Funds may use foreign currency contracts to facilitate transactions in foreign-denominated securities. Gains and losses from these transactions may arise from changes in the value of the foreign currency or if the counterparties do not perform under the contracts' terms.
Foreign-denominated assets, including investment securities, and liabilities are translated into U.S. dollars at the exchange rates at period end. Purchases and sales of investment securities, income and dividends received, and expenses denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date.
The effects of exchange rate fluctuations on investments are included with the net realized and unrealized gain (loss) on investment securities. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.
Investment Transactions and Income. For financial reporting purposes, the Fund's investment holdings and NAV include trades executed through the end of the last business day of the period. The NAV per share for processing shareholder transactions is calculated as of the close of business of the New York Stock Exchange (NYSE), normally 4:00 p.m. Eastern time and includes trades executed through the end of the prior business day. Gains and losses on securities sold are determined on the basis of identified cost and include proceeds received from litigation. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities where the ex-dividend date may have passed, which are recorded as soon as the Fund is informed of the ex-dividend date. Non-cash dividends included in dividend income, if any, are recorded at the fair market value of the securities received. Income and capital gain distributions from Fidelity Central Funds, if any, are recorded on the ex-dividend date. Certain distributions received by the Fund represent a return of capital or capital gain. The Fund determines the components of these distributions subsequent to the ex-dividend date, based upon receipt of tax filings or other correspondence relating to the underlying investment. These distributions are recorded as a reduction of cost of investments and/or as a realized gain. Investment income is recorded net of foreign taxes withheld where recovery of such taxes is uncertain.
Expenses. Expenses directly attributable to a fund are charged to that fund. Expenses attributable to more than one fund are allocated among the respective funds on the basis of relative net assets or other appropriate methods. Expenses included in the accompanying financial statements reflect the expenses of that fund and do not include any expenses associated with any underlying mutual funds or exchange-traded funds. Although not included in a fund's expenses, a fund indirectly bears its proportionate share of these expenses through the net asset value of each underlying mutual fund or exchange-traded fund. Expense estimates are accrued in the period to which they relate and adjustments are made when actual amounts are known.
Income Tax Information and Distributions to Shareholders. Each year, the Fund intends to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code, including distributing substantially all of its taxable income and realized gains. As a result, no provision for U.S. Federal income taxes is required. The Fund files a U.S. federal tax return, in addition to state and local tax returns as required. The Fund's federal income tax returns are subject to examination by the Internal Revenue Service (IRS) for a period of three fiscal years after they are filed. State and local tax returns may be subject to examination for an additional fiscal year depending on the jurisdiction. Foreign taxes are provided for based on the Fund's understanding of the tax rules and rates that exist in the foreign markets in which it invests.
Distributions are declared and recorded on the ex-dividend date. Income and capital gain distributions are determined in accordance with income tax regulations, which may differ from GAAP.
Capital accounts within the financial statements are adjusted for permanent book-tax differences. These adjustments have no impact on net assets or the results of operations. Capital accounts are not adjusted for temporary book-tax differences which will reverse in a subsequent period.
Book-tax differences are primarily due to futures contracts, foreign currency transactions, passive foreign investment companies (PFIC), market discount, partnerships, capital loss carryforwards and losses deferred due to wash sales.
As of period end, the cost and unrealized appreciation (depreciation) in securities, and derivatives if applicable, for federal income tax purposes were as follows:
Gross unrealized appreciation | $7,110,493,898 |
Gross unrealized depreciation | (182,440,661) |
Net unrealized appreciation (depreciation) | $6,928,053,237 |
Tax cost | $5,693,865,652 |
Capital loss carryforwards are only available to offset future capital gains of the Fund to the extent provided by regulations and may be limited. The capital loss carryforward information presented below, including any applicable limitation, is estimated as of prior fiscal period end and is subject to adjustment.
No expiration | |
Long-term | $(25,939,687) |
Total capital loss carryforward | $(25,939,687) |
Restricted Securities (including Private Placements). Funds may invest in securities that are subject to legal or contractual restrictions on resale. These securities generally may be resold in transactions exempt from registration or to the public if the securities are registered. Disposal of these securities may involve time-consuming negotiations and expense, and prompt sale at an acceptable price may be difficult. Information regarding restricted securities held at period end is included at the end of the Schedule of Investments, if applicable.
4. Derivative Instruments.
Risk Exposures and the Use of Derivative Instruments. The Fund's investment objective allows the Fund to enter into various types of derivative contracts, including futures contracts. Derivatives are investments whose value is primarily derived from underlying assets, indices or reference rates and may be transacted on an exchange or over-the-counter (OTC). Derivatives may involve a future commitment to buy or sell a specified asset based on specified terms, to exchange future cash flows at periodic intervals based on a notional principal amount, or for one party to make one or more payments upon the occurrence of specified events in exchange for periodic payments from the other party.
The Fund used derivatives to increase returns and to manage exposure to certain risks as defined below. The success of any strategy involving derivatives depends on analysis of numerous economic factors, and if the strategies for investment do not work as intended, the Fund may not achieve its objectives.
The Fund's use of derivatives increased or decreased its exposure to the following risk:
Equity Risk | Equity risk relates to the fluctuations in the value of financial instruments as a result of changes in market prices (other than those arising from interest rate risk or foreign exchange risk), whether caused by factors specific to an individual investment, its issuer, or all factors affecting all instruments traded in a market or market segment. |
The Fund is also exposed to additional risks from investing in derivatives, such as liquidity risk and counterparty credit risk. Liquidity risk is the risk that the Fund will be unable to close out the derivative in the open market in a timely manner. Counterparty credit risk is the risk that the counterparty will not be able to fulfill its obligation to the Fund. Counterparty credit risk related to exchange-traded futures contracts may be mitigated by the protection provided by the exchange on which they trade.
Investing in derivatives may involve greater risks than investing in the underlying assets directly and, to varying degrees, may involve risk of loss in excess of any initial investment and collateral received and amounts recognized in the Statement of Assets and Liabilities. In addition, there may be the risk that the change in value of the derivative contract does not correspond to the change in value of the underlying instrument.
Futures Contracts. A futures contract is an agreement between two parties to buy or sell a specified underlying instrument for a fixed price at a specified future date. The Fund used futures contracts to manage its exposure to the stock market.
Upon entering into a futures contract, a fund is required to deposit either cash or securities (initial margin) with a clearing broker in an amount equal to a certain percentage of the face value of the contract. Futures contracts are marked-to-market daily and subsequent daily payments (variation margin) are made or received by a fund depending on the daily fluctuations in the value of the futures contracts and are recorded as unrealized appreciation or (depreciation). This receivable and/or payable, if any, is included in daily variation margin on futures contracts in the Statement of Assets and Liabilities. Realized gain or (loss) is recorded upon the expiration or closing of a futures contract. The net realized gain (loss) and change in net unrealized appreciation (depreciation) on futures contracts during the period is presented in the Statement of Operations.
Any open futures contracts at period end are presented in the Schedule of Investments under the caption "Futures Contracts". The notional amount at value reflects each contract's exposure to the underlying instrument or index at period end and is representative of volume of activity during the period. Cash deposited to meet initial margin requirements is presented as segregated cash with brokers for derivative instruments in the Statement of Assets and Liabilities.
5. Purchases and Sales of Investments.
Purchases and sales of securities, other than short-term securities, are noted in the table below.
Purchases ($) | Sales ($) | |
Fidelity Nasdaq Composite Index Fund | 1,170,066,132 | 492,795,514 |
6. Fees and Other Transactions with Affiliates.
Management Fee. Fidelity Management & Research Company LLC (the investment adviser) and its affiliates provide the Fund with investment management related services for which the Fund pays a monthly management fee that is based on an annual rate of .24% of the Fund's average net assets.
Sub-Adviser. Geode Capital Management, LLC (Geode), serves as sub-adviser for the Fund. Geode provides discretionary investment advisory services to the Fund and is paid by the investment adviser for providing these services.
Transfer Agent Fees. Fidelity Investments Institutional Operations Company LLC (FIIOC), an affiliate of the investment adviser, is the Fund's transfer, dividend disbursing and shareholder servicing agent. FIIOC receives an asset-based fee of .10% of the Fund's average net assets. FIIOC pays for typesetting, printing and mailing of shareholder reports, except proxy statements.
Accounting Fees. Fidelity Service Company, Inc. (FSC), an affiliate of the investment adviser, maintains the Fund's accounting records. The accounting fee is based on the level of average net assets for each month. For the period, the fees were equivalent to the following annualized rates:
% of Average Net Assets | |
Fidelity Nasdaq Composite Index Fund | –(a) |
(a) Amount represents less than .005%.
Interfund Trades. Funds may purchase from or sell securities to other Fidelity Funds under procedures adopted by the Board. The procedures have been designed to ensure these interfund trades are executed in accordance with Rule 17a-7 of the 1940 Act. Any interfund trades are included within the respective purchases and sales amounts shown in the Purchases and Sales of Investments note.
7. Committed Line of Credit.
Certain Funds participate with other funds managed by the investment adviser or an affiliate in a $4.25 billion credit facility (the "line of credit") to be utilized for temporary or emergency purposes to fund shareholder redemptions or for other short-term liquidity purposes. The participating funds have agreed to pay commitment fees on their pro-rata portion of the line of credit, which are reflected in Miscellaneous expenses on the Statement of Operations, and are listed below. During the period, there were no borrowings on this line of credit.
Amount | |
Fidelity Nasdaq Composite Index Fund | $10,810 |
8. Security Lending.
Funds lend portfolio securities from time to time in order to earn additional income. Lending agents are used, including National Financial Services (NFS), an affiliate of the investment adviser. Pursuant to a securities lending agreement, NFS will receive a fee, which is capped at 9.9% of a fund's daily lending revenue, for its services as lending agent. A fund may lend securities to certain qualified borrowers, including NFS. On the settlement date of the loan, a fund receives collateral (in the form of U.S. Treasury obligations, letters of credit and/or cash) against the loaned securities and maintains collateral in an amount not less than 100% of the market value of the loaned securities during the period of the loan. The market value of the loaned securities is determined at the close of business of a fund and any additional required collateral is delivered to a fund on the next business day. A fund or borrower may terminate the loan at any time, and if the borrower defaults on its obligation to return the securities loaned because of insolvency or other reasons, a fund may apply collateral received from the borrower against the obligation. A fund may experience delays and costs in recovering the securities loaned. Any cash collateral received is invested in the Fidelity Securities Lending Cash Central Fund. Any loaned securities are identified as such in the Schedule of Investments, and the value of loaned securities and cash collateral at period end, as applicable, are presented in the Statement of Assets and Liabilities. Security lending income represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities. Security lending income is presented in the Statement of Operations as a component of income from Fidelity Central Funds. Affiliated security lending activity, if any, was as follows:
Total Security Lending Fees Paid to NFS | Security Lending Income From Securities Loaned to NFS | Value of Securities Loaned to NFS at Period End | |
Fidelity Nasdaq Composite Index Fund | $702,032 | $80,000 | $4,007,736 |
9. Expense Reductions.
The investment adviser contractually agreed to reimburse the Fund to the extent annual operating expenses exceeded .29% of average net assets. This reimbursement will remain in place through March 31, 2022. Some expenses, for example the compensation of the independent Trustees, and certain miscellaneous expenses such as proxy and shareholder meeting expenses, are excluded from this reimbursement. During the period this reimbursement reduced the Fund's expenses by $3,260,320.
In addition, through arrangements with the Fund's custodian, credits realized as a result of certain uninvested cash balances were used to reduce the Fund's expenses by $347.
10. Other.
Fund's organizational documents provide former and current trustees and officers with a limited indemnification against liabilities arising in connection with the performance of their duties to the fund. In the normal course of business, the fund may also enter into contracts that provide general indemnifications. The fund's maximum exposure under these arrangements is unknown as this would be dependent on future claims that may be made against the fund. The risk of material loss from such claims is considered remote.
11. Coronavirus (COVID-19) Pandemic.
An outbreak of COVID-19 first detected in China during December 2019 has since spread globally and was declared a pandemic by the World Health Organization during March 2020. Developments that disrupt global economies and financial markets, such as the COVID-19 pandemic, may magnify factors that affect the Fund's performance.
Shareholder Expense Example
As a shareholder, you incur two types of costs: (1) transaction costs, which may include sales charges (loads) on purchase payments or redemption proceeds, as applicable and (2) ongoing costs, which generally include management fees, distribution and/or service (12b-1) fees and other Fund expenses. This Example is intended to help you understand your ongoing costs (in dollars) of investing in a fund and to compare these costs with the ongoing costs of investing in other mutual funds.
The Example is based on an investment of $1,000 invested at the beginning of the period and held for the entire period (December 1, 2020 to May 31, 2021).
Actual Expenses
The first line of the accompanying table provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000.00 (for example, an $8,600 account value divided by $1,000.00 = 8.6), then multiply the result by the number in the first line for a class/Fund under the heading entitled "Expenses Paid During Period" to estimate the expenses you paid on your account during this period. If any fund is a shareholder of any underlying mutual funds or exchange-traded funds (ETFs) (the Underlying Funds), such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses incurred presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.
Hypothetical Example for Comparison Purposes
The second line of the accompanying table provides information about hypothetical account values and hypothetical expenses based on the actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in the Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. If any fund is a shareholder of any Underlying Funds, such fund indirectly bears its proportional share of the expenses of the Underlying Funds in addition to the direct expenses as presented in the table. These fees and expenses are not included in the annualized expense ratio used to calculate the expense estimate in the table below.
Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transaction costs. Therefore, the second line of the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.
Annualized Expense Ratio-A | Beginning Account Value December 1, 2020 | Ending Account Value May 31, 2021 | Expenses Paid During Period-B December 1, 2020 to May 31, 2021 | |
Fidelity Nasdaq Composite Index Fund | .29% | |||
Actual | $1,000.00 | $1,130.40 | $1.54 | |
Hypothetical-C | $1,000.00 | $1,023.49 | $1.46 |
A Annualized expense ratio reflects expenses net of applicable fee waivers.
B Expenses are equal to the annualized expense ratio, multiplied by the average account value over the period, multiplied by 182/ 365 (to reflect the one-half year period). The fees and expenses of any Underlying Funds are not included in each annualized expense ratio.
C 5% return per year before expenses
Board Approval of Investment Advisory Contracts and Management Fees
Fidelity Nasdaq Composite Index Fund
Each year, the Board of Trustees, including a majority of the Independent Trustees (together, the Board), votes on the renewal of the management contract with Fidelity Management & Research Company LLC (FMR) and the sub-advisory agreement (Sub-Advisory Agreement) for the fund with Geode Capital Management, LLC (Geode) (together, the Advisory Contracts). FMR and Geode are referred to herein as the Investment Advisers. The Board, assisted by the advice of fund counsel and Independent Trustees' counsel, requests and considers a broad range of information relevant to the renewal of the Advisory Contracts throughout the year.The Board meets regularly and, at each of its meetings, covers an extensive agenda of topics and materials and considers factors that are relevant to its annual consideration of the renewal of the fund's Advisory Contracts, including the services and support provided to the fund and its shareholders. The Board has established various standing committees (Committees), each composed of and chaired by Independent Trustees with varying backgrounds, to which the Board has assigned specific subject matter responsibilities in order to enhance effective decision-making by the Board. The Board, acting directly and through its Committees, requests and receives information concerning the annual consideration of the renewal of the fund's Advisory Contracts. The Board also meets as needed to review matters specifically related to the Board's annual consideration of the renewal of the Advisory Contracts. Members of the Board may also meet with trustees of other Fidelity funds through joint ad hoc committees to discuss certain matters relevant to all of the Fidelity funds.At its January 2021 meeting, the Board of Trustees voted to continue the fund's management contract with FMR, and the sub-advisory agreements and sub-subadvisory agreements, in each case, where applicable, (together, the Advisory Contracts), without modification, for four months from February 1, 2021 through May 31, 2021, in connection with changes to the Board's meeting calendar. The Board considered that the approval of the fund's Advisory Contracts will not result in any changes in (i) the investment process or strategies employed in the management of the fund's assets; (ii) the fees and expenses paid by shareholders; (iii) the nature, extent or quality of services provided under the fund's Advisory Contracts; or (iv) the day-to-day management of the fund or the persons primarily responsible for such management. The Board also considered that since its last approval of the fund's Advisory Contracts, FMR had provided additional information on the fund in support of the annual contract renewal process, including competitive analyses on total expenses and management fees and in-depth reviews of fund performance and fund profitability information. The Board also considered the findings of certain ad hoc committees that had been previously formed to discuss matters relevant to all of the Fidelity funds, including economies of scale, fall-out benefits and retail vs. institutional funds. The Board concluded that the fund's Advisory Contracts are fair and reasonable, and that the fund's Advisory Contracts should be renewed, without modification, through May 31, 2021, with the understanding that the Board will consider the annual renewal for a full one year period in May 2021.At its May 2021 meeting, the Board of Trustees, including a majority of the Independent Trustees (together, the Board), determined to renew the fund's Advisory Contracts through November 30, 2021. In reaching its determination, the Board considered all factors it believed relevant, including (i) the nature, extent, and quality of the services provided to the fund and its shareholders (including the investment performance of the fund); (ii) the competitiveness of the fund's management fee and total expense ratio relative to peer funds; (iii) the total costs of the services provided by and the profits realized by Fidelity and Geode from their respective relationships with the fund; and (iv) the extent to which, if any, economies of scale exist and are realized as the fund grows, and whether any economies of scale are appropriately shared with fund shareholders. Certain Independent Trustees, currently engaged in a review in response to an individual shareholder's demand, abstained from the May 2021 vote.In considering whether to renew the Advisory Contracts for the fund, the Board reached a determination, with the assistance of fund counsel and Independent Trustees' counsel and through the exercise of its business judgment, that the renewal of the Advisory Contracts was in the best interests of the fund and its shareholders and that the compensation payable under the Advisory Contracts was fair and reasonable. The Board's decision to renew the Advisory Contracts was not based on any single factor, but rather was based on a comprehensive consideration of all the information provided to the Board at its meetings throughout the year. The Board, in reaching its determination to renew the Advisory Contracts, was aware that shareholders of the fund have a broad range of investment choices available to them, including a wide choice among funds offered by Fidelity's competitors, and that the fund's shareholders, who have the opportunity to review and weigh the disclosure provided by the fund in its prospectus and other public disclosures, have chosen to invest in this fund, which is part of the Fidelity family of funds.Nature, Extent, and Quality of Services Provided. The Board considered staffing as it relates to the fund, including the backgrounds of investment personnel of Fidelity and Geode, and also considered the fund's investment objective, strategies, and related investment philosophy. The Independent Trustees also had discussions with senior management of Fidelity's investment operations and investment groups and with senior management of Geode. The Board considered the structure of the investment personnel compensation programs and whether the structures provide appropriate incentives to act in the best interests of the fund. Additionally, the Board considered the portfolio managers' investments, if any, in the funds that they manage.The Trustees also discussed with representatives of Fidelity, at meetings throughout the year, Fidelity's role in, among other things, overseeing compliance with federal securities laws and other applicable requirements by Geode with respect to the fund and monitoring and overseeing the performance and investment capabilities of Geode. The Trustees considered that the Board had received from Fidelity periodic reports about its oversight and due diligence processes, as well as periodic reports regarding the performance of Geode.The Board also considered the nature, extent and quality of services provided by Geode. The Trustees noted that under the Sub-Advisory Agreement, subject to oversight by Fidelity, Geode is responsible for, among other things, identifying investments and arranging for execution of portfolio transactions to implement the fund's investment strategy. In addition, the Trustees noted that Geode is responsible for providing such reporting as may be requested by Fidelity to fulfill its oversight responsibilities discussed above.Resources Dedicated to Investment Management and Support Services. The Board and the Fund Oversight and Research Committees reviewed the general qualifications and capabilities of Fidelity's and Geode's investment staffs, including their size, education, experience, and resources, as well as Fidelity's and Geode's approach to recruiting, training, managing, and compensating investment personnel. The Board considered that Fidelity's and Geode's investment professionals have extensive resources, tools and capabilities so as to provide competitive investment results over time, and that those professionals also have access to sophisticated tools that permit them to assess portfolio construction and risk and performance attribution characteristics continuously. Additionally, in its deliberations, the Board considered Fidelity's and Geode's trading, risk management, compliance, and technology and operations capabilities and resources, which are integral parts of the investment management process. The Board also considered Fidelity's and Geode's investments in business continuity planning, and their success in continuously providing services to the fund notwithstanding the severe disruptions caused by the COVID-19 pandemic.Shareholder and Administrative Services. The Board considered (i) the nature, extent, quality, and cost of advisory, administrative, and shareholder services performed by the Investment Advisers and their affiliates under the Advisory Contracts and by FMR's affiliates under separate agreements covering transfer agency, pricing and bookkeeping, and securities lending services for the fund; (ii) the nature and extent of the supervision of third party service providers, principally custodians, subcustodians, and pricing vendors; and (iii) the resources devoted to, and the record of compliance with, the fund's compliance policies and procedures. The Board also reviewed the allocation of fund brokerage, including allocations to brokers affiliated with the Investment Advisers.The Board noted that the growth of fund assets over time across the complex allows Fidelity to reinvest in the development of services designed to enhance the value and convenience of the Fidelity funds as investment vehicles. These services include 24-hour access to account information and market information over the Internet and through telephone representatives, investor education materials and asset allocation tools, and the expanded availability of Fidelity Investor Centers.The Board noted that, in the past, it and the boards of certain other Fidelity funds had formed an ad hoc Committee on Transfer Agency Fees to review the variety of transfer agency fee structures throughout the industry and Fidelity's competitive positioning with respect to industry participants.Investment in a Large Fund Family. The Board considered the benefits to shareholders of investing in a Fidelity fund, including the benefits of investing in a fund that is part of a large family of funds offering a variety of investment disciplines and providing a large variety of mutual fund investor services. The Board noted that Fidelity had taken, or had made recommendations that resulted in the Fidelity funds taking, a number of actions over the previous year that benefited particular funds, including: (i) continuing to dedicate additional resources to Fidelity's investment research process, which includes meetings with management of issuers of securities in which the funds invest, and to the support of the senior management team that oversees asset management; (ii) continuing efforts to enhance Fidelity's global research capabilities; (iii) launching new funds and ETFs with innovative structures, strategies and pricing and making other enhancements to meet client needs; (iv) launching new share classes of existing funds; (v) eliminating purchase minimums and broadening eligibility requirements for certain funds and share classes; (vi) approving the reduction in the holding period for the Class C to Class A conversion policy; (vii) reducing management fees and total expenses for certain target date funds and classes and index funds; (viii) lowering expenses for certain existing funds and classes by implementing or lowering expense caps; (ix) rationalizing product lines and gaining increased efficiencies from fund mergers, liquidations, and share class consolidations; (x) continuing to develop, acquire and implement systems and technology to improve services to the funds and shareholders, strengthen information security, and increase efficiency; and (xi) continuing to implement enhancements to further strengthen Fidelity's product line to increase investors' probability of success in achieving their investment goals, including retirement income goals.Investment Performance. The Board considered whether the fund has operated in accordance with its investment objective, as well as its record of compliance with its investment restrictions and its performance history.The Board took into account discussions that occur at Board meetings throughout the year with representatives of the Investment Advisers about fund investment performance. In this regard the Board noted that as part of regularly scheduled fund reviews and other reports to the Board on fund performance, the Board considers annualized return information for the fund for different time periods, measured against the securities market index the fund seeks to track. The Board also periodically considers the fund's tracking error versus its benchmark index. In its evaluation of fund investment performance, the Board gave particular attention to information indicating changes in performance of certain Fidelity funds for specific time periods and discussed with the Investment Advisers the reasons for any overperformance or underperformance.In addition to reviewing absolute and relative fund performance, the Independent Trustees periodically consider the appropriateness of fund performance metrics in evaluating the results achieved. In general, the Independent Trustees believe that an index fund's performance should be evaluated based on net performance (after fees and expenses) of both the highest performing and lowest performing fund share classes, where applicable, compared to a fund's benchmark index, over appropriate time periods taking into account relevant factors including the following: general market conditions; the characteristics of the fund's benchmark index; the extent to which statistical sampling is employed; any securities lending revenues; and fund cash flows and other factors.The Independent Trustees recognize that shareholders evaluate performance on a net basis over their own holding periods, for which one-, three-, and five-year periods are often used as a proxy. For this reason, the performance information reviewed by the Board also included net cumulative total return information for the fund and its benchmark index for the most recent one-, three-, and five-year periods ended September 30, 2020, as shown below. A peer group is not shown below because the fund does not generally utilize a peer group for performance comparison purposes.Fidelity Nasdaq Composite Index Fund
Fidelity Nasdaq Composite Index Fund
Liquidity Risk Management Program
The Securities and Exchange Commission adopted Rule 22e-4 under the Investment Company Act of 1940 (the Liquidity Rule) to promote effective liquidity risk management throughout the open-end investment company industry, thereby reducing the risk that funds will be unable to meet their redemption obligations and mitigating dilution of the interests of fund shareholders.
The Fund has adopted and implemented a liquidity risk management program pursuant to the Liquidity Rule (the Program) effective December 1, 2018. The Program is reasonably designed to assess and manage the Fund’s liquidity risk and to comply with the requirements of the Liquidity Rule. The Fund’s Board of Trustees (the Board) has designated the Fund’s investment adviser as administrator of the Program. The Fidelity advisers have established a Liquidity Risk Management Committee (the LRM Committee) to manage the Program for each of the Fidelity Funds. The LRM Committee monitors the adequacy and effectiveness of implementation of the Program and on a periodic basis assesses each Fund’s liquidity risk based on a variety of factors including (1) the Fund’s investment strategy, (2) portfolio liquidity and cash flow projections during normal and reasonably foreseeable stressed conditions, (3) shareholder redemptions, (4) borrowings and other funding sources and (5) in the case of exchange-traded funds, certain additional factors including the effect of the Fund’s prices and spreads, market participants, and basket compositions on the overall liquidity of the Fund’s portfolio, as applicable.
In accordance with the Program, each of the Fund’s portfolio investments is classified into one of four liquidity categories described below based on a determination of a reasonable expectation for how long it would take to convert the investment to cash (or sell or dispose of the investment) without significantly changing its market value.
- Highly liquid investments – cash or convertible to cash within three business days or less
- Moderately liquid investments – convertible to cash in three to seven calendar days
- Less liquid investments – can be sold or disposed of, but not settled, within seven calendar days
- Illiquid investments – cannot be sold or disposed of within seven calendar days
Liquidity classification determinations take into account a variety of factors including various market, trading and investment-specific considerations, as well as market depth, and generally utilize analysis from a third-party liquidity metrics service.
The Liquidity Rule places a 15% limit on a fund’s illiquid investments and requires funds that do not primarily hold assets that are highly liquid investments to determine and maintain a minimum percentage of the fund’s net assets to be invested in highly liquid investments (highly liquid investment minimum or HLIM). The Program includes provisions reasonably designed to comply with the 15% limit on illiquid investments and for determining, periodically reviewing and complying with the HLIM requirement as applicable.
At a recent meeting of the Fund’s Board of Trustees, the LRM Committee provided a written report to the Board pertaining to the operation, adequacy, and effectiveness of implementation of the Program for the annual period from December 1, 2019 through November 30, 2020. The report concluded that the Program has been implemented and is operating effectively and is reasonably designed to assess and manage the Fund’s liquidity risk.
EIF-SANN-0721
1.795567.117
Item 2.
Code of Ethics
Not applicable.
Item 3.
Audit Committee Financial Expert
Not applicable.
Item 4.
Principal Accountant Fees and Services
Not applicable.
Item 5.
Audit Committee of Listed Registrants
Not applicable.
Item 6.
Investments
(a)
Not applicable.
(b)
Not applicable
Item 7.
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies
Not applicable.
Item 8.
Portfolio Managers of Closed-End Management Investment Companies
Not applicable.
Item 9.
Purchase of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers
Not applicable.
Item 10.
Submission of Matters to a Vote of Security Holders
There were no material changes to the procedures by which shareholders may recommend nominees to the Fidelity Concord Street Trust’s Board of Trustees.
Item 11.
Controls and Procedures
(a)(i) The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Concord Street Trust’s (the “Trust”) disclosure controls and procedures (as
defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.
(a)(ii) There was no change in the Trust’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the Trust’s internal control over financial reporting.
Item 12.
Disclosure of Securities Lending Activities for Closed-End Management
Investment Companies
Not applicable.
Item 13.
Exhibits
(a) | (1) | Not applicable. |
(a) | (2) | |
(a) | (3) | Not applicable. |
(b) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Fidelity Concord Street Trust
By: | /s/Stacie M. Smith |
Stacie M. Smith | |
President and Treasurer | |
Date: | July 22, 2021 |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
By: | /s/Stacie M. Smith |
Stacie M. Smith | |
President and Treasurer | |
Date: | July 22, 2021 |
By: | /s/John J. Burke III |
John J. Burke III | |
Chief Financial Officer | |
Date: | July 22, 2021 |